data_1yp8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1yp8 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.41 ' C ' ' H ' ' A' ' 3' ' ' GLU . 64.6 m . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 120.814 0.34 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.71 48.27 2.91 Favored Glycine 0 C--O 1.229 -0.175 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 21.5 mm-40 -80.44 -176.05 5.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.743 -0.729 . . . . 0.0 112.801 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 65.9 m -150.6 63.15 0.94 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.481 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.4 p -72.85 57.03 0.43 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.236 0.541 . . . . 0.0 110.368 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -57.52 -40.36 78.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.808 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.1 mt -80.95 -49.33 11.11 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.814 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.09 -39.72 0.46 Allowed Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 p -86.97 142.5 27.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.269 -0.465 . . . . 0.0 110.86 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.4 m -100.04 162.42 12.99 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -89.56 -50.8 5.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.693 0.282 . . . . 0.0 111.151 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.6 m -64.93 118.7 9.46 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.337 0.589 . . . . 0.0 111.61 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -59.95 133.06 55.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.232 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.01 -27.29 20.66 Favored Glycine 0 N--CA 1.44 -1.08 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.506 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.5 m -83.19 112.89 20.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.897 0.38 . . . . 0.0 109.993 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.6 m -102.19 130.06 48.74 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.011 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 24.4 t -62.79 104.88 0.58 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.222 0.534 . . . . 0.0 110.705 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.47 154.82 49.44 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-O 119.196 -0.78 . . . . 0.0 111.194 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.549 ' C ' ' H ' ' A' ' 21' ' ' LYS . 41.5 tt0 -40.31 -42.77 1.6 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.127 0.971 . . . . 0.0 112.873 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.693 ' CD1' ' HB2' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -73.86 25.73 0.07 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.088 0.47 . . . . 0.0 111.304 179.083 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.549 ' H ' ' C ' ' A' ' 19' ' ' GLU . 39.9 tttp 52.17 44.8 29.34 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.579 1.151 . . . . 0.0 111.757 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.693 ' HB2' ' CD1' ' A' ' 20' ' ' TRP . 98.0 mt -139.59 119.25 13.16 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.328 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 16' ' ' SER . 31.9 m -70.96 127.6 33.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.195 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -116.64 127.43 54.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.698 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -75.56 130.51 11.23 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.224 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -133.47 64.53 1.61 Allowed 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -95.45 124.35 39.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.518 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.5 34.81 77.14 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.094 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.98 -0.35 72.91 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.665 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 26' ' ' THR . 7.9 m -89.21 121.13 31.22 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 50.7 mt -102.0 131.37 50.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.54 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.52 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 12.6 p90 -156.7 142.31 17.65 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.039 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.7 t0 . . . . . 0 C--N 1.324 -0.533 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.498 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 39.0 m . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.78 61.76 1.26 Allowed Glycine 0 CA--C 1.517 0.206 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.446 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -146.39 173.29 12.4 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.419 0.628 . . . . 0.0 111.576 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.9 p -150.13 135.41 18.03 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.392 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.56 ' SG ' ' HG3' ' A' ' 21' ' ' LYS . 28.8 p -74.61 61.55 0.97 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.089 0.471 . . . . 0.0 111.803 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.604 ' HD1' ' HG ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -65.4 -35.61 81.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.022 179.138 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.604 ' HG ' ' HD1' ' A' ' 6' ' ' PHE . 90.4 mt -99.24 39.03 1.32 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.205 0.526 . . . . 0.0 110.065 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.87 -49.78 3.52 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.292 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 m -123.57 148.47 46.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.867 0.333 . . . . 0.0 111.114 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.4 m -75.35 164.05 26.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.659 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -88.38 -48.11 7.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.45 0.167 . . . . 0.0 111.336 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.7 m -65.1 116.06 6.1 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.285 0.564 . . . . 0.0 111.042 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -59.77 132.01 52.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.108 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.493 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 101.98 -28.16 17.19 Favored Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.512 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 60.3 m -81.3 112.01 18.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.147 0.499 . . . . 0.0 110.118 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m -98.95 137.92 36.81 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.354 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.8 t -72.32 140.07 48.31 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.895 0.379 . . . . 0.0 110.802 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.44 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -144.51 -156.26 6.75 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -43.24 139.52 1.87 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 4.5 t90 60.06 24.36 13.58 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.343 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.56 ' HG3' ' SG ' ' A' ' 5' ' ' CYS . 22.2 ttmm 58.45 37.4 25.68 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.312 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.7 mt -94.84 127.84 41.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.417 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.3 m -88.06 130.84 34.88 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.44 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 3.0 p90 -133.83 128.76 35.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.185 0.517 . . . . 0.0 110.403 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -70.75 140.06 31.04 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.963 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 30' ' ' THR . 6.7 m -138.56 64.71 1.48 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.494 HD21 ' HZ ' ' A' ' 32' ' ' PHE . 72.9 m-20 -98.46 126.01 43.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.562 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.31 35.71 79.89 Favored Glycine 0 C--O 1.228 -0.228 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.365 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.3 2.79 74.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.735 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 26' ' ' THR . 10.0 m -94.11 122.98 37.18 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 120.681 0.277 . . . . 0.0 110.411 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.62 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 4.5 mp -102.73 131.42 50.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.201 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.578 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 11.6 p90 -151.05 137.55 18.67 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.046 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.9 t70 . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.245 -178.715 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.55 57.83 2.5 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.233 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -138.2 167.74 21.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.655 0.74 . . . . 0.0 111.91 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t -143.8 132.98 23.03 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.185 -1.37 . . . . 0.0 107.583 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.442 ' SG ' ' HG3' ' A' ' 21' ' ' LYS . 28.8 p -73.4 60.87 0.64 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.332 0.587 . . . . 0.0 111.527 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -66.6 -39.7 88.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.6 mt -93.59 38.47 1.06 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.21 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.62 -50.24 3.2 Favored Glycine 0 CA--C 1.52 0.373 0 CA-C-N 115.835 -0.62 . . . . 0.0 113.087 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 m -125.99 149.16 49.01 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.681 -0.305 . . . . 0.0 110.956 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.6 m -74.05 159.33 32.82 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -88.98 -38.73 14.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.432 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 7.2 m -67.5 122.25 17.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.24 0.543 . . . . 0.0 111.393 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -60.41 127.82 33.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.728 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.09 -26.98 22.14 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.509 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.506 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.9 m -79.69 114.8 18.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.197 0.522 . . . . 0.0 110.205 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.7 m -108.6 138.11 45.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.935 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 5' ' ' CYS . 5.9 t -66.68 134.3 51.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.999 0.428 . . . . 0.0 111.085 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -143.3 -155.45 6.43 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.487 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 26.1 tp10 -42.12 137.7 1.82 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 12.4 t90 65.68 20.33 11.53 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.906 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.442 ' HG3' ' SG ' ' A' ' 5' ' ' CYS . 15.0 ttmm 56.0 37.78 29.23 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.969 0.89 . . . . 0.0 109.144 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.4 tp -102.67 136.88 41.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.166 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 61.3 m -87.21 127.66 35.15 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.903 0.383 . . . . 0.0 111.256 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -118.77 128.5 54.54 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -77.64 131.2 10.86 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.835 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.0 t -134.97 67.91 1.48 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 122.045 0.926 . . . . 0.0 109.104 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -89.13 110.6 21.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.3 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.25 36.65 91.39 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.325 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.25 -7.17 72.94 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.101 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 26' ' ' THR . 9.0 m -84.91 122.36 29.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.132 0.466 . . . . 0.0 109.863 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 5.4 tp -96.55 142.85 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.097 0.475 . . . . 0.0 110.715 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.614 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 23.5 p90 -162.08 132.79 4.97 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.4 t70 . . . . . 0 C--N 1.321 -0.665 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.311 -178.426 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.464 ' C ' ' H ' ' A' ' 3' ' ' GLU . 17.8 m . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.34 42.24 1.91 Allowed Glycine 0 CA--C 1.517 0.215 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 21.2 mm-40 -90.85 171.46 9.3 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 123.713 0.805 . . . . 0.0 111.647 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.0 m -152.07 119.16 5.86 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.76 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.4 p -78.24 48.94 0.78 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.978 0.418 . . . . 0.0 111.502 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.604 ' HD1' ' HG ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -65.56 -32.1 73.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.723 179.34 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.604 ' HG ' ' HD1' ' A' ' 6' ' ' PHE . 96.2 mt -99.19 39.0 1.32 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.129 0.49 . . . . 0.0 109.953 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.99 -41.47 2.61 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.838 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.3 m -136.2 150.04 48.83 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.55 -0.382 . . . . 0.0 110.63 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.4 m -69.25 160.8 30.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.704 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -87.65 -45.5 10.35 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.249 -0.18 . . . . 0.0 111.418 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.8 m -66.18 113.43 4.53 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.435 0.636 . . . . 0.0 110.595 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -59.38 133.14 55.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.432 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.45 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 101.06 -29.47 12.44 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -178.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.497 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 60.8 m -82.48 113.98 20.59 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 15.8 m -103.24 129.02 50.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.295 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.7 t -63.01 130.54 45.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.875 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -137.2 -153.8 6.49 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.901 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -43.41 139.65 1.94 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 3.4 t90 58.1 27.91 15.63 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.805 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' ' 21' ' ' LYS . 11.9 ttpt 60.2 34.99 21.03 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.231 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.8 mt -101.58 117.32 34.67 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.289 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.64 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 58.2 m -82.38 127.11 32.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -117.13 129.54 56.04 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.894 0.378 . . . . 0.0 110.521 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.657 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -75.8 135.41 17.95 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.514 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 30' ' ' THR . 1.2 t -144.21 65.22 1.3 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 122.193 0.997 . . . . 0.0 109.098 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -92.17 120.15 32.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.223 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.31 34.52 74.7 Favored Glycine 0 C--O 1.228 -0.229 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.252 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.15 -6.8 74.12 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.979 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.559 ' O ' ' HA ' ' A' ' 26' ' ' THR . 7.0 m -84.59 115.87 22.86 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.25 0.525 . . . . 0.0 109.908 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.657 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 62.7 mt -100.41 133.6 42.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.206 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.585 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 8.6 p90 -154.95 140.77 18.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.018 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 C--N 1.323 -0.563 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.125 -179.088 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.16 58.88 1.48 Allowed Glycine 0 C--O 1.229 -0.165 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.929 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -144.73 161.72 38.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.513 0.673 . . . . 0.0 111.344 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.5 m -135.84 129.7 32.79 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.29 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 25.0 p -69.61 65.98 0.21 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -66.85 -38.55 86.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.4 ' HA ' HD22 ' A' ' 7' ' ' LEU . 95.3 mt -99.11 45.67 0.99 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.359 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.11 -46.94 3.06 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.264 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -136.91 161.09 36.96 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 96.4 m -85.77 177.68 7.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.484 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -88.55 -43.35 11.46 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.439 HG21 ' SG ' ' A' ' 15' ' ' CYS . 33.2 m -64.36 110.29 2.21 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.423 0.63 . . . . 0.0 110.634 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.479 ' HB2' ' HZ2' ' A' ' 13' ' ' LYS . 4.4 ttmp? -64.58 123.17 18.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.193 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.423 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 117.58 -29.64 6.55 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.439 ' SG ' HG21 ' A' ' 12' ' ' THR . 64.2 m -82.23 111.66 18.53 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.219 -0.49 . . . . 0.0 109.863 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 16.1 m -102.12 133.49 46.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.4 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.8 t -67.85 131.42 45.49 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.301 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.22 -140.77 3.22 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-O 119.251 -0.749 . . . . 0.0 111.878 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.467 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 27.7 tp10 -37.08 133.97 0.59 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.642 0.777 . . . . 0.0 112.988 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 42.5 m0 62.94 20.14 12.05 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.553 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.4 tttm 57.72 38.0 27.38 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.748 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.3 mt -113.0 139.82 48.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.298 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 17' ' ' CYS . 68.7 m -83.99 131.6 34.82 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.391 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -128.24 133.79 48.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.812 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.596 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -70.52 146.09 41.59 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.723 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 30' ' ' THR . 16.9 m -139.92 62.04 1.52 Allowed 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -89.73 116.0 27.51 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.612 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.46 35.39 79.53 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.843 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.99 -4.11 77.08 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.689 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 26' ' ' THR . 16.2 m -84.74 122.4 29.06 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.038 0.419 . . . . 0.0 110.196 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 37.3 mm -98.0 133.59 39.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.311 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.596 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 17.9 p90 -155.34 137.36 14.6 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.7 t70 . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.456 -178.844 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.405 ' C ' ' H ' ' A' ' 3' ' ' GLU . 59.1 m . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.57 48.75 2.28 Favored Glycine 0 N--CA 1.459 0.209 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 23.5 mm-40 -85.42 174.21 9.7 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.7 0.762 . . . . 0.0 112.854 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.2 m -150.24 74.97 1.22 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.733 -1.122 . . . . 0.0 109.519 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 p -71.25 54.01 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.18 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.651 ' HD1' ' HG ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -65.33 -27.7 68.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.027 0.441 . . . . 0.0 109.996 178.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.651 ' HG ' ' HD1' ' A' ' 6' ' ' PHE . 97.0 mt -95.9 27.13 3.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.71 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.12 -43.07 2.19 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.913 -0.585 . . . . 0.0 113.323 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -99.53 148.91 23.78 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.182 0.515 . . . . 0.0 111.431 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 9.5 m -90.74 158.73 16.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.403 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -88.13 -42.91 12.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.968 0.413 . . . . 0.0 110.347 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.0 m -73.96 105.96 5.44 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.278 0.561 . . . . 0.0 109.941 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -60.35 129.84 43.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.374 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.475 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 111.97 -28.6 9.17 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 -178.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.519 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 61.0 m -86.94 116.03 24.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 16.1 m -91.76 127.99 37.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.338 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.574 ' HB2' ' SG ' ' A' ' 10' ' ' CYS . 50.5 t -66.53 115.62 6.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.211 0.529 . . . . 0.0 111.821 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.93 149.45 22.26 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.444 ' C ' ' H ' ' A' ' 21' ' ' LYS . 85.3 tt0 -40.33 -44.08 1.87 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.882 0.873 . . . . 0.0 113.067 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -75.6 32.69 0.11 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.449 ' HE3' ' HB3' ' A' ' 21' ' ' LYS . 12.6 ttpp 51.82 49.31 21.04 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.013 0.525 . . . . 0.0 110.262 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.2 tp -141.56 111.09 6.46 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.157 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.584 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 42.7 m -79.68 132.57 36.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.69 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -125.89 128.05 46.98 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.145 0.497 . . . . 0.0 110.257 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.649 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -68.7 141.3 36.37 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.59 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 30' ' ' THR . 6.2 m -140.73 64.72 1.42 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.708 0.766 . . . . 0.0 109.056 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.501 HD21 ' HZ ' ' A' ' 32' ' ' PHE . 72.7 m-20 -95.55 122.78 38.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.318 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.76 34.43 77.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.991 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.58 -2.65 71.81 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.754 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 26' ' ' THR . 10.5 m -87.25 121.59 29.91 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 122.556 -0.379 . . . . 0.0 110.168 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.649 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 62.0 mt -102.1 132.17 48.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.591 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.584 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 10.8 p90 -151.9 140.87 21.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.172 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.9 t70 . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.551 -178.971 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.93 62.19 1.3 Allowed Glycine 0 CA--C 1.518 0.221 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.842 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -146.69 -178.67 6.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.409 0.623 . . . . 0.0 111.425 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.3 m -150.71 119.16 6.43 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.087 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.416 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 1.3 p -73.61 60.83 0.69 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.253 0.549 . . . . 0.0 110.831 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -57.26 -41.37 79.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.745 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 pp -97.58 28.17 3.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.623 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.33 -41.18 2.24 Favored Glycine 0 CA--C 1.518 0.239 0 CA-C-N 115.681 -0.69 . . . . 0.0 113.165 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 m -101.7 144.87 29.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.852 0.358 . . . . 0.0 111.097 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.416 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 30.3 m -96.61 164.16 12.72 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -88.74 -48.62 7.38 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.122 -0.231 . . . . 0.0 111.285 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.0 m -66.17 116.48 7.29 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.437 0.637 . . . . 0.0 110.921 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.498 ' HD2' ' N ' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -62.48 132.8 53.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.354 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.485 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 105.51 -30.4 9.91 Favored Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -178.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.518 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 49.9 m -82.56 115.4 21.52 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m -105.24 139.73 39.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.812 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.9 t -62.6 128.36 35.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.347 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -143.03 -159.57 8.0 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.865 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.535 ' HG2' ' CD1' ' A' ' 20' ' ' TRP . 36.4 tt0 -42.63 140.74 1.2 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.611 0.764 . . . . 0.0 112.639 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.535 ' CD1' ' HG2' ' A' ' 19' ' ' GLU . 41.1 m0 64.57 18.67 11.5 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.226 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.0 tptm 58.56 37.09 25.49 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.67 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.7 mt -103.63 139.75 38.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.387 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.2 m -84.8 125.34 32.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.298 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -123.1 123.65 41.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.871 0.367 . . . . 0.0 111.193 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.532 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -73.23 130.6 13.84 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.716 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.694 HG23 HG13 ' A' ' 31' ' ' ILE . 1.1 m -129.74 68.3 1.44 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.501 0.667 . . . . 0.0 109.225 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.49 HD21 ' HZ ' ' A' ' 32' ' ' PHE . 75.2 m-20 -98.7 127.56 44.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.877 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.9 36.33 79.82 Favored Glycine 0 C--O 1.228 -0.239 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.233 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.89 4.65 72.36 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.611 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 26' ' ' THR . 12.3 m -95.75 123.71 39.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.694 HG13 HG23 ' A' ' 26' ' ' THR . 4.8 mp -102.37 129.59 53.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.149 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.532 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 13.6 p90 -150.33 138.98 20.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.122 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.4 t0 . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.538 -179.015 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.51 54.21 1.98 Allowed Glycine 0 C--N 1.324 -0.135 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.426 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.666 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 97.0 mt-10 -139.26 152.3 47.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.416 0.627 . . . . 0.0 110.899 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.545 ' HB3' ' HE3' ' A' ' 21' ' ' LYS . 30.4 m -130.03 135.34 48.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.035 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 22.7 p -74.1 55.07 0.56 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.258 0.551 . . . . 0.0 111.635 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -64.1 -36.55 84.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.724 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 25.0 tp -98.8 41.47 1.14 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.857 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.07 -42.1 2.49 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.913 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 10' ' ' CYS . 22.6 m -142.47 152.37 42.66 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.666 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 94.7 m -77.77 -157.27 0.1 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.02 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -117.35 -44.68 2.76 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.424 HG21 ' SG ' ' A' ' 15' ' ' CYS . 86.9 m -68.11 110.54 4.02 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.389 0.614 . . . . 0.0 110.681 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -62.73 122.92 17.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.248 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.86 -27.12 7.64 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 61.2 m -82.46 113.67 20.37 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 16.9 m -98.64 131.51 44.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.329 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 2.8 t -67.83 139.32 56.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.853 0.359 . . . . 0.0 111.025 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.423 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -152.41 -149.07 5.02 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-O 119.496 -0.614 . . . . 0.0 111.7 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.465 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 28.5 tp10 -39.6 135.46 1.15 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.541 0.736 . . . . 0.0 112.756 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 43.1 m0 64.51 19.54 11.84 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.851 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.545 ' HE3' ' HB3' ' A' ' 4' ' ' SER . 34.6 ttpt 59.73 38.21 21.81 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.592 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.9 mt -108.33 134.08 51.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.406 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 32.6 m -87.39 131.74 34.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.213 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.423 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 2.7 p90 -124.14 128.82 49.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.084 0.469 . . . . 0.0 109.883 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.625 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -71.65 142.29 33.43 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.858 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.9 t -143.81 63.77 1.34 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 122.17 0.986 . . . . 0.0 109.115 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -89.35 114.8 26.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.297 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.7 33.14 71.34 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.178 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.05 -8.93 76.64 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.653 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 26' ' ' THR . 3.5 m -80.32 116.24 20.29 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 63.3 mt -98.47 131.62 45.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.771 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.598 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 12.6 p90 -153.18 136.56 15.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.015 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 50.3 t0 . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.808 -178.903 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 54.5 m . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.16 56.17 1.88 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.462 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -141.76 158.84 43.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.6 0.714 . . . . 0.0 111.515 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.4 m -136.99 134.98 37.22 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.496 -1.229 . . . . 0.0 107.817 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.5 p -72.55 56.41 0.38 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.198 0.523 . . . . 0.0 111.769 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -66.51 -39.28 88.58 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 7' ' ' LEU . 3.2 mm? -90.99 39.91 1.01 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.998 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.11 -51.92 3.27 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.121 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 10' ' ' CYS . 9.1 m -127.05 152.27 47.49 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 122.73 -0.276 . . . . 0.0 110.862 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.416 ' N ' HG22 ' A' ' 9' ' ' THR . 7.7 m -71.2 159.8 34.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.122 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -90.4 -45.27 9.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.622 0.249 . . . . 0.0 111.302 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.404 HG21 ' SG ' ' A' ' 15' ' ' CYS . 88.3 m -70.71 112.35 6.86 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.304 0.573 . . . . 0.0 110.844 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -58.91 131.98 52.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.598 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.441 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 105.87 -27.59 17.04 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.509 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.1 m -86.73 117.43 25.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m -106.0 135.24 47.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.441 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 t -68.42 139.23 55.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.829 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.468 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -152.41 -154.21 6.58 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-O 119.576 -0.569 . . . . 0.0 111.704 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.459 ' O ' ' HG ' ' A' ' 22' ' ' LEU . 36.9 tt0 -39.06 138.53 0.57 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.567 0.747 . . . . 0.0 112.564 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.436 ' HB3' HD21 ' A' ' 22' ' ' LEU . 9.0 t90 65.62 15.49 10.07 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.071 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.9 tttp 58.84 38.76 24.54 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.527 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 19' ' ' GLU . 4.3 pp -107.97 144.38 35.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.809 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 61.5 m -92.47 127.98 38.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.921 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.468 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 1.9 p90 -119.54 128.85 54.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.092 0.472 . . . . 0.0 110.36 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 15' ' ' CYS . . . -80.93 141.75 22.77 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.669 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 30' ' ' THR . 48.2 m -148.85 104.97 3.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.132 0.491 . . . . 0.0 110.437 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -150.38 147.03 27.08 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.75 33.03 76.02 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.008 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.41 27.02 72.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.396 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 26' ' ' THR . 17.7 m -125.08 132.32 53.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.685 0.278 . . . . 0.0 110.397 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.48 HG12 HG23 ' A' ' 26' ' ' THR . 58.9 mt -112.24 133.87 56.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.889 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -152.81 140.89 20.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.395 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.9 t70 . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.489 -179.162 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.85 53.96 1.7 Allowed Glycine 0 C--O 1.23 -0.136 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.709 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.604 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 53.8 mt-10 -140.71 155.24 46.51 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.157 0.503 . . . . 0.0 110.818 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 p -127.3 135.47 50.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.746 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.566 ' SG ' ' HG3' ' A' ' 21' ' ' LYS . 26.5 p -71.25 94.6 1.2 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -67.22 -34.37 77.34 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.5 mt -114.85 -129.79 0.3 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.451 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.35 -36.73 92.05 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.821 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.0 t -162.8 -172.52 3.12 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.604 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 96.7 m -86.77 -176.71 5.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.764 0.316 . . . . 0.0 111.491 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -90.96 -36.12 14.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.109 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.667 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -61.31 116.57 4.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.223 0.535 . . . . 0.0 111.087 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -61.41 132.32 53.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.993 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.487 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 95.9 -24.43 29.81 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.578 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.667 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 59.2 m -81.38 113.1 19.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.19 0.519 . . . . 0.0 110.481 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.4 m -102.11 136.56 41.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.729 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.1 t -68.84 142.57 54.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.962 0.411 . . . . 0.0 111.213 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.428 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -146.35 -158.74 7.89 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.486 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -44.47 141.72 1.84 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 62.47 20.73 12.13 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.037 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.566 ' HG3' ' SG ' ' A' ' 5' ' ' CYS . 21.3 ttmm 58.86 37.94 24.68 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.953 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.41 127.83 49.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.141 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 64.4 m -89.14 134.63 33.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.137 0.494 . . . . 0.0 111.572 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.428 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 1.4 p90 -125.58 129.42 49.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.015 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -81.5 143.46 23.65 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.86 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 30' ' ' THR . 8.5 m -141.27 66.23 1.37 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.769 0.795 . . . . 0.0 108.981 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -89.52 120.02 30.47 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.385 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.86 36.25 72.03 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.086 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.5 -4.68 71.92 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.962 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.526 ' O ' ' HA ' ' A' ' 26' ' ' THR . 7.5 m -86.28 119.21 26.31 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 117.113 0.457 . . . . 0.0 110.263 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 56.8 mt -98.05 132.55 42.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.511 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.525 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 12.2 p90 -153.34 142.53 21.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.222 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.3 t70 . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.994 -179.311 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 82.9 m . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.34 57.23 2.41 Favored Glycine 0 C--N 1.323 -0.144 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.784 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -137.01 -178.13 5.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.515 0.674 . . . . 0.0 111.152 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.6 m -151.44 127.68 10.55 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.157 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 p -75.12 55.96 0.76 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.225 0.536 . . . . 0.0 111.293 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -64.9 -30.37 71.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.201 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.5 tp -103.6 37.76 1.95 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.243 0.544 . . . . 0.0 109.859 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.61 -40.44 2.03 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.087 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -130.19 157.19 43.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.995 0.426 . . . . 0.0 111.087 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.5 m -83.3 165.2 19.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.635 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -89.77 -46.69 8.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.793 0.33 . . . . 0.0 111.065 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.6 m -66.36 118.42 10.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.342 0.591 . . . . 0.0 110.943 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.568 ' HD3' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -58.04 134.03 56.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.664 0.745 . . . . 0.0 111.72 -179.236 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.56 -27.55 19.62 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.531 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.541 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 55.8 m -77.81 111.49 13.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.447 0.641 . . . . 0.0 110.149 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -90.41 138.22 31.72 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.774 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.5 t -60.3 124.62 20.86 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.359 0.599 . . . . 0.0 111.433 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.31 147.36 20.73 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.413 ' C ' ' H ' ' A' ' 21' ' ' LYS . 85.6 tt0 -43.68 -46.29 7.36 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.093 0.557 . . . . 0.0 112.352 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 20.7 m-90 -78.57 37.09 0.27 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.579 0.228 . . . . 0.0 111.473 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' A' ' 19' ' ' GLU . 79.8 tttt 55.47 37.61 29.12 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.331 0.652 . . . . 0.0 111.015 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.2 mt -106.95 -161.01 0.76 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.893 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 93.2 m -151.27 126.66 10.02 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -127.89 117.11 21.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.127 0.489 . . . . 0.0 111.202 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.549 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -68.22 127.13 23.79 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.758 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -122.89 67.79 0.97 Allowed 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.306 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -88.89 113.47 24.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.702 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.67 38.51 88.22 Favored Glycine 0 C--O 1.228 -0.258 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.485 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.91 -3.98 77.35 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.104 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 26' ' ' THR . 13.6 m -87.71 124.91 34.06 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 117.124 0.462 . . . . 0.0 109.846 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 66.6 mt -102.16 128.23 54.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.042 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.549 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 17.7 p90 -150.06 135.97 18.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.422 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.8 t0 . . . . . 0 C--N 1.324 -0.535 0 CA-C-O 120.758 0.314 . . . . 0.0 110.573 -178.662 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 80.9 m . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.31 63.18 0.79 Allowed Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.0 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -147.75 -178.45 6.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.514 0.673 . . . . 0.0 111.229 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.536 ' HB2' ' HE2' ' A' ' 21' ' ' LYS . 35.7 p -151.56 124.46 8.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.159 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.66 59.54 0.65 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.095 0.474 . . . . 0.0 111.688 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -62.63 -36.57 83.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.744 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.2 tp -97.78 35.89 1.62 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.844 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.93 -45.25 2.2 Favored Glycine 0 CA--C 1.52 0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.251 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 t -116.64 153.12 32.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.91 0.386 . . . . 0.0 111.237 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.7 m -89.96 166.04 13.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.264 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -89.12 -47.44 8.09 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.489 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.5 m -62.08 115.6 4.23 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.471 0.653 . . . . 0.0 110.624 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -63.49 127.03 29.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.369 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.54 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 110.89 -27.94 10.45 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -178.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.533 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 58.0 m -83.88 115.45 22.28 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.3 m -102.32 141.01 35.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.908 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.65 147.49 47.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.353 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.497 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -168.19 -149.58 6.19 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.944 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -35.23 131.92 0.41 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.283 1.033 . . . . 0.0 113.361 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 58.28 24.27 11.34 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.734 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.557 ' NZ ' ' HB3' ' A' ' 21' ' ' LYS . 1.2 ttpm? 59.16 44.92 15.13 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.6 mt -107.81 148.72 29.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.109 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.1 m -98.64 127.68 44.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.71 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.497 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 3.0 p90 -129.83 123.7 31.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.331 0.586 . . . . 0.0 110.759 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.54 ' HA2' ' O ' ' A' ' 14' ' ' GLY . . . -80.16 141.81 23.55 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.487 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 30' ' ' THR . 24.0 m -130.16 112.65 13.6 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.973 0.415 . . . . 0.0 110.024 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -143.98 134.94 25.37 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.83 35.61 87.22 Favored Glycine 0 C--O 1.229 -0.212 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.068 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.1 22.95 71.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.391 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 26' ' ' THR . 19.3 m -120.2 131.9 55.16 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.6 mt -106.54 130.66 57.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.137 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -142.1 139.68 32.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.315 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.5 t70 . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.469 -178.825 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.57 54.97 2.04 Favored Glycine 0 C--O 1.229 -0.177 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.473 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -140.58 159.46 42.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.639 0.733 . . . . 0.0 111.355 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.4 t -140.91 137.62 33.28 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.7 p -70.03 64.29 0.23 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.09 0.471 . . . . 0.0 111.942 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -71.01 -32.27 69.01 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.6 tp -103.4 38.46 1.78 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.354 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.12 -48.11 3.0 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.985 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.2 m -122.6 150.53 42.51 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 122.714 -0.286 . . . . 0.0 110.901 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.8 m -74.01 165.11 25.72 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.828 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -89.07 -43.45 11.07 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 120.669 0.271 . . . . 0.0 110.698 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.8 m -74.16 109.69 7.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.568 0.699 . . . . 0.0 110.321 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.94 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -66.03 119.26 11.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.889 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.434 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 124.13 -29.1 5.18 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -177.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.488 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 61.3 m -87.71 114.96 24.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.056 -0.572 . . . . 0.0 109.798 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 20.4 m -97.28 134.27 40.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.175 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 3.9 t -70.26 110.87 5.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.114 0.483 . . . . 0.0 110.382 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.455 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -82.26 159.77 39.48 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.783 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.525 ' C ' ' H ' ' A' ' 21' ' ' LYS . 9.2 tp10 -34.99 -47.34 0.36 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.978 1.311 . . . . 0.0 113.732 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 7.6 t90 -75.87 29.08 0.11 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.352 0.596 . . . . 0.0 110.965 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.525 ' H ' ' C ' ' A' ' 19' ' ' GLU . 40.5 tttm 50.49 41.05 24.66 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.184 0.994 . . . . 0.0 111.444 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.8 mt -129.21 121.49 27.76 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.187 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 17' ' ' CYS . 49.8 m -74.31 129.93 38.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.614 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.455 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 2.7 p90 -133.13 133.53 43.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.051 0.453 . . . . 0.0 110.058 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.604 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -71.25 148.81 44.71 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.725 -0.67 . . . . 0.0 113.359 -178.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 30' ' ' THR . 9.1 m -147.28 60.3 1.17 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.136 0.97 . . . . 0.0 108.485 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -90.08 120.73 31.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.878 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.19 36.5 75.54 Favored Glycine 0 C--O 1.228 -0.278 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.261 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.46 1.34 86.17 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.851 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 26' ' ' THR . 11.4 m -92.86 120.91 33.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.975 0.387 . . . . 0.0 110.127 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.604 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 4.5 mp -99.81 132.96 44.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.264 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.587 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 14.0 p90 -151.98 137.32 17.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.984 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.1 t0 . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.982 -178.878 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 37.7 m . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.92 60.7 1.34 Allowed Glycine 0 N--CA 1.454 -0.158 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.53 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -148.04 168.72 21.62 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.652 0.739 . . . . 0.0 111.745 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.5 t -149.68 141.23 23.43 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.694 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.0 p -69.77 64.5 0.21 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.967 0.413 . . . . 0.0 111.618 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -74.98 -31.4 61.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.93 0.395 . . . . 0.0 110.159 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 25.9 tp -103.89 45.59 0.95 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.509 0.671 . . . . 0.0 109.374 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.98 -47.38 3.33 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.516 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -137.48 164.17 29.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.627 0.251 . . . . 0.0 110.581 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.3 m -78.79 158.69 28.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.559 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -88.47 -46.53 9.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.413 0.149 . . . . 0.0 111.279 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.7 m -64.06 113.82 3.75 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.275 0.56 . . . . 0.0 110.765 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -61.1 130.9 48.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.676 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.518 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 105.36 -31.47 8.47 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.496 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 62.4 m -83.3 117.16 22.79 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.8 m -109.56 136.79 48.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.508 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.9 t -68.5 134.17 49.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.957 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.48 -145.6 4.16 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.352 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.478 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 26.6 tp10 -39.01 136.24 0.81 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 8.2 t90 62.53 21.53 12.7 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.137 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.8 tttm 56.76 39.37 29.68 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.886 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.62 137.74 47.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.39 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 17' ' ' CYS . 86.3 m -85.88 129.06 34.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.514 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -135.03 135.34 41.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.036 0.446 . . . . 0.0 110.459 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.639 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -70.59 148.54 45.37 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.754 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 30' ' ' THR . 3.3 t -145.59 62.35 1.27 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.307 1.051 . . . . 0.0 109.368 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -89.22 115.96 27.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.585 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.17 35.57 78.23 Favored Glycine 0 C--O 1.227 -0.302 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.157 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.1 -5.43 76.53 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.858 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 26' ' ' THR . 10.2 m -85.2 118.3 24.67 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 117.045 0.422 . . . . 0.0 109.937 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.639 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 64.3 mt -99.4 132.4 44.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.713 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.627 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 10.8 p90 -149.09 136.57 20.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.865 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.6 t70 . . . . . 0 C--N 1.322 -0.591 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.406 -178.464 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 62.5 m . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.34 52.18 2.61 Favored Glycine 0 C--O 1.228 -0.267 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 177.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 32.8 mm-40 -114.35 160.9 18.59 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.71 -0.745 . . . . 0.0 111.965 -177.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.2 m -151.72 118.65 5.82 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.927 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.3 p -73.59 67.93 1.15 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.068 0.461 . . . . 0.0 111.904 -178.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -58.52 -40.85 84.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.044 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.453 HD11 ' O ' ' A' ' 9' ' ' THR . 1.4 pp -109.22 38.37 2.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.847 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.18 -44.39 2.63 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.865 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.453 ' O ' HD11 ' A' ' 7' ' ' LEU . 9.8 m -101.11 144.62 29.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.66 0.267 . . . . 0.0 110.922 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.4 m -85.06 163.67 18.69 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -87.84 -43.25 11.96 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.623 0.249 . . . . 0.0 110.617 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.409 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 53.1 m -72.71 100.81 2.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.145 0.497 . . . . 0.0 110.037 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.461 ' HE3' ' HB3' ' A' ' 13' ' ' LYS . 12.2 ttpp -60.83 106.32 0.56 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.255 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.477 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 137.44 -21.94 3.23 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.505 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 59.4 m -97.74 122.02 40.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.509 -0.846 . . . . 0.0 110.002 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.6 m -103.83 131.04 51.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.673 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 2.5 t -61.53 135.02 57.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.176 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.23 -144.72 3.98 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.108 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -38.3 133.96 0.9 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.717 0.807 . . . . 0.0 112.962 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 61.12 23.79 13.95 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.165 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.0 tttp 58.56 35.59 24.66 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.907 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' A' ' 22' ' ' LEU . 97.9 mt -109.87 132.52 54.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.741 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.621 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 30.4 m -84.38 133.23 34.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.778 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -120.53 133.68 55.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.098 0.475 . . . . 0.0 110.314 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 15' ' ' CYS . . . -75.06 139.28 24.82 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.431 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 30' ' ' THR . 5.5 m -124.1 72.08 1.15 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.387 0.613 . . . . 0.0 109.795 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -89.06 116.48 27.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.023 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.08 34.32 72.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.265 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.44 -3.08 86.06 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.685 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 26' ' ' THR . 7.1 m -88.15 124.2 33.57 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.769 0.284 . . . . 0.0 110.256 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 4.2 mp -97.12 127.92 48.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.596 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.503 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 17.3 p90 -143.78 140.98 30.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.674 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.4 t70 . . . . . 0 C--N 1.321 -0.631 0 CA-C-O 121.072 0.463 . . . . 0.0 112.025 -178.386 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 81.2 m . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.05 58.8 1.43 Allowed Glycine 0 CA--C 1.517 0.19 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.743 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -141.27 -176.73 4.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.468 0.652 . . . . 0.0 110.878 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 m -151.15 124.81 9.03 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.491 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.2 p -77.32 54.59 1.13 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.958 0.408 . . . . 0.0 111.593 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.627 ' HD1' ' HG ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -62.39 -33.25 74.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.294 179.214 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.627 ' HG ' ' HD1' ' A' ' 6' ' ' PHE . 99.0 mt -96.13 32.08 2.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.91 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.25 -47.69 3.23 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.802 -0.635 . . . . 0.0 113.336 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.1 p -114.29 149.22 36.27 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 122.545 -0.385 . . . . 0.0 112.014 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.5 m -79.78 163.47 24.42 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -89.94 -48.43 7.23 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.911 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.3 m -64.84 117.38 7.45 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.43 0.633 . . . . 0.0 110.669 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -62.51 128.23 35.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.4 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.566 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 110.8 -27.67 10.84 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -178.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.569 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.6 m -80.55 116.32 20.53 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.7 m -94.64 137.84 33.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.221 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 22' ' ' LEU . 12.1 t -76.92 122.23 24.56 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.193 0.521 . . . . 0.0 111.866 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 20' ' ' TRP . . . -91.76 144.86 17.4 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.442 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 3.5 tp10 -69.95 42.46 0.05 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.505 1.145 . . . . 0.0 113.158 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.504 ' H ' ' C ' ' A' ' 18' ' ' GLY . 96.6 m95 -133.08 12.72 4.27 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 175.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 0.6 OUTLIER 62.51 39.55 11.6 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 111.865 -2.425 . . . . 0.0 109.272 -178.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 17' ' ' CYS . 90.1 mt -116.11 178.71 4.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.48 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 93.9 m -141.75 127.53 19.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.466 0.174 . . . . 0.0 110.63 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -133.36 122.71 24.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.292 0.567 . . . . 0.0 110.835 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' A' ' 15' ' ' CYS . . . -77.63 150.04 35.84 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.458 -0.792 . . . . 0.0 113.343 -179.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 30' ' ' THR . 6.6 t -132.21 123.29 26.72 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.349 0.595 . . . . 0.0 109.762 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -150.56 129.18 12.27 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.68 35.27 85.49 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.168 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.89 23.44 74.26 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.476 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 26' ' ' THR . 23.6 m -118.3 132.09 56.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 31' ' ' ILE . 46.8 mm -103.38 130.93 52.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.431 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -144.71 129.96 18.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.88 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.9 t70 . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.361 -178.519 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.58 55.16 2.05 Favored Glycine 0 C--N 1.321 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.984 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.529 ' OE2' ' HB2' ' A' ' 11' ' ' TYR . 57.7 mt-10 -135.17 154.42 51.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.192 0.52 . . . . 0.0 111.109 -178.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 t -137.85 132.91 33.26 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.655 ' SG ' ' HE2' ' A' ' 21' ' ' LYS . 8.5 p -69.27 85.56 0.39 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.228 0.537 . . . . 0.0 111.808 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -67.55 -34.62 77.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.483 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.417 HD11 ' O ' ' A' ' 7' ' ' LEU . 0.9 OUTLIER -120.55 39.77 3.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.714 179.384 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.86 -40.66 2.3 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.791 -0.64 . . . . 0.0 113.187 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.2 m -102.02 148.89 24.83 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.678 -0.307 . . . . 0.0 111.074 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 35.0 m -85.22 -155.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.529 ' HB2' ' OE2' ' A' ' 3' ' ' GLU . 16.9 m-85 -127.69 -49.71 1.37 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.453 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.418 HG23 ' SG ' ' A' ' 15' ' ' CYS . 98.6 m -72.32 121.93 20.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.196 0.522 . . . . 0.0 110.538 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -61.21 127.77 33.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.766 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.495 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 106.61 -29.23 11.23 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -178.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.505 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 59.2 m -81.59 120.76 25.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.916 0.389 . . . . 0.0 110.15 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.4 m -112.54 132.33 55.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.214 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 3.8 t -65.7 137.47 57.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.759 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -160.28 -148.88 5.4 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.661 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.502 ' O ' ' HG ' ' A' ' 22' ' ' LEU . 5.8 tp10 -40.81 143.0 0.4 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.889 0.876 . . . . 0.0 113.125 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.718 ' HB3' HD22 ' A' ' 22' ' ' LEU . 12.9 t-105 66.52 17.61 10.67 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.071 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.655 ' HE2' ' SG ' ' A' ' 5' ' ' CYS . 0.2 OUTLIER 56.64 45.18 22.56 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.171 179.406 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.718 HD22 ' HB3' ' A' ' 20' ' ' TRP . 4.6 pp -133.42 151.24 51.79 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.649 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 17' ' ' CYS . 78.8 m -89.5 131.11 35.7 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.026 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -128.96 133.51 47.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.038 0.447 . . . . 0.0 110.034 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.735 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -69.85 142.32 36.26 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.45 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.8 t -150.46 62.86 0.95 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.841 0.829 . . . . 0.0 110.084 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.482 ' OD1' ' HB ' ' A' ' 30' ' ' THR . 15.2 p-10 -89.9 112.98 24.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.589 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.99 34.06 65.06 Favored Glycine 0 C--O 1.227 -0.3 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.664 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.88 -14.54 65.15 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.06 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 26' ' ' THR . 2.3 m -75.15 114.42 13.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.292 0.546 . . . . 0.0 109.793 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 30.9 mm -102.71 135.31 40.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.141 -179.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.735 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 7.2 p90 -158.5 137.47 11.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.895 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.69 -178.855 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.457 ' C ' ' H ' ' A' ' 3' ' ' GLU . 53.3 m . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.11 46.0 2.37 Favored Glycine 0 C--O 1.229 -0.204 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.635 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 40.3 mm-40 -111.62 159.72 17.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.654 -0.773 . . . . 0.0 111.488 -178.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.1 t -151.01 131.93 14.2 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.76 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.44 ' SG ' ' HD2' ' A' ' 21' ' ' LYS . 22.9 p -79.07 51.8 1.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.044 0.449 . . . . 0.0 111.391 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -66.63 -32.94 74.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.923 0.392 . . . . 0.0 110.065 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.408 HD22 ' HH ' ' A' ' 11' ' ' TYR . 26.2 tp -100.02 40.17 1.27 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.423 0.63 . . . . 0.0 109.583 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.52 -43.02 2.68 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.026 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.4 m -138.06 149.06 45.66 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.416 -0.461 . . . . 0.0 110.845 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.6 m -68.88 159.38 32.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.894 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.408 ' HH ' HD22 ' A' ' 7' ' ' LEU . 3.0 m-85 -88.01 -42.7 12.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.63 0.252 . . . . 0.0 111.288 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.492 HG23 ' SG ' ' A' ' 15' ' ' CYS . 71.2 m -71.93 106.54 4.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.366 0.603 . . . . 0.0 110.833 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.14 127.38 31.65 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.468 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.502 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 110.9 -28.29 10.05 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.636 -0.985 . . . . 0.0 110.636 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.514 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 62.7 m -85.59 119.03 25.48 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.6 m -102.84 132.01 49.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.597 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 4.0 t -63.09 140.75 58.9 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.074 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.46 -154.0 6.5 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.196 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -43.24 142.84 0.95 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.418 0.687 . . . . 0.0 112.755 -178.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 17.9 t-105 62.56 20.4 11.95 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.121 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.44 ' HD2' ' SG ' ' A' ' 5' ' ' CYS . 3.3 tppp? 57.84 38.85 27.26 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.499 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.1 tp -113.18 131.59 55.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.952 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.635 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 32.0 m -88.79 138.15 31.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.206 0.527 . . . . 0.0 111.451 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -132.38 134.24 44.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.82 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.751 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -67.56 142.67 40.96 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.743 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 30' ' ' THR . 3.2 t -150.82 62.47 0.93 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.813 0.816 . . . . 0.0 110.346 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.407 ' OD1' ' HB ' ' A' ' 30' ' ' THR . 15.1 p-10 -89.83 113.64 25.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.213 0.53 . . . . 0.0 110.728 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.9 34.71 61.88 Favored Glycine 0 C--O 1.227 -0.286 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.804 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.13 -14.54 65.06 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.047 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.576 ' O ' ' HA ' ' A' ' 26' ' ' THR . 2.3 m -75.22 113.39 12.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.266 0.533 . . . . 0.0 109.733 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.61 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 28.9 mm -103.05 135.58 39.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.201 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.751 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 6.9 p90 -159.63 138.29 10.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.949 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.44 -179.069 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 57.4 m . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 121.2 0.524 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.03 61.22 1.75 Allowed Glycine 0 C--O 1.23 -0.13 0 CA-C-N 115.031 -0.986 . . . . 0.0 113.125 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.454 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 13.2 mt-10 -139.58 -172.07 3.28 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.87 0.367 . . . . 0.0 110.496 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t -150.81 115.21 5.13 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.649 179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 p -79.34 55.94 2.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.343 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.851 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 25.1 t80 -56.5 -40.74 75.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.404 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 54.7 tp -76.86 -49.27 16.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.549 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.24 -38.51 0.16 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.3 m -141.37 143.46 33.99 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.454 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 83.0 m -76.76 -176.79 4.0 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 123.256 0.347 . . . . 0.0 111.013 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -89.12 -40.16 13.11 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.437 HG21 ' SG ' ' A' ' 15' ' ' CYS . 40.4 m -62.19 111.64 2.05 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.324 0.583 . . . . 0.0 110.854 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -64.86 118.42 9.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.627 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.66 -28.84 5.82 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.532 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 61.3 m -80.03 114.1 18.69 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.3 m -101.08 136.55 40.75 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.794 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.6 t -67.61 133.82 50.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.081 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.89 -154.12 6.49 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.478 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -41.69 140.58 0.95 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.549 0.74 . . . . 0.0 112.681 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 11.0 t90 66.71 16.12 10.3 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.135 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.851 ' HE3' ' HA ' ' A' ' 6' ' ' PHE . 56.9 tttp 57.32 41.43 26.6 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.833 0.825 . . . . 0.0 109.04 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.7 tp -116.52 145.0 43.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.647 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.532 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 87.4 m -92.49 131.85 37.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.178 0.514 . . . . 0.0 111.615 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -121.47 127.9 51.55 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.675 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -70.3 142.18 35.28 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.152 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.2 t -148.61 60.02 1.08 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 122.584 1.183 . . . . 0.0 108.257 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -89.14 110.85 21.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.294 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.28 34.16 87.15 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.002 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.74 -11.36 68.94 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.764 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 26' ' ' THR . 2.3 m -78.83 114.88 18.13 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.977 0.388 . . . . 0.0 110.002 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 60.5 mt -100.22 132.99 44.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.64 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.565 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 8.0 p90 -158.78 142.02 14.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.323 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.8 t70 . . . . . 0 C--N 1.323 -0.569 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.442 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 57.2 m . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.07 58.27 2.28 Favored Glycine 0 C--O 1.228 -0.259 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 2.5 mm-40 -106.21 179.3 4.31 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.6 m -150.02 83.15 1.38 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.836 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.557 ' O ' ' HE2' ' A' ' 21' ' ' LYS . 1.9 p -72.87 56.57 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.883 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -58.53 -34.23 70.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.814 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.5 tp -95.83 24.19 5.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.279 0.561 . . . . 0.0 110.174 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.96 -39.44 2.23 Favored Glycine 0 C--O 1.228 -0.278 0 CA-C-N 116.002 -0.544 . . . . 0.0 113.192 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 t -96.05 147.51 23.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.05 0.452 . . . . 0.0 111.249 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 20.5 m -99.18 156.47 16.95 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -89.51 -39.51 13.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.994 0.426 . . . . 0.0 110.271 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 m -71.55 111.38 6.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.599 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.493 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -61.04 134.45 57.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.544 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.507 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 102.31 -31.02 9.19 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -178.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.512 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.7 m -86.39 119.3 26.51 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m -107.65 136.03 48.09 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.954 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.9 t -66.25 136.12 55.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.027 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.474 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -155.91 -145.57 4.22 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.598 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -40.1 135.0 1.45 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.429 0.691 . . . . 0.0 112.837 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 18.1 t-105 62.54 21.69 12.81 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.142 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.557 ' HE2' ' O ' ' A' ' 5' ' ' CYS . 70.0 tttt 54.91 43.6 29.67 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.245 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.4 tp -113.83 137.5 51.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.997 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.573 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 59.7 m -85.05 126.31 33.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.988 0.423 . . . . 0.0 111.28 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.474 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 1.6 p90 -124.24 130.04 51.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.231 0.538 . . . . 0.0 110.091 178.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.621 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -72.32 143.2 33.96 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.948 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 30' ' ' THR . 11.2 m -138.2 66.2 1.45 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.628 0.728 . . . . 0.0 109.088 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -89.01 115.8 26.84 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.33 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.43 35.33 71.57 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.934 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.94 -5.18 77.2 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.787 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 26' ' ' THR . 14.0 m -84.19 123.13 29.77 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 117.066 0.433 . . . . 0.0 110.135 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 39.4 mm -95.33 133.07 37.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.61 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.621 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 23.0 p90 -152.37 135.26 15.55 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 50.1 t0 . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.098 -178.725 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.41 ' C ' ' H ' ' A' ' 3' ' ' GLU . 64.6 m . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 120.814 0.34 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.71 48.27 2.91 Favored Glycine 0 C--O 1.229 -0.175 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 21.5 mm-40 -80.44 -176.05 5.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.743 -0.729 . . . . 0.0 112.801 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 65.9 m -150.6 63.15 0.94 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.481 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.4 p -72.85 57.03 0.43 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.236 0.541 . . . . 0.0 110.368 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -57.52 -40.36 78.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.808 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.1 mt -80.95 -49.33 11.11 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.814 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.09 -39.72 0.46 Allowed Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 p -86.97 142.5 27.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.269 -0.465 . . . . 0.0 110.86 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.4 m -100.04 162.42 12.99 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -89.56 -50.8 5.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.693 0.282 . . . . 0.0 111.151 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.6 m -64.93 118.7 9.46 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.337 0.589 . . . . 0.0 111.61 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -59.95 133.06 55.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.232 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.01 -27.29 20.66 Favored Glycine 0 N--CA 1.44 -1.08 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.506 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.5 m -83.19 112.89 20.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.897 0.38 . . . . 0.0 109.993 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.6 m -102.19 130.06 48.74 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.011 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 24.4 t -62.79 104.88 0.58 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.222 0.534 . . . . 0.0 110.705 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.47 154.82 49.44 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-O 119.196 -0.78 . . . . 0.0 111.194 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.549 ' C ' ' H ' ' A' ' 21' ' ' LYS . 41.5 tt0 -40.31 -42.77 1.6 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.127 0.971 . . . . 0.0 112.873 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.693 ' CD1' ' HB2' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -73.86 25.73 0.07 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.088 0.47 . . . . 0.0 111.304 179.083 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.549 ' H ' ' C ' ' A' ' 19' ' ' GLU . 39.9 tttp 52.17 44.8 29.34 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.579 1.151 . . . . 0.0 111.757 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.693 ' HB2' ' CD1' ' A' ' 20' ' ' TRP . 98.0 mt -139.59 119.25 13.16 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.328 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 16' ' ' SER . 31.9 m -70.96 127.6 33.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.195 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -116.64 127.43 54.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.698 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -75.56 130.51 11.23 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.224 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -133.47 64.53 1.61 Allowed 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -95.45 124.35 39.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.518 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.5 34.81 77.14 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.094 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.98 -0.35 72.91 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.665 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 26' ' ' THR . 7.9 m -89.21 121.13 31.22 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 50.7 mt -102.0 131.37 50.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.54 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.52 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 12.6 p90 -156.7 142.31 17.65 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.039 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.7 t0 . . . . . 0 C--N 1.324 -0.533 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.498 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 39.0 m . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.78 61.76 1.26 Allowed Glycine 0 CA--C 1.517 0.206 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.446 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -146.39 173.29 12.4 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.419 0.628 . . . . 0.0 111.576 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.9 p -150.13 135.41 18.03 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.392 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.56 ' SG ' ' HG3' ' A' ' 21' ' ' LYS . 28.8 p -74.61 61.55 0.97 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.089 0.471 . . . . 0.0 111.803 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.604 ' HD1' ' HG ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -65.4 -35.61 81.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.022 179.138 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.604 ' HG ' ' HD1' ' A' ' 6' ' ' PHE . 90.4 mt -99.24 39.03 1.32 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.205 0.526 . . . . 0.0 110.065 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.87 -49.78 3.52 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.292 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 m -123.57 148.47 46.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.867 0.333 . . . . 0.0 111.114 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.4 m -75.35 164.05 26.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.659 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -88.38 -48.11 7.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.45 0.167 . . . . 0.0 111.336 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.7 m -65.1 116.06 6.1 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.285 0.564 . . . . 0.0 111.042 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -59.77 132.01 52.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.108 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.493 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 101.98 -28.16 17.19 Favored Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.512 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 60.3 m -81.3 112.01 18.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.147 0.499 . . . . 0.0 110.118 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m -98.95 137.92 36.81 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.354 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.8 t -72.32 140.07 48.31 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.895 0.379 . . . . 0.0 110.802 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.44 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -144.51 -156.26 6.75 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -43.24 139.52 1.87 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 4.5 t90 60.06 24.36 13.58 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.343 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.56 ' HG3' ' SG ' ' A' ' 5' ' ' CYS . 22.2 ttmm 58.45 37.4 25.68 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.312 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.7 mt -94.84 127.84 41.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.417 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.3 m -88.06 130.84 34.88 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.44 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 3.0 p90 -133.83 128.76 35.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.185 0.517 . . . . 0.0 110.403 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -70.75 140.06 31.04 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.963 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 30' ' ' THR . 6.7 m -138.56 64.71 1.48 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.494 HD21 ' HZ ' ' A' ' 32' ' ' PHE . 72.9 m-20 -98.46 126.01 43.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.562 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.31 35.71 79.89 Favored Glycine 0 C--O 1.228 -0.228 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.365 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.3 2.79 74.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.735 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 26' ' ' THR . 10.0 m -94.11 122.98 37.18 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 120.681 0.277 . . . . 0.0 110.411 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.62 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 4.5 mp -102.73 131.42 50.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.201 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.578 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 11.6 p90 -151.05 137.55 18.67 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.046 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.9 t70 . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.245 -178.715 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.55 57.83 2.5 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.233 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -138.2 167.74 21.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.655 0.74 . . . . 0.0 111.91 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t -143.8 132.98 23.03 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.185 -1.37 . . . . 0.0 107.583 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.442 ' SG ' ' HG3' ' A' ' 21' ' ' LYS . 28.8 p -73.4 60.87 0.64 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.332 0.587 . . . . 0.0 111.527 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -66.6 -39.7 88.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.6 mt -93.59 38.47 1.06 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.21 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.62 -50.24 3.2 Favored Glycine 0 CA--C 1.52 0.373 0 CA-C-N 115.835 -0.62 . . . . 0.0 113.087 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 m -125.99 149.16 49.01 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.681 -0.305 . . . . 0.0 110.956 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.6 m -74.05 159.33 32.82 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -88.98 -38.73 14.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.432 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 7.2 m -67.5 122.25 17.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.24 0.543 . . . . 0.0 111.393 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -60.41 127.82 33.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.728 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.09 -26.98 22.14 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.509 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.506 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.9 m -79.69 114.8 18.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.197 0.522 . . . . 0.0 110.205 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.7 m -108.6 138.11 45.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.935 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 5' ' ' CYS . 5.9 t -66.68 134.3 51.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.999 0.428 . . . . 0.0 111.085 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -143.3 -155.45 6.43 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.487 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 26.1 tp10 -42.12 137.7 1.82 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 12.4 t90 65.68 20.33 11.53 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.906 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.442 ' HG3' ' SG ' ' A' ' 5' ' ' CYS . 15.0 ttmm 56.0 37.78 29.23 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.969 0.89 . . . . 0.0 109.144 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.4 tp -102.67 136.88 41.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.166 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 61.3 m -87.21 127.66 35.15 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.903 0.383 . . . . 0.0 111.256 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -118.77 128.5 54.54 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -77.64 131.2 10.86 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.835 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.0 t -134.97 67.91 1.48 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 122.045 0.926 . . . . 0.0 109.104 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -89.13 110.6 21.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.3 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.25 36.65 91.39 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.325 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.25 -7.17 72.94 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.101 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 26' ' ' THR . 9.0 m -84.91 122.36 29.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.132 0.466 . . . . 0.0 109.863 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 5.4 tp -96.55 142.85 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.097 0.475 . . . . 0.0 110.715 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.614 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 23.5 p90 -162.08 132.79 4.97 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.4 t70 . . . . . 0 C--N 1.321 -0.665 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.311 -178.426 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.464 ' C ' ' H ' ' A' ' 3' ' ' GLU . 17.8 m . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.34 42.24 1.91 Allowed Glycine 0 CA--C 1.517 0.215 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 21.2 mm-40 -90.85 171.46 9.3 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 123.713 0.805 . . . . 0.0 111.647 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.0 m -152.07 119.16 5.86 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.76 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.4 p -78.24 48.94 0.78 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.978 0.418 . . . . 0.0 111.502 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.604 ' HD1' ' HG ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -65.56 -32.1 73.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.723 179.34 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.604 ' HG ' ' HD1' ' A' ' 6' ' ' PHE . 96.2 mt -99.19 39.0 1.32 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.129 0.49 . . . . 0.0 109.953 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.99 -41.47 2.61 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.838 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.3 m -136.2 150.04 48.83 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.55 -0.382 . . . . 0.0 110.63 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.4 m -69.25 160.8 30.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.704 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -87.65 -45.5 10.35 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.249 -0.18 . . . . 0.0 111.418 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.8 m -66.18 113.43 4.53 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.435 0.636 . . . . 0.0 110.595 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -59.38 133.14 55.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.432 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.45 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 101.06 -29.47 12.44 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -178.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.497 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 60.8 m -82.48 113.98 20.59 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 15.8 m -103.24 129.02 50.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.295 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.7 t -63.01 130.54 45.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.875 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -137.2 -153.8 6.49 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.901 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -43.41 139.65 1.94 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 3.4 t90 58.1 27.91 15.63 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.805 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' ' 21' ' ' LYS . 11.9 ttpt 60.2 34.99 21.03 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.231 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.8 mt -101.58 117.32 34.67 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.289 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.64 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 58.2 m -82.38 127.11 32.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -117.13 129.54 56.04 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.894 0.378 . . . . 0.0 110.521 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.657 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -75.8 135.41 17.95 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.514 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 30' ' ' THR . 1.2 t -144.21 65.22 1.3 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 122.193 0.997 . . . . 0.0 109.098 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -92.17 120.15 32.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.223 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.31 34.52 74.7 Favored Glycine 0 C--O 1.228 -0.229 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.252 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.15 -6.8 74.12 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.979 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.559 ' O ' ' HA ' ' A' ' 26' ' ' THR . 7.0 m -84.59 115.87 22.86 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.25 0.525 . . . . 0.0 109.908 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.657 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 62.7 mt -100.41 133.6 42.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.206 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.585 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 8.6 p90 -154.95 140.77 18.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.018 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 C--N 1.323 -0.563 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.125 -179.088 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.16 58.88 1.48 Allowed Glycine 0 C--O 1.229 -0.165 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.929 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -144.73 161.72 38.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.513 0.673 . . . . 0.0 111.344 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.5 m -135.84 129.7 32.79 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.29 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 25.0 p -69.61 65.98 0.21 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -66.85 -38.55 86.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.4 ' HA ' HD22 ' A' ' 7' ' ' LEU . 95.3 mt -99.11 45.67 0.99 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.359 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.11 -46.94 3.06 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.264 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -136.91 161.09 36.96 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 96.4 m -85.77 177.68 7.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.484 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -88.55 -43.35 11.46 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.439 HG21 ' SG ' ' A' ' 15' ' ' CYS . 33.2 m -64.36 110.29 2.21 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.423 0.63 . . . . 0.0 110.634 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.479 ' HB2' ' HZ2' ' A' ' 13' ' ' LYS . 4.4 ttmp? -64.58 123.17 18.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.193 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.423 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 117.58 -29.64 6.55 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.439 ' SG ' HG21 ' A' ' 12' ' ' THR . 64.2 m -82.23 111.66 18.53 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.219 -0.49 . . . . 0.0 109.863 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 16.1 m -102.12 133.49 46.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.4 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.8 t -67.85 131.42 45.49 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.301 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.22 -140.77 3.22 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-O 119.251 -0.749 . . . . 0.0 111.878 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.467 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 27.7 tp10 -37.08 133.97 0.59 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.642 0.777 . . . . 0.0 112.988 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 42.5 m0 62.94 20.14 12.05 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.553 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.4 tttm 57.72 38.0 27.38 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.748 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.3 mt -113.0 139.82 48.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.298 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 17' ' ' CYS . 68.7 m -83.99 131.6 34.82 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.391 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -128.24 133.79 48.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.812 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.596 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -70.52 146.09 41.59 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.723 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 30' ' ' THR . 16.9 m -139.92 62.04 1.52 Allowed 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -89.73 116.0 27.51 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.612 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.46 35.39 79.53 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.843 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.99 -4.11 77.08 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.689 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 26' ' ' THR . 16.2 m -84.74 122.4 29.06 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.038 0.419 . . . . 0.0 110.196 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 37.3 mm -98.0 133.59 39.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.311 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.596 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 17.9 p90 -155.34 137.36 14.6 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.7 t70 . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.456 -178.844 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.405 ' C ' ' H ' ' A' ' 3' ' ' GLU . 59.1 m . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.57 48.75 2.28 Favored Glycine 0 N--CA 1.459 0.209 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 23.5 mm-40 -85.42 174.21 9.7 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.7 0.762 . . . . 0.0 112.854 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.2 m -150.24 74.97 1.22 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.733 -1.122 . . . . 0.0 109.519 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 p -71.25 54.01 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.18 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.651 ' HD1' ' HG ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -65.33 -27.7 68.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.027 0.441 . . . . 0.0 109.996 178.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.651 ' HG ' ' HD1' ' A' ' 6' ' ' PHE . 97.0 mt -95.9 27.13 3.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.71 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.12 -43.07 2.19 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.913 -0.585 . . . . 0.0 113.323 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -99.53 148.91 23.78 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.182 0.515 . . . . 0.0 111.431 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 9.5 m -90.74 158.73 16.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.403 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -88.13 -42.91 12.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.968 0.413 . . . . 0.0 110.347 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.0 m -73.96 105.96 5.44 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.278 0.561 . . . . 0.0 109.941 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -60.35 129.84 43.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.374 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.475 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 111.97 -28.6 9.17 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 -178.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.519 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 61.0 m -86.94 116.03 24.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 16.1 m -91.76 127.99 37.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.338 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.574 ' HB2' ' SG ' ' A' ' 10' ' ' CYS . 50.5 t -66.53 115.62 6.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.211 0.529 . . . . 0.0 111.821 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.93 149.45 22.26 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.444 ' C ' ' H ' ' A' ' 21' ' ' LYS . 85.3 tt0 -40.33 -44.08 1.87 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.882 0.873 . . . . 0.0 113.067 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -75.6 32.69 0.11 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.449 ' HE3' ' HB3' ' A' ' 21' ' ' LYS . 12.6 ttpp 51.82 49.31 21.04 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.013 0.525 . . . . 0.0 110.262 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.2 tp -141.56 111.09 6.46 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.157 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.584 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 42.7 m -79.68 132.57 36.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.69 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -125.89 128.05 46.98 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.145 0.497 . . . . 0.0 110.257 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.649 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -68.7 141.3 36.37 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.59 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 30' ' ' THR . 6.2 m -140.73 64.72 1.42 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.708 0.766 . . . . 0.0 109.056 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.501 HD21 ' HZ ' ' A' ' 32' ' ' PHE . 72.7 m-20 -95.55 122.78 38.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.318 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.76 34.43 77.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.991 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.58 -2.65 71.81 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.754 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 26' ' ' THR . 10.5 m -87.25 121.59 29.91 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 122.556 -0.379 . . . . 0.0 110.168 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.649 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 62.0 mt -102.1 132.17 48.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.591 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.584 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 10.8 p90 -151.9 140.87 21.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.172 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.9 t70 . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.551 -178.971 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.93 62.19 1.3 Allowed Glycine 0 CA--C 1.518 0.221 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.842 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -146.69 -178.67 6.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.409 0.623 . . . . 0.0 111.425 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.3 m -150.71 119.16 6.43 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.087 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.416 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 1.3 p -73.61 60.83 0.69 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.253 0.549 . . . . 0.0 110.831 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -57.26 -41.37 79.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.745 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 pp -97.58 28.17 3.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.623 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.33 -41.18 2.24 Favored Glycine 0 CA--C 1.518 0.239 0 CA-C-N 115.681 -0.69 . . . . 0.0 113.165 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 m -101.7 144.87 29.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.852 0.358 . . . . 0.0 111.097 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.416 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 30.3 m -96.61 164.16 12.72 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -88.74 -48.62 7.38 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.122 -0.231 . . . . 0.0 111.285 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.0 m -66.17 116.48 7.29 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.437 0.637 . . . . 0.0 110.921 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.498 ' HD2' ' N ' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -62.48 132.8 53.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.354 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.485 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 105.51 -30.4 9.91 Favored Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -178.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.518 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 49.9 m -82.56 115.4 21.52 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m -105.24 139.73 39.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.812 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.9 t -62.6 128.36 35.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.347 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -143.03 -159.57 8.0 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.865 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.535 ' HG2' ' CD1' ' A' ' 20' ' ' TRP . 36.4 tt0 -42.63 140.74 1.2 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.611 0.764 . . . . 0.0 112.639 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.535 ' CD1' ' HG2' ' A' ' 19' ' ' GLU . 41.1 m0 64.57 18.67 11.5 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.226 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.0 tptm 58.56 37.09 25.49 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.67 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.7 mt -103.63 139.75 38.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.387 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.2 m -84.8 125.34 32.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.298 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -123.1 123.65 41.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.871 0.367 . . . . 0.0 111.193 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.532 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -73.23 130.6 13.84 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.716 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.694 HG23 HG13 ' A' ' 31' ' ' ILE . 1.1 m -129.74 68.3 1.44 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.501 0.667 . . . . 0.0 109.225 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.49 HD21 ' HZ ' ' A' ' 32' ' ' PHE . 75.2 m-20 -98.7 127.56 44.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.877 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.9 36.33 79.82 Favored Glycine 0 C--O 1.228 -0.239 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.233 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.89 4.65 72.36 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.611 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 26' ' ' THR . 12.3 m -95.75 123.71 39.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.694 HG13 HG23 ' A' ' 26' ' ' THR . 4.8 mp -102.37 129.59 53.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.149 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.532 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 13.6 p90 -150.33 138.98 20.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.122 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.4 t0 . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.538 -179.015 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.51 54.21 1.98 Allowed Glycine 0 C--N 1.324 -0.135 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.426 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.666 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 97.0 mt-10 -139.26 152.3 47.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.416 0.627 . . . . 0.0 110.899 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.545 ' HB3' ' HE3' ' A' ' 21' ' ' LYS . 30.4 m -130.03 135.34 48.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.035 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 22.7 p -74.1 55.07 0.56 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.258 0.551 . . . . 0.0 111.635 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -64.1 -36.55 84.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.724 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 25.0 tp -98.8 41.47 1.14 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.857 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.07 -42.1 2.49 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.913 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 10' ' ' CYS . 22.6 m -142.47 152.37 42.66 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.666 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 94.7 m -77.77 -157.27 0.1 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.02 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -117.35 -44.68 2.76 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.424 HG21 ' SG ' ' A' ' 15' ' ' CYS . 86.9 m -68.11 110.54 4.02 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.389 0.614 . . . . 0.0 110.681 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -62.73 122.92 17.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.248 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.86 -27.12 7.64 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 61.2 m -82.46 113.67 20.37 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 16.9 m -98.64 131.51 44.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.329 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 2.8 t -67.83 139.32 56.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.853 0.359 . . . . 0.0 111.025 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.423 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -152.41 -149.07 5.02 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-O 119.496 -0.614 . . . . 0.0 111.7 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.465 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 28.5 tp10 -39.6 135.46 1.15 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.541 0.736 . . . . 0.0 112.756 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 43.1 m0 64.51 19.54 11.84 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.851 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.545 ' HE3' ' HB3' ' A' ' 4' ' ' SER . 34.6 ttpt 59.73 38.21 21.81 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.592 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.9 mt -108.33 134.08 51.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.406 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 32.6 m -87.39 131.74 34.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.213 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.423 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 2.7 p90 -124.14 128.82 49.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.084 0.469 . . . . 0.0 109.883 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.625 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -71.65 142.29 33.43 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.858 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.9 t -143.81 63.77 1.34 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 122.17 0.986 . . . . 0.0 109.115 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -89.35 114.8 26.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.297 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.7 33.14 71.34 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.178 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.05 -8.93 76.64 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.653 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 26' ' ' THR . 3.5 m -80.32 116.24 20.29 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 63.3 mt -98.47 131.62 45.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.771 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.598 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 12.6 p90 -153.18 136.56 15.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.015 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 50.3 t0 . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.808 -178.903 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 54.5 m . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.16 56.17 1.88 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.462 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -141.76 158.84 43.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.6 0.714 . . . . 0.0 111.515 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.4 m -136.99 134.98 37.22 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.496 -1.229 . . . . 0.0 107.817 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.5 p -72.55 56.41 0.38 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.198 0.523 . . . . 0.0 111.769 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -66.51 -39.28 88.58 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 7' ' ' LEU . 3.2 mm? -90.99 39.91 1.01 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.998 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.11 -51.92 3.27 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.121 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 10' ' ' CYS . 9.1 m -127.05 152.27 47.49 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 122.73 -0.276 . . . . 0.0 110.862 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.416 ' N ' HG22 ' A' ' 9' ' ' THR . 7.7 m -71.2 159.8 34.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.122 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -90.4 -45.27 9.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.622 0.249 . . . . 0.0 111.302 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.404 HG21 ' SG ' ' A' ' 15' ' ' CYS . 88.3 m -70.71 112.35 6.86 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.304 0.573 . . . . 0.0 110.844 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -58.91 131.98 52.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.598 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.441 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 105.87 -27.59 17.04 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.509 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.1 m -86.73 117.43 25.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m -106.0 135.24 47.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.441 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 t -68.42 139.23 55.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.829 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.468 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -152.41 -154.21 6.58 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-O 119.576 -0.569 . . . . 0.0 111.704 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.459 ' O ' ' HG ' ' A' ' 22' ' ' LEU . 36.9 tt0 -39.06 138.53 0.57 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.567 0.747 . . . . 0.0 112.564 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.436 ' HB3' HD21 ' A' ' 22' ' ' LEU . 9.0 t90 65.62 15.49 10.07 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.071 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.9 tttp 58.84 38.76 24.54 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.527 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 19' ' ' GLU . 4.3 pp -107.97 144.38 35.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.809 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 61.5 m -92.47 127.98 38.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.921 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.468 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 1.9 p90 -119.54 128.85 54.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.092 0.472 . . . . 0.0 110.36 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 15' ' ' CYS . . . -80.93 141.75 22.77 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.669 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 30' ' ' THR . 48.2 m -148.85 104.97 3.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.132 0.491 . . . . 0.0 110.437 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -150.38 147.03 27.08 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.75 33.03 76.02 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.008 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.41 27.02 72.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.396 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 26' ' ' THR . 17.7 m -125.08 132.32 53.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.685 0.278 . . . . 0.0 110.397 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.48 HG12 HG23 ' A' ' 26' ' ' THR . 58.9 mt -112.24 133.87 56.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.889 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -152.81 140.89 20.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.395 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.9 t70 . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.489 -179.162 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.85 53.96 1.7 Allowed Glycine 0 C--O 1.23 -0.136 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.709 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.604 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 53.8 mt-10 -140.71 155.24 46.51 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.157 0.503 . . . . 0.0 110.818 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 p -127.3 135.47 50.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.746 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.566 ' SG ' ' HG3' ' A' ' 21' ' ' LYS . 26.5 p -71.25 94.6 1.2 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -67.22 -34.37 77.34 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.5 mt -114.85 -129.79 0.3 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.451 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.35 -36.73 92.05 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.821 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.0 t -162.8 -172.52 3.12 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.604 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 96.7 m -86.77 -176.71 5.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.764 0.316 . . . . 0.0 111.491 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -90.96 -36.12 14.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.109 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.667 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -61.31 116.57 4.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.223 0.535 . . . . 0.0 111.087 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -61.41 132.32 53.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.993 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.487 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 95.9 -24.43 29.81 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.578 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.667 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 59.2 m -81.38 113.1 19.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.19 0.519 . . . . 0.0 110.481 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.4 m -102.11 136.56 41.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.729 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.1 t -68.84 142.57 54.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.962 0.411 . . . . 0.0 111.213 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.428 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -146.35 -158.74 7.89 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.486 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -44.47 141.72 1.84 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 62.47 20.73 12.13 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.037 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.566 ' HG3' ' SG ' ' A' ' 5' ' ' CYS . 21.3 ttmm 58.86 37.94 24.68 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.953 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.41 127.83 49.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.141 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 64.4 m -89.14 134.63 33.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.137 0.494 . . . . 0.0 111.572 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.428 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 1.4 p90 -125.58 129.42 49.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.015 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -81.5 143.46 23.65 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.86 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 30' ' ' THR . 8.5 m -141.27 66.23 1.37 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.769 0.795 . . . . 0.0 108.981 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -89.52 120.02 30.47 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.385 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.86 36.25 72.03 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.086 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.5 -4.68 71.92 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.962 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.526 ' O ' ' HA ' ' A' ' 26' ' ' THR . 7.5 m -86.28 119.21 26.31 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 117.113 0.457 . . . . 0.0 110.263 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 56.8 mt -98.05 132.55 42.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.511 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.525 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 12.2 p90 -153.34 142.53 21.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.222 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.3 t70 . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.994 -179.311 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 82.9 m . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.34 57.23 2.41 Favored Glycine 0 C--N 1.323 -0.144 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.784 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -137.01 -178.13 5.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.515 0.674 . . . . 0.0 111.152 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.6 m -151.44 127.68 10.55 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.157 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 p -75.12 55.96 0.76 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.225 0.536 . . . . 0.0 111.293 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -64.9 -30.37 71.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.201 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.5 tp -103.6 37.76 1.95 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.243 0.544 . . . . 0.0 109.859 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.61 -40.44 2.03 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.087 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -130.19 157.19 43.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.995 0.426 . . . . 0.0 111.087 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.5 m -83.3 165.2 19.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.635 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -89.77 -46.69 8.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.793 0.33 . . . . 0.0 111.065 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.6 m -66.36 118.42 10.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.342 0.591 . . . . 0.0 110.943 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.568 ' HD3' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -58.04 134.03 56.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.664 0.745 . . . . 0.0 111.72 -179.236 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.56 -27.55 19.62 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.531 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.541 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 55.8 m -77.81 111.49 13.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.447 0.641 . . . . 0.0 110.149 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -90.41 138.22 31.72 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.774 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.5 t -60.3 124.62 20.86 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.359 0.599 . . . . 0.0 111.433 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.31 147.36 20.73 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.413 ' C ' ' H ' ' A' ' 21' ' ' LYS . 85.6 tt0 -43.68 -46.29 7.36 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.093 0.557 . . . . 0.0 112.352 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 20.7 m-90 -78.57 37.09 0.27 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.579 0.228 . . . . 0.0 111.473 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' A' ' 19' ' ' GLU . 79.8 tttt 55.47 37.61 29.12 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.331 0.652 . . . . 0.0 111.015 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.2 mt -106.95 -161.01 0.76 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.893 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 93.2 m -151.27 126.66 10.02 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -127.89 117.11 21.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.127 0.489 . . . . 0.0 111.202 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.549 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -68.22 127.13 23.79 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.758 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 30' ' ' THR . 0.3 OUTLIER -122.89 67.79 0.97 Allowed 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.306 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -88.89 113.47 24.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.702 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.67 38.51 88.22 Favored Glycine 0 C--O 1.228 -0.258 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.485 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.91 -3.98 77.35 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.104 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 26' ' ' THR . 13.6 m -87.71 124.91 34.06 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 117.124 0.462 . . . . 0.0 109.846 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 66.6 mt -102.16 128.23 54.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.042 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.549 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 17.7 p90 -150.06 135.97 18.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.422 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.8 t0 . . . . . 0 C--N 1.324 -0.535 0 CA-C-O 120.758 0.314 . . . . 0.0 110.573 -178.662 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 80.9 m . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.31 63.18 0.79 Allowed Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.0 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -147.75 -178.45 6.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.514 0.673 . . . . 0.0 111.229 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.536 ' HB2' ' HE2' ' A' ' 21' ' ' LYS . 35.7 p -151.56 124.46 8.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.159 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.66 59.54 0.65 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.095 0.474 . . . . 0.0 111.688 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -62.63 -36.57 83.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.744 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.2 tp -97.78 35.89 1.62 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.844 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.93 -45.25 2.2 Favored Glycine 0 CA--C 1.52 0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.251 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 t -116.64 153.12 32.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.91 0.386 . . . . 0.0 111.237 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.7 m -89.96 166.04 13.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.264 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -89.12 -47.44 8.09 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.489 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.5 m -62.08 115.6 4.23 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.471 0.653 . . . . 0.0 110.624 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -63.49 127.03 29.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.369 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.54 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 110.89 -27.94 10.45 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -178.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.533 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 58.0 m -83.88 115.45 22.28 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.3 m -102.32 141.01 35.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.908 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.65 147.49 47.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.353 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.497 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -168.19 -149.58 6.19 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.944 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -35.23 131.92 0.41 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.283 1.033 . . . . 0.0 113.361 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 58.28 24.27 11.34 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.734 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.557 ' NZ ' ' HB3' ' A' ' 21' ' ' LYS . 1.2 ttpm? 59.16 44.92 15.13 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.6 mt -107.81 148.72 29.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.109 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.1 m -98.64 127.68 44.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.71 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.497 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 3.0 p90 -129.83 123.7 31.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.331 0.586 . . . . 0.0 110.759 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.54 ' HA2' ' O ' ' A' ' 14' ' ' GLY . . . -80.16 141.81 23.55 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.487 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 30' ' ' THR . 24.0 m -130.16 112.65 13.6 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.973 0.415 . . . . 0.0 110.024 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -143.98 134.94 25.37 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.83 35.61 87.22 Favored Glycine 0 C--O 1.229 -0.212 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.068 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.1 22.95 71.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.391 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 26' ' ' THR . 19.3 m -120.2 131.9 55.16 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.6 mt -106.54 130.66 57.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.137 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -142.1 139.68 32.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.315 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.5 t70 . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.469 -178.825 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.57 54.97 2.04 Favored Glycine 0 C--O 1.229 -0.177 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.473 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -140.58 159.46 42.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.639 0.733 . . . . 0.0 111.355 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.4 t -140.91 137.62 33.28 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.7 p -70.03 64.29 0.23 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.09 0.471 . . . . 0.0 111.942 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -71.01 -32.27 69.01 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.6 tp -103.4 38.46 1.78 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.354 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.12 -48.11 3.0 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.985 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.2 m -122.6 150.53 42.51 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 122.714 -0.286 . . . . 0.0 110.901 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.8 m -74.01 165.11 25.72 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.828 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -89.07 -43.45 11.07 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 120.669 0.271 . . . . 0.0 110.698 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.8 m -74.16 109.69 7.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.568 0.699 . . . . 0.0 110.321 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.94 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -66.03 119.26 11.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.889 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.434 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 124.13 -29.1 5.18 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -177.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.488 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 61.3 m -87.71 114.96 24.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.056 -0.572 . . . . 0.0 109.798 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 20.4 m -97.28 134.27 40.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.175 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 3.9 t -70.26 110.87 5.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.114 0.483 . . . . 0.0 110.382 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.455 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -82.26 159.77 39.48 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.783 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.525 ' C ' ' H ' ' A' ' 21' ' ' LYS . 9.2 tp10 -34.99 -47.34 0.36 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.978 1.311 . . . . 0.0 113.732 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 7.6 t90 -75.87 29.08 0.11 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.352 0.596 . . . . 0.0 110.965 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.525 ' H ' ' C ' ' A' ' 19' ' ' GLU . 40.5 tttm 50.49 41.05 24.66 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.184 0.994 . . . . 0.0 111.444 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.8 mt -129.21 121.49 27.76 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.187 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 17' ' ' CYS . 49.8 m -74.31 129.93 38.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.614 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.455 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 2.7 p90 -133.13 133.53 43.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.051 0.453 . . . . 0.0 110.058 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.604 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -71.25 148.81 44.71 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.725 -0.67 . . . . 0.0 113.359 -178.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 30' ' ' THR . 9.1 m -147.28 60.3 1.17 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.136 0.97 . . . . 0.0 108.485 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -90.08 120.73 31.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.878 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.19 36.5 75.54 Favored Glycine 0 C--O 1.228 -0.278 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.261 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.46 1.34 86.17 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.851 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 26' ' ' THR . 11.4 m -92.86 120.91 33.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.975 0.387 . . . . 0.0 110.127 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.604 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 4.5 mp -99.81 132.96 44.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.264 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.587 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 14.0 p90 -151.98 137.32 17.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.984 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.1 t0 . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.982 -178.878 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 37.7 m . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.92 60.7 1.34 Allowed Glycine 0 N--CA 1.454 -0.158 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.53 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -148.04 168.72 21.62 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.652 0.739 . . . . 0.0 111.745 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.5 t -149.68 141.23 23.43 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.694 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.0 p -69.77 64.5 0.21 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.967 0.413 . . . . 0.0 111.618 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -74.98 -31.4 61.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.93 0.395 . . . . 0.0 110.159 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 25.9 tp -103.89 45.59 0.95 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.509 0.671 . . . . 0.0 109.374 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.98 -47.38 3.33 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.516 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -137.48 164.17 29.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.627 0.251 . . . . 0.0 110.581 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.3 m -78.79 158.69 28.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.559 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -88.47 -46.53 9.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.413 0.149 . . . . 0.0 111.279 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.7 m -64.06 113.82 3.75 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.275 0.56 . . . . 0.0 110.765 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -61.1 130.9 48.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.676 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.518 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 105.36 -31.47 8.47 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.496 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 62.4 m -83.3 117.16 22.79 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.8 m -109.56 136.79 48.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.508 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.9 t -68.5 134.17 49.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.957 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.48 -145.6 4.16 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.352 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.478 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 26.6 tp10 -39.01 136.24 0.81 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 8.2 t90 62.53 21.53 12.7 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.137 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.8 tttm 56.76 39.37 29.68 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.886 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.62 137.74 47.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.39 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 17' ' ' CYS . 86.3 m -85.88 129.06 34.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.514 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -135.03 135.34 41.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.036 0.446 . . . . 0.0 110.459 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.639 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -70.59 148.54 45.37 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.754 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 30' ' ' THR . 3.3 t -145.59 62.35 1.27 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.307 1.051 . . . . 0.0 109.368 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -89.22 115.96 27.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.585 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.17 35.57 78.23 Favored Glycine 0 C--O 1.227 -0.302 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.157 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.1 -5.43 76.53 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.858 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 26' ' ' THR . 10.2 m -85.2 118.3 24.67 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 117.045 0.422 . . . . 0.0 109.937 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.639 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 64.3 mt -99.4 132.4 44.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.713 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.627 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 10.8 p90 -149.09 136.57 20.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.865 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.6 t70 . . . . . 0 C--N 1.322 -0.591 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.406 -178.464 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 62.5 m . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.34 52.18 2.61 Favored Glycine 0 C--O 1.228 -0.267 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 177.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 32.8 mm-40 -114.35 160.9 18.59 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.71 -0.745 . . . . 0.0 111.965 -177.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.2 m -151.72 118.65 5.82 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.927 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.3 p -73.59 67.93 1.15 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.068 0.461 . . . . 0.0 111.904 -178.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -58.52 -40.85 84.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.044 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.453 HD11 ' O ' ' A' ' 9' ' ' THR . 1.4 pp -109.22 38.37 2.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.847 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.18 -44.39 2.63 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.865 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.453 ' O ' HD11 ' A' ' 7' ' ' LEU . 9.8 m -101.11 144.62 29.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.66 0.267 . . . . 0.0 110.922 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.4 m -85.06 163.67 18.69 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -87.84 -43.25 11.96 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.623 0.249 . . . . 0.0 110.617 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.409 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 53.1 m -72.71 100.81 2.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.145 0.497 . . . . 0.0 110.037 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.461 ' HE3' ' HB3' ' A' ' 13' ' ' LYS . 12.2 ttpp -60.83 106.32 0.56 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.255 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.477 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 137.44 -21.94 3.23 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.505 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 59.4 m -97.74 122.02 40.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.509 -0.846 . . . . 0.0 110.002 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.6 m -103.83 131.04 51.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.673 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 2.5 t -61.53 135.02 57.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.176 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.23 -144.72 3.98 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.108 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -38.3 133.96 0.9 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.717 0.807 . . . . 0.0 112.962 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 61.12 23.79 13.95 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.165 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.0 tttp 58.56 35.59 24.66 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.907 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' A' ' 22' ' ' LEU . 97.9 mt -109.87 132.52 54.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.741 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.621 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 30.4 m -84.38 133.23 34.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.778 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -120.53 133.68 55.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.098 0.475 . . . . 0.0 110.314 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 15' ' ' CYS . . . -75.06 139.28 24.82 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.431 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 30' ' ' THR . 5.5 m -124.1 72.08 1.15 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.387 0.613 . . . . 0.0 109.795 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -89.06 116.48 27.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.023 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.08 34.32 72.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.265 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.44 -3.08 86.06 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.685 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 26' ' ' THR . 7.1 m -88.15 124.2 33.57 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.769 0.284 . . . . 0.0 110.256 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 4.2 mp -97.12 127.92 48.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.596 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.503 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 17.3 p90 -143.78 140.98 30.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.674 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.4 t70 . . . . . 0 C--N 1.321 -0.631 0 CA-C-O 121.072 0.463 . . . . 0.0 112.025 -178.386 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 81.2 m . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.05 58.8 1.43 Allowed Glycine 0 CA--C 1.517 0.19 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.743 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -141.27 -176.73 4.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.468 0.652 . . . . 0.0 110.878 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 m -151.15 124.81 9.03 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.491 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.2 p -77.32 54.59 1.13 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.958 0.408 . . . . 0.0 111.593 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.627 ' HD1' ' HG ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -62.39 -33.25 74.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.294 179.214 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.627 ' HG ' ' HD1' ' A' ' 6' ' ' PHE . 99.0 mt -96.13 32.08 2.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.91 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.25 -47.69 3.23 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.802 -0.635 . . . . 0.0 113.336 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.1 p -114.29 149.22 36.27 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 122.545 -0.385 . . . . 0.0 112.014 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.5 m -79.78 163.47 24.42 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -89.94 -48.43 7.23 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.911 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.3 m -64.84 117.38 7.45 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.43 0.633 . . . . 0.0 110.669 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -62.51 128.23 35.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.4 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.566 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 110.8 -27.67 10.84 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -178.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.569 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.6 m -80.55 116.32 20.53 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.7 m -94.64 137.84 33.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.221 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 22' ' ' LEU . 12.1 t -76.92 122.23 24.56 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.193 0.521 . . . . 0.0 111.866 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 20' ' ' TRP . . . -91.76 144.86 17.4 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.442 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 3.5 tp10 -69.95 42.46 0.05 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.505 1.145 . . . . 0.0 113.158 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.504 ' H ' ' C ' ' A' ' 18' ' ' GLY . 96.6 m95 -133.08 12.72 4.27 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 175.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 0.6 OUTLIER 62.51 39.55 11.6 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 111.865 -2.425 . . . . 0.0 109.272 -178.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 17' ' ' CYS . 90.1 mt -116.11 178.71 4.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.48 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 93.9 m -141.75 127.53 19.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.466 0.174 . . . . 0.0 110.63 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -133.36 122.71 24.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.292 0.567 . . . . 0.0 110.835 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' A' ' 15' ' ' CYS . . . -77.63 150.04 35.84 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.458 -0.792 . . . . 0.0 113.343 -179.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 30' ' ' THR . 6.6 t -132.21 123.29 26.72 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.349 0.595 . . . . 0.0 109.762 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -150.56 129.18 12.27 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.68 35.27 85.49 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.168 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.89 23.44 74.26 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.476 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 26' ' ' THR . 23.6 m -118.3 132.09 56.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 31' ' ' ILE . 46.8 mm -103.38 130.93 52.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.431 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -144.71 129.96 18.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.88 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.9 t70 . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.361 -178.519 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.58 55.16 2.05 Favored Glycine 0 C--N 1.321 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.984 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.529 ' OE2' ' HB2' ' A' ' 11' ' ' TYR . 57.7 mt-10 -135.17 154.42 51.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.192 0.52 . . . . 0.0 111.109 -178.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 t -137.85 132.91 33.26 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.655 ' SG ' ' HE2' ' A' ' 21' ' ' LYS . 8.5 p -69.27 85.56 0.39 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.228 0.537 . . . . 0.0 111.808 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -67.55 -34.62 77.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.483 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.417 HD11 ' O ' ' A' ' 7' ' ' LEU . 0.9 OUTLIER -120.55 39.77 3.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.714 179.384 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.86 -40.66 2.3 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.791 -0.64 . . . . 0.0 113.187 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.2 m -102.02 148.89 24.83 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.678 -0.307 . . . . 0.0 111.074 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 35.0 m -85.22 -155.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.529 ' HB2' ' OE2' ' A' ' 3' ' ' GLU . 16.9 m-85 -127.69 -49.71 1.37 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.453 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.418 HG23 ' SG ' ' A' ' 15' ' ' CYS . 98.6 m -72.32 121.93 20.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.196 0.522 . . . . 0.0 110.538 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -61.21 127.77 33.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.766 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.495 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 106.61 -29.23 11.23 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -178.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.505 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 59.2 m -81.59 120.76 25.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.916 0.389 . . . . 0.0 110.15 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.4 m -112.54 132.33 55.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.214 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 3.8 t -65.7 137.47 57.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.759 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -160.28 -148.88 5.4 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.661 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.502 ' O ' ' HG ' ' A' ' 22' ' ' LEU . 5.8 tp10 -40.81 143.0 0.4 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.889 0.876 . . . . 0.0 113.125 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.718 ' HB3' HD22 ' A' ' 22' ' ' LEU . 12.9 t-105 66.52 17.61 10.67 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.071 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.655 ' HE2' ' SG ' ' A' ' 5' ' ' CYS . 0.2 OUTLIER 56.64 45.18 22.56 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.171 179.406 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.718 HD22 ' HB3' ' A' ' 20' ' ' TRP . 4.6 pp -133.42 151.24 51.79 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.649 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 17' ' ' CYS . 78.8 m -89.5 131.11 35.7 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.026 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -128.96 133.51 47.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.038 0.447 . . . . 0.0 110.034 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.735 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -69.85 142.32 36.26 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.45 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.8 t -150.46 62.86 0.95 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.841 0.829 . . . . 0.0 110.084 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.482 ' OD1' ' HB ' ' A' ' 30' ' ' THR . 15.2 p-10 -89.9 112.98 24.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.589 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.99 34.06 65.06 Favored Glycine 0 C--O 1.227 -0.3 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.664 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.88 -14.54 65.15 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.06 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 26' ' ' THR . 2.3 m -75.15 114.42 13.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.292 0.546 . . . . 0.0 109.793 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 30.9 mm -102.71 135.31 40.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.141 -179.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.735 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 7.2 p90 -158.5 137.47 11.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.895 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.69 -178.855 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.457 ' C ' ' H ' ' A' ' 3' ' ' GLU . 53.3 m . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.11 46.0 2.37 Favored Glycine 0 C--O 1.229 -0.204 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.635 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 40.3 mm-40 -111.62 159.72 17.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.654 -0.773 . . . . 0.0 111.488 -178.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.1 t -151.01 131.93 14.2 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.76 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.44 ' SG ' ' HD2' ' A' ' 21' ' ' LYS . 22.9 p -79.07 51.8 1.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.044 0.449 . . . . 0.0 111.391 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -66.63 -32.94 74.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.923 0.392 . . . . 0.0 110.065 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.408 HD22 ' HH ' ' A' ' 11' ' ' TYR . 26.2 tp -100.02 40.17 1.27 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.423 0.63 . . . . 0.0 109.583 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.52 -43.02 2.68 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.026 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.4 m -138.06 149.06 45.66 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.416 -0.461 . . . . 0.0 110.845 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.6 m -68.88 159.38 32.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.894 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.408 ' HH ' HD22 ' A' ' 7' ' ' LEU . 3.0 m-85 -88.01 -42.7 12.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.63 0.252 . . . . 0.0 111.288 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.492 HG23 ' SG ' ' A' ' 15' ' ' CYS . 71.2 m -71.93 106.54 4.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.366 0.603 . . . . 0.0 110.833 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.14 127.38 31.65 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.468 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.502 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 110.9 -28.29 10.05 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.636 -0.985 . . . . 0.0 110.636 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.514 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 62.7 m -85.59 119.03 25.48 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.6 m -102.84 132.01 49.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.597 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 4.0 t -63.09 140.75 58.9 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.074 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.46 -154.0 6.5 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.196 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -43.24 142.84 0.95 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.418 0.687 . . . . 0.0 112.755 -178.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 17.9 t-105 62.56 20.4 11.95 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.121 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.44 ' HD2' ' SG ' ' A' ' 5' ' ' CYS . 3.3 tppp? 57.84 38.85 27.26 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.499 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.1 tp -113.18 131.59 55.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.952 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.635 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 32.0 m -88.79 138.15 31.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.206 0.527 . . . . 0.0 111.451 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -132.38 134.24 44.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.82 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.751 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -67.56 142.67 40.96 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.743 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 30' ' ' THR . 3.2 t -150.82 62.47 0.93 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.813 0.816 . . . . 0.0 110.346 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.407 ' OD1' ' HB ' ' A' ' 30' ' ' THR . 15.1 p-10 -89.83 113.64 25.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.213 0.53 . . . . 0.0 110.728 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.9 34.71 61.88 Favored Glycine 0 C--O 1.227 -0.286 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.804 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.13 -14.54 65.06 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.047 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.576 ' O ' ' HA ' ' A' ' 26' ' ' THR . 2.3 m -75.22 113.39 12.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.266 0.533 . . . . 0.0 109.733 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.61 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 28.9 mm -103.05 135.58 39.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.201 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.751 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 6.9 p90 -159.63 138.29 10.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.949 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.44 -179.069 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 57.4 m . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 121.2 0.524 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.03 61.22 1.75 Allowed Glycine 0 C--O 1.23 -0.13 0 CA-C-N 115.031 -0.986 . . . . 0.0 113.125 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.454 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 13.2 mt-10 -139.58 -172.07 3.28 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.87 0.367 . . . . 0.0 110.496 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t -150.81 115.21 5.13 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.649 179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 p -79.34 55.94 2.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.343 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.851 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 25.1 t80 -56.5 -40.74 75.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.404 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 54.7 tp -76.86 -49.27 16.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.549 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.24 -38.51 0.16 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.3 m -141.37 143.46 33.99 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.454 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 83.0 m -76.76 -176.79 4.0 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 123.256 0.347 . . . . 0.0 111.013 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -89.12 -40.16 13.11 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.437 HG21 ' SG ' ' A' ' 15' ' ' CYS . 40.4 m -62.19 111.64 2.05 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.324 0.583 . . . . 0.0 110.854 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -64.86 118.42 9.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.627 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.66 -28.84 5.82 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.532 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 61.3 m -80.03 114.1 18.69 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.3 m -101.08 136.55 40.75 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.794 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.6 t -67.61 133.82 50.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.081 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.89 -154.12 6.49 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.478 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -41.69 140.58 0.95 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.549 0.74 . . . . 0.0 112.681 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 11.0 t90 66.71 16.12 10.3 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.135 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.851 ' HE3' ' HA ' ' A' ' 6' ' ' PHE . 56.9 tttp 57.32 41.43 26.6 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.833 0.825 . . . . 0.0 109.04 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.7 tp -116.52 145.0 43.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.647 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.532 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 87.4 m -92.49 131.85 37.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.178 0.514 . . . . 0.0 111.615 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -121.47 127.9 51.55 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.675 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -70.3 142.18 35.28 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.152 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.2 t -148.61 60.02 1.08 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 122.584 1.183 . . . . 0.0 108.257 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -89.14 110.85 21.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.294 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.28 34.16 87.15 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.002 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.74 -11.36 68.94 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.764 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 26' ' ' THR . 2.3 m -78.83 114.88 18.13 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.977 0.388 . . . . 0.0 110.002 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 60.5 mt -100.22 132.99 44.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.64 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.565 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 8.0 p90 -158.78 142.02 14.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.323 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.8 t70 . . . . . 0 C--N 1.323 -0.569 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.442 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 57.2 m . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.07 58.27 2.28 Favored Glycine 0 C--O 1.228 -0.259 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 2.5 mm-40 -106.21 179.3 4.31 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.6 m -150.02 83.15 1.38 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.836 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.557 ' O ' ' HE2' ' A' ' 21' ' ' LYS . 1.9 p -72.87 56.57 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.883 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -58.53 -34.23 70.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.814 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.5 tp -95.83 24.19 5.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.279 0.561 . . . . 0.0 110.174 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.96 -39.44 2.23 Favored Glycine 0 C--O 1.228 -0.278 0 CA-C-N 116.002 -0.544 . . . . 0.0 113.192 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 t -96.05 147.51 23.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.05 0.452 . . . . 0.0 111.249 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 20.5 m -99.18 156.47 16.95 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -89.51 -39.51 13.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.994 0.426 . . . . 0.0 110.271 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 m -71.55 111.38 6.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.599 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.493 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -61.04 134.45 57.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.544 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.507 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 102.31 -31.02 9.19 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -178.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.512 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.7 m -86.39 119.3 26.51 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m -107.65 136.03 48.09 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.954 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.9 t -66.25 136.12 55.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.027 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.474 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -155.91 -145.57 4.22 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.598 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -40.1 135.0 1.45 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.429 0.691 . . . . 0.0 112.837 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 18.1 t-105 62.54 21.69 12.81 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.142 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.557 ' HE2' ' O ' ' A' ' 5' ' ' CYS . 70.0 tttt 54.91 43.6 29.67 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.245 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.4 tp -113.83 137.5 51.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.997 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.573 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 59.7 m -85.05 126.31 33.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.988 0.423 . . . . 0.0 111.28 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.474 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 1.6 p90 -124.24 130.04 51.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.231 0.538 . . . . 0.0 110.091 178.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.621 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -72.32 143.2 33.96 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.948 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 30' ' ' THR . 11.2 m -138.2 66.2 1.45 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.628 0.728 . . . . 0.0 109.088 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -89.01 115.8 26.84 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.33 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.43 35.33 71.57 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.934 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.94 -5.18 77.2 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.787 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 26' ' ' THR . 14.0 m -84.19 123.13 29.77 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 117.066 0.433 . . . . 0.0 110.135 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 39.4 mm -95.33 133.07 37.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.61 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.621 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 23.0 p90 -152.37 135.26 15.55 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 50.1 t0 . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.098 -178.725 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 64.6 m . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 120.814 0.34 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.71 48.27 2.91 Favored Glycine 0 C--O 1.229 -0.175 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 21.5 mm-40 -80.44 -176.05 5.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.743 -0.729 . . . . 0.0 112.801 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 65.9 m -150.6 63.15 0.94 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.481 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.4 p -72.85 57.03 0.43 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.236 0.541 . . . . 0.0 110.368 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -57.52 -40.36 78.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.808 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.1 mt -80.95 -49.33 11.11 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.814 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.09 -39.72 0.46 Allowed Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 p -86.97 142.5 27.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.269 -0.465 . . . . 0.0 110.86 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.4 m -100.04 162.42 12.99 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -89.56 -50.8 5.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.693 0.282 . . . . 0.0 111.151 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.6 m -64.93 118.7 9.46 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.337 0.589 . . . . 0.0 111.61 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -59.95 133.06 55.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.232 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.01 -27.29 20.66 Favored Glycine 0 N--CA 1.44 -1.08 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.506 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.5 m -83.19 112.89 20.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.897 0.38 . . . . 0.0 109.993 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.6 m -102.19 130.06 48.74 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.011 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 24.4 t -62.79 104.88 0.58 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.222 0.534 . . . . 0.0 110.705 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.47 154.82 49.44 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-O 119.196 -0.78 . . . . 0.0 111.194 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.522 ' C ' ' H ' ' A' ' 21' ' ' LYS . 41.5 tt0 -40.31 -42.77 1.6 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.127 0.971 . . . . 0.0 112.873 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.698 ' CD1' ' HB2' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -73.86 25.73 0.07 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.088 0.47 . . . . 0.0 111.304 179.083 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 19' ' ' GLU . 39.9 tttp 52.17 44.8 29.34 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.579 1.151 . . . . 0.0 111.757 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.698 ' HB2' ' CD1' ' A' ' 20' ' ' TRP . 98.0 mt -139.59 119.25 13.16 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.328 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 16' ' ' SER . 31.9 m -70.96 127.6 33.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.195 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -116.64 127.43 54.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.698 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -75.56 130.51 11.23 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.224 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.728 HG23 HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -133.47 64.53 1.61 Allowed 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -95.45 124.35 39.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.518 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.5 34.81 77.14 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.094 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.98 -0.35 72.91 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.665 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 26' ' ' THR . 7.9 m -89.21 121.13 31.22 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.728 HG12 HG23 ' A' ' 26' ' ' THR . 50.7 mt -102.0 131.37 50.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.54 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.525 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 12.6 p90 -156.7 142.31 17.65 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.039 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.7 t0 . . . . . 0 C--N 1.324 -0.533 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.498 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 39.0 m . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.78 61.76 1.26 Allowed Glycine 0 CA--C 1.517 0.206 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.446 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -146.39 173.29 12.4 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.419 0.628 . . . . 0.0 111.576 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.9 p -150.13 135.41 18.03 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.392 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.576 ' SG ' ' HG3' ' A' ' 21' ' ' LYS . 28.8 p -74.61 61.55 0.97 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.089 0.471 . . . . 0.0 111.803 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.624 ' HD1' ' HG ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -65.4 -35.61 81.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.022 179.138 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.624 ' HG ' ' HD1' ' A' ' 6' ' ' PHE . 90.4 mt -99.24 39.03 1.32 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.205 0.526 . . . . 0.0 110.065 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.87 -49.78 3.52 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.292 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 m -123.57 148.47 46.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.867 0.333 . . . . 0.0 111.114 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.4 m -75.35 164.05 26.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.659 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -88.38 -48.11 7.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.45 0.167 . . . . 0.0 111.336 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.7 m -65.1 116.06 6.1 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.285 0.564 . . . . 0.0 111.042 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -59.77 132.01 52.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.108 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.498 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 101.98 -28.16 17.19 Favored Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.501 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 60.3 m -81.3 112.01 18.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.147 0.499 . . . . 0.0 110.118 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m -98.95 137.92 36.81 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.354 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.8 t -72.32 140.07 48.31 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.895 0.379 . . . . 0.0 110.802 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.444 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -144.51 -156.26 6.75 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -43.24 139.52 1.87 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.549 ' HE3' HD11 ' A' ' 22' ' ' LEU . 4.5 t90 60.06 24.36 13.58 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.343 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.576 ' HG3' ' SG ' ' A' ' 5' ' ' CYS . 22.2 ttmm 58.45 37.4 25.68 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.312 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.549 HD11 ' HE3' ' A' ' 20' ' ' TRP . 89.7 mt -94.84 127.84 41.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.417 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.3 m -88.06 130.84 34.88 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.444 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 3.0 p90 -133.83 128.76 35.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.185 0.517 . . . . 0.0 110.403 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.619 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -70.75 140.06 31.04 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.963 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 30' ' ' THR . 6.7 m -138.56 64.71 1.48 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -98.46 126.01 43.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.562 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.31 35.71 79.89 Favored Glycine 0 C--O 1.228 -0.228 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.365 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.3 2.79 74.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.735 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 26' ' ' THR . 10.0 m -94.11 122.98 37.18 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 120.681 0.277 . . . . 0.0 110.411 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.619 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 4.5 mp -102.73 131.42 50.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.201 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.583 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 11.6 p90 -151.05 137.55 18.67 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.046 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.9 t70 . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.245 -178.715 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.55 57.83 2.5 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.233 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -138.2 167.74 21.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.655 0.74 . . . . 0.0 111.91 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t -143.8 132.98 23.03 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.185 -1.37 . . . . 0.0 107.583 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.462 ' SG ' ' HG3' ' A' ' 21' ' ' LYS . 28.8 p -73.4 60.87 0.64 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.332 0.587 . . . . 0.0 111.527 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -66.6 -39.7 88.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.6 mt -93.59 38.47 1.06 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.21 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.62 -50.24 3.2 Favored Glycine 0 CA--C 1.52 0.373 0 CA-C-N 115.835 -0.62 . . . . 0.0 113.087 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 m -125.99 149.16 49.01 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.681 -0.305 . . . . 0.0 110.956 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.6 m -74.05 159.33 32.82 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -88.98 -38.73 14.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.44 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 7.2 m -67.5 122.25 17.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.24 0.543 . . . . 0.0 111.393 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -60.41 127.82 33.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.728 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.09 -26.98 22.14 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.509 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.495 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.9 m -79.69 114.8 18.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.197 0.522 . . . . 0.0 110.205 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.7 m -108.6 138.11 45.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.935 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 5' ' ' CYS . 5.9 t -66.68 134.3 51.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.999 0.428 . . . . 0.0 111.085 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -143.3 -155.45 6.43 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.483 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 26.1 tp10 -42.12 137.7 1.82 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 12.4 t90 65.68 20.33 11.53 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.906 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.462 ' HG3' ' SG ' ' A' ' 5' ' ' CYS . 15.0 ttmm 56.0 37.78 29.23 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.969 0.89 . . . . 0.0 109.144 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.4 tp -102.67 136.88 41.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.166 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 61.3 m -87.21 127.66 35.15 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.903 0.383 . . . . 0.0 111.256 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -118.77 128.5 54.54 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.625 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -77.64 131.2 10.86 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.835 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.0 t -134.97 67.91 1.48 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 122.045 0.926 . . . . 0.0 109.104 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -89.13 110.6 21.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.3 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.25 36.65 91.39 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.325 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.25 -7.17 72.94 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.101 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 26' ' ' THR . 9.0 m -84.91 122.36 29.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.132 0.466 . . . . 0.0 109.863 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 5.4 tp -96.55 142.85 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.097 0.475 . . . . 0.0 110.715 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.625 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 23.5 p90 -162.08 132.79 4.97 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.4 t70 . . . . . 0 C--N 1.321 -0.665 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.311 -178.426 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.434 ' C ' ' H ' ' A' ' 3' ' ' GLU . 17.8 m . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.34 42.24 1.91 Allowed Glycine 0 CA--C 1.517 0.215 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.682 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 21.2 mm-40 -90.85 171.46 9.3 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 123.713 0.805 . . . . 0.0 111.647 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.0 m -152.07 119.16 5.86 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.76 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.4 p -78.24 48.94 0.78 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.978 0.418 . . . . 0.0 111.502 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.622 ' HD1' ' HG ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -65.56 -32.1 73.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.723 179.34 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.622 ' HG ' ' HD1' ' A' ' 6' ' ' PHE . 96.2 mt -99.19 39.0 1.32 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.129 0.49 . . . . 0.0 109.953 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.99 -41.47 2.61 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.838 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.3 m -136.2 150.04 48.83 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.55 -0.382 . . . . 0.0 110.63 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.4 m -69.25 160.8 30.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.704 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -87.65 -45.5 10.35 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.249 -0.18 . . . . 0.0 111.418 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.8 m -66.18 113.43 4.53 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.435 0.636 . . . . 0.0 110.595 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -59.38 133.14 55.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.432 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.454 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 101.06 -29.47 12.44 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -178.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.481 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 60.8 m -82.48 113.98 20.59 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 15.8 m -103.24 129.02 50.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.295 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.7 t -63.01 130.54 45.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.875 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -137.2 -153.8 6.49 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.901 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -43.41 139.65 1.94 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.613 ' HE3' HD11 ' A' ' 22' ' ' LEU . 3.4 t90 58.1 27.91 15.63 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.805 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' A' ' 21' ' ' LYS . 11.9 ttpt 60.2 34.99 21.03 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.231 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.613 HD11 ' HE3' ' A' ' 20' ' ' TRP . 92.8 mt -101.58 117.32 34.67 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.289 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.682 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 58.2 m -82.38 127.11 32.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -117.13 129.54 56.04 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.894 0.378 . . . . 0.0 110.521 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -75.8 135.41 17.95 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.514 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 30' ' ' THR . 1.2 t -144.21 65.22 1.3 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 122.193 0.997 . . . . 0.0 109.098 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -92.17 120.15 32.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.223 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.31 34.52 74.7 Favored Glycine 0 C--O 1.228 -0.229 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.252 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.15 -6.8 74.12 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.979 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 26' ' ' THR . 7.0 m -84.59 115.87 22.86 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.25 0.525 . . . . 0.0 109.908 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.663 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 62.7 mt -100.41 133.6 42.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.206 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.594 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 8.6 p90 -154.95 140.77 18.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.018 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 C--N 1.323 -0.563 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.125 -179.088 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.16 58.88 1.48 Allowed Glycine 0 C--O 1.229 -0.165 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.929 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -144.73 161.72 38.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.513 0.673 . . . . 0.0 111.344 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.5 m -135.84 129.7 32.79 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.29 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 25.0 p -69.61 65.98 0.21 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -66.85 -38.55 86.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.3 mt -99.11 45.67 0.99 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.359 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.11 -46.94 3.06 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.264 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -136.91 161.09 36.96 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 96.4 m -85.77 177.68 7.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.484 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -88.55 -43.35 11.46 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.2 m -64.36 110.29 2.21 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.423 0.63 . . . . 0.0 110.634 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.48 ' NZ ' ' HB2' ' A' ' 13' ' ' LYS . 4.4 ttmp? -64.58 123.17 18.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.193 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.429 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 117.58 -29.64 6.55 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 64.2 m -82.23 111.66 18.53 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.219 -0.49 . . . . 0.0 109.863 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 16.1 m -102.12 133.49 46.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.4 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.8 t -67.85 131.42 45.49 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.301 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.22 -140.77 3.22 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-O 119.251 -0.749 . . . . 0.0 111.878 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.453 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 27.7 tp10 -37.08 133.97 0.59 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.642 0.777 . . . . 0.0 112.988 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 42.5 m0 62.94 20.14 12.05 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.553 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.4 tttm 57.72 38.0 27.38 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.748 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.3 mt -113.0 139.82 48.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.298 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 68.7 m -83.99 131.6 34.82 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.391 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -128.24 133.79 48.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.812 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.604 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -70.52 146.09 41.59 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.723 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 30' ' ' THR . 16.9 m -139.92 62.04 1.52 Allowed 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -89.73 116.0 27.51 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.612 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.46 35.39 79.53 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.843 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.99 -4.11 77.08 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.689 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 26' ' ' THR . 16.2 m -84.74 122.4 29.06 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.038 0.419 . . . . 0.0 110.196 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 37.3 mm -98.0 133.59 39.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.311 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.604 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 17.9 p90 -155.34 137.36 14.6 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.7 t70 . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.456 -178.844 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 59.1 m . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.57 48.75 2.28 Favored Glycine 0 N--CA 1.459 0.209 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.591 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 23.5 mm-40 -85.42 174.21 9.7 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.7 0.762 . . . . 0.0 112.854 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.2 m -150.24 74.97 1.22 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.733 -1.122 . . . . 0.0 109.519 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 p -71.25 54.01 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.18 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.671 ' HD1' ' HG ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -65.33 -27.7 68.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.027 0.441 . . . . 0.0 109.996 178.883 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.671 ' HG ' ' HD1' ' A' ' 6' ' ' PHE . 97.0 mt -95.9 27.13 3.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.71 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.12 -43.07 2.19 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.913 -0.585 . . . . 0.0 113.323 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -99.53 148.91 23.78 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.182 0.515 . . . . 0.0 111.431 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 9.5 m -90.74 158.73 16.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.403 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -88.13 -42.91 12.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.968 0.413 . . . . 0.0 110.347 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.0 m -73.96 105.96 5.44 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.278 0.561 . . . . 0.0 109.941 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -60.35 129.84 43.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.374 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.479 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 111.97 -28.6 9.17 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 -178.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.508 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 61.0 m -86.94 116.03 24.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 16.1 m -91.76 127.99 37.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.338 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.584 ' HB2' ' SG ' ' A' ' 10' ' ' CYS . 50.5 t -66.53 115.62 6.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.211 0.529 . . . . 0.0 111.821 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.93 149.45 22.26 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' A' ' 21' ' ' LYS . 85.3 tt0 -40.33 -44.08 1.87 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.882 0.873 . . . . 0.0 113.067 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -75.6 32.69 0.11 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.434 ' HE3' ' HB3' ' A' ' 21' ' ' LYS . 12.6 ttpp 51.82 49.31 21.04 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.013 0.525 . . . . 0.0 110.262 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.2 tp -141.56 111.09 6.46 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.157 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.591 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 42.7 m -79.68 132.57 36.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.69 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -125.89 128.05 46.98 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.145 0.497 . . . . 0.0 110.257 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -68.7 141.3 36.37 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.59 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 30' ' ' THR . 6.2 m -140.73 64.72 1.42 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.708 0.766 . . . . 0.0 109.056 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -95.55 122.78 38.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.318 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.76 34.43 77.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.991 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.58 -2.65 71.81 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.754 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 26' ' ' THR . 10.5 m -87.25 121.59 29.91 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 122.556 -0.379 . . . . 0.0 110.168 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.654 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 62.0 mt -102.1 132.17 48.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.591 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.592 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 10.8 p90 -151.9 140.87 21.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.172 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.9 t70 . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.551 -178.971 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.93 62.19 1.3 Allowed Glycine 0 CA--C 1.518 0.221 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.842 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -146.69 -178.67 6.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.409 0.623 . . . . 0.0 111.425 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.3 m -150.71 119.16 6.43 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.087 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.421 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 1.3 p -73.61 60.83 0.69 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.253 0.549 . . . . 0.0 110.831 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -57.26 -41.37 79.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.745 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.444 HD12 ' H ' ' A' ' 9' ' ' THR . 2.1 pp -97.58 28.17 3.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.623 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.33 -41.18 2.24 Favored Glycine 0 CA--C 1.518 0.239 0 CA-C-N 115.681 -0.69 . . . . 0.0 113.165 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.444 ' H ' HD12 ' A' ' 7' ' ' LEU . 9.0 m -101.7 144.87 29.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.852 0.358 . . . . 0.0 111.097 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 30.3 m -96.61 164.16 12.72 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -88.74 -48.62 7.38 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.122 -0.231 . . . . 0.0 111.285 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.0 m -66.17 116.48 7.29 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.437 0.637 . . . . 0.0 110.921 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.506 ' N ' ' HD2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -62.48 132.8 53.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.354 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.49 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 105.51 -30.4 9.91 Favored Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -178.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.505 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 49.9 m -82.56 115.4 21.52 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m -105.24 139.73 39.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.812 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.9 t -62.6 128.36 35.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.347 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -143.03 -159.57 8.0 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.865 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.555 ' HG2' ' CD1' ' A' ' 20' ' ' TRP . 36.4 tt0 -42.63 140.74 1.2 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.611 0.764 . . . . 0.0 112.639 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.555 ' CD1' ' HG2' ' A' ' 19' ' ' GLU . 41.1 m0 64.57 18.67 11.5 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.226 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.0 tptm 58.56 37.09 25.49 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.67 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.7 mt -103.63 139.75 38.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.387 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 69.2 m -84.8 125.34 32.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.298 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -123.1 123.65 41.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.871 0.367 . . . . 0.0 111.193 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.537 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -73.23 130.6 13.84 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.716 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.759 HG23 HG13 ' A' ' 31' ' ' ILE . 1.1 m -129.74 68.3 1.44 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.501 0.667 . . . . 0.0 109.225 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -98.7 127.56 44.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.877 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.9 36.33 79.82 Favored Glycine 0 C--O 1.228 -0.239 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.233 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.89 4.65 72.36 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.611 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 26' ' ' THR . 12.3 m -95.75 123.71 39.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.759 HG13 HG23 ' A' ' 26' ' ' THR . 4.8 mp -102.37 129.59 53.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.149 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.537 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 13.6 p90 -150.33 138.98 20.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.122 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.4 t0 . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.538 -179.015 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.51 54.21 1.98 Allowed Glycine 0 C--N 1.324 -0.135 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.426 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.681 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 97.0 mt-10 -139.26 152.3 47.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.416 0.627 . . . . 0.0 110.899 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.575 ' HB3' ' HE3' ' A' ' 21' ' ' LYS . 30.4 m -130.03 135.34 48.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.035 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 22.7 p -74.1 55.07 0.56 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.258 0.551 . . . . 0.0 111.635 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -64.1 -36.55 84.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.724 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 25.0 tp -98.8 41.47 1.14 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.857 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.07 -42.1 2.49 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.913 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 m -142.47 152.37 42.66 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.681 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 94.7 m -77.77 -157.27 0.1 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.02 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -117.35 -44.68 2.76 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -68.11 110.54 4.02 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.389 0.614 . . . . 0.0 110.681 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -62.73 122.92 17.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.248 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.86 -27.12 7.64 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 61.2 m -82.46 113.67 20.37 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 16.9 m -98.64 131.51 44.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.329 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 2.8 t -67.83 139.32 56.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.853 0.359 . . . . 0.0 111.025 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.421 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -152.41 -149.07 5.02 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-O 119.496 -0.614 . . . . 0.0 111.7 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.455 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 28.5 tp10 -39.6 135.46 1.15 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.541 0.736 . . . . 0.0 112.756 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 43.1 m0 64.51 19.54 11.84 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.851 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.575 ' HE3' ' HB3' ' A' ' 4' ' ' SER . 34.6 ttpt 59.73 38.21 21.81 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.592 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.9 mt -108.33 134.08 51.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.406 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 32.6 m -87.39 131.74 34.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.213 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.421 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 2.7 p90 -124.14 128.82 49.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.084 0.469 . . . . 0.0 109.883 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.631 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -71.65 142.29 33.43 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.858 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.9 t -143.81 63.77 1.34 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 122.17 0.986 . . . . 0.0 109.115 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -89.35 114.8 26.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.297 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.7 33.14 71.34 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.178 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.05 -8.93 76.64 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.653 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 26' ' ' THR . 3.5 m -80.32 116.24 20.29 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.631 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 63.3 mt -98.47 131.62 45.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.771 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.61 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 12.6 p90 -153.18 136.56 15.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.015 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 50.3 t0 . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.808 -178.903 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 54.5 m . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.16 56.17 1.88 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.462 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -141.76 158.84 43.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.6 0.714 . . . . 0.0 111.515 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.4 m -136.99 134.98 37.22 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.496 -1.229 . . . . 0.0 107.817 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.5 p -72.55 56.41 0.38 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.198 0.523 . . . . 0.0 111.769 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -66.51 -39.28 88.58 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.99 39.91 1.01 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.998 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.11 -51.92 3.27 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.121 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 m -127.05 152.27 47.49 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 122.73 -0.276 . . . . 0.0 110.862 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.7 m -71.2 159.8 34.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.122 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -90.4 -45.27 9.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.622 0.249 . . . . 0.0 111.302 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.3 m -70.71 112.35 6.86 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.304 0.573 . . . . 0.0 110.844 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -58.91 131.98 52.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.598 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.449 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 105.87 -27.59 17.04 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.503 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.1 m -86.73 117.43 25.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m -106.0 135.24 47.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.441 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 t -68.42 139.23 55.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.829 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.47 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -152.41 -154.21 6.58 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-O 119.576 -0.569 . . . . 0.0 111.704 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.458 ' O ' ' HG ' ' A' ' 22' ' ' LEU . 36.9 tt0 -39.06 138.53 0.57 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.567 0.747 . . . . 0.0 112.564 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.471 ' HB3' HD23 ' A' ' 22' ' ' LEU . 9.0 t90 65.62 15.49 10.07 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.071 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.9 tttp 58.84 38.76 24.54 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.527 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.471 HD23 ' HB3' ' A' ' 20' ' ' TRP . 4.3 pp -107.97 144.38 35.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.809 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 61.5 m -92.47 127.98 38.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.921 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.47 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 1.9 p90 -119.54 128.85 54.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.092 0.472 . . . . 0.0 110.36 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 15' ' ' CYS . . . -80.93 141.75 22.77 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.669 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 30' ' ' THR . 48.2 m -148.85 104.97 3.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.132 0.491 . . . . 0.0 110.437 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -150.38 147.03 27.08 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.75 33.03 76.02 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.008 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.41 27.02 72.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.396 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 26' ' ' THR . 17.7 m -125.08 132.32 53.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.685 0.278 . . . . 0.0 110.397 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 58.9 mt -112.24 133.87 56.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.889 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -152.81 140.89 20.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.395 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.9 t70 . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.489 -179.162 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.85 53.96 1.7 Allowed Glycine 0 C--O 1.23 -0.136 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.709 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.61 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 53.8 mt-10 -140.71 155.24 46.51 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.157 0.503 . . . . 0.0 110.818 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 p -127.3 135.47 50.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.746 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.583 ' SG ' ' HG3' ' A' ' 21' ' ' LYS . 26.5 p -71.25 94.6 1.2 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -67.22 -34.37 77.34 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.5 mt -114.85 -129.79 0.3 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.451 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.35 -36.73 92.05 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.821 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.0 t -162.8 -172.52 3.12 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.61 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 96.7 m -86.77 -176.71 5.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.764 0.316 . . . . 0.0 111.491 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -90.96 -36.12 14.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.109 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.667 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -61.31 116.57 4.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.223 0.535 . . . . 0.0 111.087 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -61.41 132.32 53.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.993 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.492 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 95.9 -24.43 29.81 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.578 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.667 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 59.2 m -81.38 113.1 19.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.19 0.519 . . . . 0.0 110.481 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.4 m -102.11 136.56 41.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.729 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.1 t -68.84 142.57 54.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.962 0.411 . . . . 0.0 111.213 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.435 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -146.35 -158.74 7.89 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.486 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -44.47 141.72 1.84 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 62.47 20.73 12.13 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.037 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.583 ' HG3' ' SG ' ' A' ' 5' ' ' CYS . 21.3 ttmm 58.86 37.94 24.68 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.953 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.41 127.83 49.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.141 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 64.4 m -89.14 134.63 33.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.137 0.494 . . . . 0.0 111.572 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.435 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 1.4 p90 -125.58 129.42 49.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.015 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -81.5 143.46 23.65 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.86 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 30' ' ' THR . 8.5 m -141.27 66.23 1.37 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.769 0.795 . . . . 0.0 108.981 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -89.52 120.02 30.47 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.385 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.86 36.25 72.03 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.086 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.5 -4.68 71.92 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.962 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 26' ' ' THR . 7.5 m -86.28 119.21 26.31 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 117.113 0.457 . . . . 0.0 110.263 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 56.8 mt -98.05 132.55 42.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.511 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.531 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 12.2 p90 -153.34 142.53 21.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.222 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.3 t70 . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.994 -179.311 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 82.9 m . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.34 57.23 2.41 Favored Glycine 0 C--N 1.323 -0.144 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.784 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -137.01 -178.13 5.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.515 0.674 . . . . 0.0 111.152 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.6 m -151.44 127.68 10.55 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.157 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 p -75.12 55.96 0.76 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.225 0.536 . . . . 0.0 111.293 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -64.9 -30.37 71.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.201 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.5 tp -103.6 37.76 1.95 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.243 0.544 . . . . 0.0 109.859 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.61 -40.44 2.03 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.087 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -130.19 157.19 43.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.995 0.426 . . . . 0.0 111.087 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.5 m -83.3 165.2 19.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.635 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -89.77 -46.69 8.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.793 0.33 . . . . 0.0 111.065 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.6 m -66.36 118.42 10.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.342 0.591 . . . . 0.0 110.943 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.562 ' HD3' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -58.04 134.03 56.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.664 0.745 . . . . 0.0 111.72 -179.236 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.56 -27.55 19.62 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.531 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.541 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 55.8 m -77.81 111.49 13.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.447 0.641 . . . . 0.0 110.149 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -90.41 138.22 31.72 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.774 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.5 t -60.3 124.62 20.86 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.359 0.599 . . . . 0.0 111.433 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.31 147.36 20.73 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -43.68 -46.29 7.36 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.093 0.557 . . . . 0.0 112.352 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 20.7 m-90 -78.57 37.09 0.27 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.579 0.228 . . . . 0.0 111.473 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 79.8 tttt 55.47 37.61 29.12 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.331 0.652 . . . . 0.0 111.015 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.2 mt -106.95 -161.01 0.76 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.893 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 93.2 m -151.27 126.66 10.02 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -127.89 117.11 21.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.127 0.489 . . . . 0.0 111.202 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.553 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -68.22 127.13 23.79 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.758 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.527 HG23 HG12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -122.89 67.79 0.97 Allowed 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.306 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -88.89 113.47 24.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.702 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.67 38.51 88.22 Favored Glycine 0 C--O 1.228 -0.258 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.485 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.91 -3.98 77.35 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.104 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 26' ' ' THR . 13.6 m -87.71 124.91 34.06 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 117.124 0.462 . . . . 0.0 109.846 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 26' ' ' THR . 66.6 mt -102.16 128.23 54.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.042 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.553 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 17.7 p90 -150.06 135.97 18.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.422 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.8 t0 . . . . . 0 C--N 1.324 -0.535 0 CA-C-O 120.758 0.314 . . . . 0.0 110.573 -178.662 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 80.9 m . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.31 63.18 0.79 Allowed Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.0 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -147.75 -178.45 6.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.514 0.673 . . . . 0.0 111.229 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.564 ' HB2' ' HE2' ' A' ' 21' ' ' LYS . 35.7 p -151.56 124.46 8.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.159 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.66 59.54 0.65 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.095 0.474 . . . . 0.0 111.688 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -62.63 -36.57 83.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.744 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.2 tp -97.78 35.89 1.62 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.844 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.93 -45.25 2.2 Favored Glycine 0 CA--C 1.52 0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.251 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 t -116.64 153.12 32.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.91 0.386 . . . . 0.0 111.237 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.7 m -89.96 166.04 13.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.264 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -89.12 -47.44 8.09 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.489 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.5 m -62.08 115.6 4.23 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.471 0.653 . . . . 0.0 110.624 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -63.49 127.03 29.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.369 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.546 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 110.89 -27.94 10.45 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -178.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.525 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 58.0 m -83.88 115.45 22.28 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.3 m -102.32 141.01 35.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.908 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.65 147.49 47.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.353 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.499 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -168.19 -149.58 6.19 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.944 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -35.23 131.92 0.41 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.283 1.033 . . . . 0.0 113.361 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 58.28 24.27 11.34 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.734 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.564 ' HE2' ' HB2' ' A' ' 4' ' ' SER . 1.2 ttpm? 59.16 44.92 15.13 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.6 mt -107.81 148.72 29.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.109 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.1 m -98.64 127.68 44.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.71 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.499 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 3.0 p90 -129.83 123.7 31.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.331 0.586 . . . . 0.0 110.759 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 14' ' ' GLY . . . -80.16 141.81 23.55 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.487 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 30' ' ' THR . 24.0 m -130.16 112.65 13.6 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.973 0.415 . . . . 0.0 110.024 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -143.98 134.94 25.37 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.83 35.61 87.22 Favored Glycine 0 C--O 1.229 -0.212 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.068 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.1 22.95 71.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.391 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 26' ' ' THR . 19.3 m -120.2 131.9 55.16 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.6 mt -106.54 130.66 57.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.137 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -142.1 139.68 32.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.315 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.5 t70 . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.469 -178.825 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.57 54.97 2.04 Favored Glycine 0 C--O 1.229 -0.177 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.473 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -140.58 159.46 42.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.639 0.733 . . . . 0.0 111.355 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.4 t -140.91 137.62 33.28 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.7 p -70.03 64.29 0.23 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.09 0.471 . . . . 0.0 111.942 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -71.01 -32.27 69.01 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.6 tp -103.4 38.46 1.78 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.354 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.12 -48.11 3.0 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.985 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.2 m -122.6 150.53 42.51 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 122.714 -0.286 . . . . 0.0 110.901 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.8 m -74.01 165.11 25.72 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.828 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -89.07 -43.45 11.07 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 120.669 0.271 . . . . 0.0 110.698 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.8 m -74.16 109.69 7.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.568 0.699 . . . . 0.0 110.321 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.968 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -66.03 119.26 11.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.889 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.442 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 124.13 -29.1 5.18 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -177.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.479 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 61.3 m -87.71 114.96 24.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.056 -0.572 . . . . 0.0 109.798 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 20.4 m -97.28 134.27 40.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.175 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 3.9 t -70.26 110.87 5.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.114 0.483 . . . . 0.0 110.382 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.47 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -82.26 159.77 39.48 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.783 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' A' ' 21' ' ' LYS . 9.2 tp10 -34.99 -47.34 0.36 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.978 1.311 . . . . 0.0 113.732 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 7.6 t90 -75.87 29.08 0.11 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.352 0.596 . . . . 0.0 110.965 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.496 ' H ' ' C ' ' A' ' 19' ' ' GLU . 40.5 tttm 50.49 41.05 24.66 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.184 0.994 . . . . 0.0 111.444 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.8 mt -129.21 121.49 27.76 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.187 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 16' ' ' SER . 49.8 m -74.31 129.93 38.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.614 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.47 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 2.7 p90 -133.13 133.53 43.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.051 0.453 . . . . 0.0 110.058 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -71.25 148.81 44.71 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.725 -0.67 . . . . 0.0 113.359 -178.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 30' ' ' THR . 9.1 m -147.28 60.3 1.17 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.136 0.97 . . . . 0.0 108.485 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -90.08 120.73 31.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.878 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.19 36.5 75.54 Favored Glycine 0 C--O 1.228 -0.278 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.261 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.46 1.34 86.17 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.851 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 26' ' ' THR . 11.4 m -92.86 120.91 33.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.975 0.387 . . . . 0.0 110.127 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 4.5 mp -99.81 132.96 44.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.264 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.598 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 14.0 p90 -151.98 137.32 17.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.984 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.1 t0 . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.982 -178.878 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 37.7 m . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.92 60.7 1.34 Allowed Glycine 0 N--CA 1.454 -0.158 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.53 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -148.04 168.72 21.62 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.652 0.739 . . . . 0.0 111.745 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.5 t -149.68 141.23 23.43 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.694 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.0 p -69.77 64.5 0.21 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.967 0.413 . . . . 0.0 111.618 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -74.98 -31.4 61.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.93 0.395 . . . . 0.0 110.159 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 25.9 tp -103.89 45.59 0.95 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.509 0.671 . . . . 0.0 109.374 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.98 -47.38 3.33 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.516 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -137.48 164.17 29.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.627 0.251 . . . . 0.0 110.581 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.3 m -78.79 158.69 28.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.559 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -88.47 -46.53 9.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.413 0.149 . . . . 0.0 111.279 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.7 m -64.06 113.82 3.75 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.275 0.56 . . . . 0.0 110.765 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -61.1 130.9 48.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.676 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.526 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 105.36 -31.47 8.47 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.492 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 62.4 m -83.3 117.16 22.79 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.8 m -109.56 136.79 48.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.508 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.9 t -68.5 134.17 49.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.957 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.4 ' HA3' ' OH ' ' A' ' 24' ' ' TYR . . . -151.48 -145.6 4.16 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.352 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.463 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 26.6 tp10 -39.01 136.24 0.81 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 8.2 t90 62.53 21.53 12.7 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.137 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.8 tttm 56.76 39.37 29.68 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.886 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.62 137.74 47.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.39 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 17' ' ' CYS . 86.3 m -85.88 129.06 34.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.514 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.4 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 2.3 p90 -135.03 135.34 41.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.036 0.446 . . . . 0.0 110.459 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.643 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -70.59 148.54 45.37 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.754 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 30' ' ' THR . 3.3 t -145.59 62.35 1.27 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.307 1.051 . . . . 0.0 109.368 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -89.22 115.96 27.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.585 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.17 35.57 78.23 Favored Glycine 0 C--O 1.227 -0.302 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.157 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.1 -5.43 76.53 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.858 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 26' ' ' THR . 10.2 m -85.2 118.3 24.67 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 117.045 0.422 . . . . 0.0 109.937 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.643 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 64.3 mt -99.4 132.4 44.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.713 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.636 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 10.8 p90 -149.09 136.57 20.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.865 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.6 t70 . . . . . 0 C--N 1.322 -0.591 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.406 -178.464 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 62.5 m . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.34 52.18 2.61 Favored Glycine 0 C--O 1.228 -0.267 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 177.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.651 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 32.8 mm-40 -114.35 160.9 18.59 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.71 -0.745 . . . . 0.0 111.965 -177.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.2 m -151.72 118.65 5.82 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.927 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.3 p -73.59 67.93 1.15 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.068 0.461 . . . . 0.0 111.904 -178.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -58.52 -40.85 84.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.044 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.4 pp -109.22 38.37 2.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.847 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.18 -44.39 2.63 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.865 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 m -101.11 144.62 29.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.66 0.267 . . . . 0.0 110.922 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.4 m -85.06 163.67 18.69 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -87.84 -43.25 11.96 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.623 0.249 . . . . 0.0 110.617 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.444 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 53.1 m -72.71 100.81 2.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.145 0.497 . . . . 0.0 110.037 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 13' ' ' LYS . 12.2 ttpp -60.83 106.32 0.56 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.255 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.487 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 137.44 -21.94 3.23 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.483 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 59.4 m -97.74 122.02 40.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.509 -0.846 . . . . 0.0 110.002 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.6 m -103.83 131.04 51.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.673 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 2.5 t -61.53 135.02 57.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.176 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.23 -144.72 3.98 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.108 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -38.3 133.96 0.9 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.717 0.807 . . . . 0.0 112.962 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 61.12 23.79 13.95 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.165 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.0 tttp 58.56 35.59 24.66 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.907 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.9 mt -109.87 132.52 54.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.741 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.651 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 30.4 m -84.38 133.23 34.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.778 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -120.53 133.68 55.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.098 0.475 . . . . 0.0 110.314 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.507 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -75.06 139.28 24.82 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.431 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 30' ' ' THR . 5.5 m -124.1 72.08 1.15 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.387 0.613 . . . . 0.0 109.795 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -89.06 116.48 27.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.023 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.08 34.32 72.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.265 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.44 -3.08 86.06 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.685 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 26' ' ' THR . 7.1 m -88.15 124.2 33.57 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.769 0.284 . . . . 0.0 110.256 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 4.2 mp -97.12 127.92 48.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.596 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.507 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 17.3 p90 -143.78 140.98 30.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.674 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.4 t70 . . . . . 0 C--N 1.321 -0.631 0 CA-C-O 121.072 0.463 . . . . 0.0 112.025 -178.386 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 81.2 m . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.05 58.8 1.43 Allowed Glycine 0 CA--C 1.517 0.19 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.743 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -141.27 -176.73 4.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.468 0.652 . . . . 0.0 110.878 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 m -151.15 124.81 9.03 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.491 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.2 p -77.32 54.59 1.13 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.958 0.408 . . . . 0.0 111.593 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.641 ' HD1' ' HG ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -62.39 -33.25 74.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.294 179.214 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.641 ' HG ' ' HD1' ' A' ' 6' ' ' PHE . 99.0 mt -96.13 32.08 2.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.91 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.25 -47.69 3.23 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.802 -0.635 . . . . 0.0 113.336 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.1 p -114.29 149.22 36.27 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 122.545 -0.385 . . . . 0.0 112.014 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.5 m -79.78 163.47 24.42 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -89.94 -48.43 7.23 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.911 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.3 m -64.84 117.38 7.45 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.43 0.633 . . . . 0.0 110.669 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -62.51 128.23 35.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.4 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.572 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 110.8 -27.67 10.84 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -178.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.561 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.6 m -80.55 116.32 20.53 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.7 m -94.64 137.84 33.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.221 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 22' ' ' LEU . 12.1 t -76.92 122.23 24.56 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.193 0.521 . . . . 0.0 111.866 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 20' ' ' TRP . . . -91.76 144.86 17.4 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.441 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 3.5 tp10 -69.95 42.46 0.05 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.505 1.145 . . . . 0.0 113.158 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.48 ' H ' ' C ' ' A' ' 18' ' ' GLY . 96.6 m95 -133.08 12.72 4.27 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 175.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER 62.51 39.55 11.6 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 111.865 -2.425 . . . . 0.0 109.272 -178.838 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 17' ' ' CYS . 90.1 mt -116.11 178.71 4.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.48 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 93.9 m -141.75 127.53 19.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.466 0.174 . . . . 0.0 110.63 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -133.36 122.71 24.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.292 0.567 . . . . 0.0 110.835 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 14' ' ' GLY . . . -77.63 150.04 35.84 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.458 -0.792 . . . . 0.0 113.343 -179.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 30' ' ' THR . 6.6 t -132.21 123.29 26.72 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.349 0.595 . . . . 0.0 109.762 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -150.56 129.18 12.27 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.68 35.27 85.49 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.168 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.89 23.44 74.26 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.476 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 26' ' ' THR . 23.6 m -118.3 132.09 56.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.8 mm -103.38 130.93 52.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.431 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -144.71 129.96 18.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.88 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.9 t70 . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.361 -178.519 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.58 55.16 2.05 Favored Glycine 0 C--N 1.321 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.984 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.53 ' OE2' ' HB2' ' A' ' 11' ' ' TYR . 57.7 mt-10 -135.17 154.42 51.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.192 0.52 . . . . 0.0 111.109 -178.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 t -137.85 132.91 33.26 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.66 ' SG ' ' HE2' ' A' ' 21' ' ' LYS . 8.5 p -69.27 85.56 0.39 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.228 0.537 . . . . 0.0 111.808 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -67.55 -34.62 77.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.483 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.55 39.77 3.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.714 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.86 -40.66 2.3 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.791 -0.64 . . . . 0.0 113.187 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.2 m -102.02 148.89 24.83 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.678 -0.307 . . . . 0.0 111.074 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 35.0 m -85.22 -155.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.53 ' HB2' ' OE2' ' A' ' 3' ' ' GLU . 16.9 m-85 -127.69 -49.71 1.37 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.453 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.437 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 98.6 m -72.32 121.93 20.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.196 0.522 . . . . 0.0 110.538 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -61.21 127.77 33.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.766 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.5 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 106.61 -29.23 11.23 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -178.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.507 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 59.2 m -81.59 120.76 25.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.916 0.389 . . . . 0.0 110.15 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.4 m -112.54 132.33 55.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.214 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 3.8 t -65.7 137.47 57.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.759 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -160.28 -148.88 5.4 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.661 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.504 ' O ' ' HG ' ' A' ' 22' ' ' LEU . 5.8 tp10 -40.81 143.0 0.4 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.889 0.876 . . . . 0.0 113.125 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 12.9 t-105 66.52 17.61 10.67 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.071 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.66 ' HE2' ' SG ' ' A' ' 5' ' ' CYS . 0.2 OUTLIER 56.64 45.18 22.56 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.171 179.406 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 19' ' ' GLU . 4.6 pp -133.42 151.24 51.79 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.649 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 17' ' ' CYS . 78.8 m -89.5 131.11 35.7 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.026 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -128.96 133.51 47.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.038 0.447 . . . . 0.0 110.034 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.744 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -69.85 142.32 36.26 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.45 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.8 t -150.46 62.86 0.95 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.841 0.829 . . . . 0.0 110.084 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.494 ' OD1' ' HB ' ' A' ' 30' ' ' THR . 15.2 p-10 -89.9 112.98 24.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.589 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.99 34.06 65.06 Favored Glycine 0 C--O 1.227 -0.3 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.664 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.88 -14.54 65.15 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.06 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 26' ' ' THR . 2.3 m -75.15 114.42 13.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.292 0.546 . . . . 0.0 109.793 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.626 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 30.9 mm -102.71 135.31 40.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.141 -179.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.744 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 7.2 p90 -158.5 137.47 11.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.895 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.69 -178.855 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.422 ' C ' ' H ' ' A' ' 3' ' ' GLU . 53.3 m . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.11 46.0 2.37 Favored Glycine 0 C--O 1.229 -0.204 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.678 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 40.3 mm-40 -111.62 159.72 17.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.654 -0.773 . . . . 0.0 111.488 -178.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.1 t -151.01 131.93 14.2 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.76 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.464 ' SG ' ' HD2' ' A' ' 21' ' ' LYS . 22.9 p -79.07 51.8 1.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.044 0.449 . . . . 0.0 111.391 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -66.63 -32.94 74.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.923 0.392 . . . . 0.0 110.065 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 26.2 tp -100.02 40.17 1.27 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.423 0.63 . . . . 0.0 109.583 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.52 -43.02 2.68 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.026 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.4 m -138.06 149.06 45.66 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.416 -0.461 . . . . 0.0 110.845 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.6 m -68.88 159.38 32.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.894 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -88.01 -42.7 12.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.63 0.252 . . . . 0.0 111.288 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.466 ' HB ' ' HG3' ' A' ' 3' ' ' GLU . 71.2 m -71.93 106.54 4.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.366 0.603 . . . . 0.0 110.833 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.14 127.38 31.65 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.468 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.51 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 110.9 -28.29 10.05 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.636 -0.985 . . . . 0.0 110.636 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.506 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 62.7 m -85.59 119.03 25.48 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.6 m -102.84 132.01 49.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.597 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 4.0 t -63.09 140.75 58.9 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.074 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.46 -154.0 6.5 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.196 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -43.24 142.84 0.95 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.418 0.687 . . . . 0.0 112.755 -178.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 17.9 t-105 62.56 20.4 11.95 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.121 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.464 ' HD2' ' SG ' ' A' ' 5' ' ' CYS . 3.3 tppp? 57.84 38.85 27.26 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.499 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.1 tp -113.18 131.59 55.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.952 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.678 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 32.0 m -88.79 138.15 31.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.206 0.527 . . . . 0.0 111.451 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -132.38 134.24 44.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.82 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.758 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -67.56 142.67 40.96 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.743 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 30' ' ' THR . 3.2 t -150.82 62.47 0.93 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.813 0.816 . . . . 0.0 110.346 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.418 ' OD1' ' HB ' ' A' ' 30' ' ' THR . 15.1 p-10 -89.83 113.64 25.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.213 0.53 . . . . 0.0 110.728 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.9 34.71 61.88 Favored Glycine 0 C--O 1.227 -0.286 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.804 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.13 -14.54 65.06 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.047 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 26' ' ' THR . 2.3 m -75.22 113.39 12.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.266 0.533 . . . . 0.0 109.733 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.611 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 28.9 mm -103.05 135.58 39.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.201 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.758 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 6.9 p90 -159.63 138.29 10.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.949 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.44 -179.069 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 57.4 m . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 121.2 0.524 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.03 61.22 1.75 Allowed Glycine 0 C--O 1.23 -0.13 0 CA-C-N 115.031 -0.986 . . . . 0.0 113.125 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.459 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 13.2 mt-10 -139.58 -172.07 3.28 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.87 0.367 . . . . 0.0 110.496 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t -150.81 115.21 5.13 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.649 179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 p -79.34 55.94 2.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.343 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.872 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 25.1 t80 -56.5 -40.74 75.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.404 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 54.7 tp -76.86 -49.27 16.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.549 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.24 -38.51 0.16 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.3 m -141.37 143.46 33.99 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.459 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 83.0 m -76.76 -176.79 4.0 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 123.256 0.347 . . . . 0.0 111.013 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -89.12 -40.16 13.11 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.4 m -62.19 111.64 2.05 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.324 0.583 . . . . 0.0 110.854 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -64.86 118.42 9.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.627 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.66 -28.84 5.82 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 61.3 m -80.03 114.1 18.69 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.3 m -101.08 136.55 40.75 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.794 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.6 t -67.61 133.82 50.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.081 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.89 -154.12 6.49 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.478 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -41.69 140.58 0.95 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.549 0.74 . . . . 0.0 112.681 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 11.0 t90 66.71 16.12 10.3 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.135 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.872 ' HE3' ' HA ' ' A' ' 6' ' ' PHE . 56.9 tttp 57.32 41.43 26.6 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.833 0.825 . . . . 0.0 109.04 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.7 tp -116.52 145.0 43.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.647 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 87.4 m -92.49 131.85 37.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.178 0.514 . . . . 0.0 111.615 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -121.47 127.9 51.55 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.679 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -70.3 142.18 35.28 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.152 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.2 t -148.61 60.02 1.08 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 122.584 1.183 . . . . 0.0 108.257 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -89.14 110.85 21.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.294 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.28 34.16 87.15 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.002 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.74 -11.36 68.94 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.764 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 26' ' ' THR . 2.3 m -78.83 114.88 18.13 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.977 0.388 . . . . 0.0 110.002 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.679 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 60.5 mt -100.22 132.99 44.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.64 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.576 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 8.0 p90 -158.78 142.02 14.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.323 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.8 t70 . . . . . 0 C--N 1.323 -0.569 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.442 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 57.2 m . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.07 58.27 2.28 Favored Glycine 0 C--O 1.228 -0.259 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.592 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 2.5 mm-40 -106.21 179.3 4.31 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.6 m -150.02 83.15 1.38 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.836 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.572 ' O ' ' HE2' ' A' ' 21' ' ' LYS . 1.9 p -72.87 56.57 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.883 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -58.53 -34.23 70.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.814 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.5 tp -95.83 24.19 5.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.279 0.561 . . . . 0.0 110.174 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.96 -39.44 2.23 Favored Glycine 0 C--O 1.228 -0.278 0 CA-C-N 116.002 -0.544 . . . . 0.0 113.192 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 t -96.05 147.51 23.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.05 0.452 . . . . 0.0 111.249 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 20.5 m -99.18 156.47 16.95 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -89.51 -39.51 13.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.994 0.426 . . . . 0.0 110.271 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 m -71.55 111.38 6.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.599 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.541 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -61.04 134.45 57.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.544 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.512 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 102.31 -31.02 9.19 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -178.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.512 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.7 m -86.39 119.3 26.51 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m -107.65 136.03 48.09 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.954 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.9 t -66.25 136.12 55.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.027 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.475 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -155.91 -145.57 4.22 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.598 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -40.1 135.0 1.45 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.429 0.691 . . . . 0.0 112.837 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 18.1 t-105 62.54 21.69 12.81 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.142 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.572 ' HE2' ' O ' ' A' ' 5' ' ' CYS . 70.0 tttt 54.91 43.6 29.67 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.245 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.4 tp -113.83 137.5 51.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.997 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.592 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 59.7 m -85.05 126.31 33.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.988 0.423 . . . . 0.0 111.28 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.475 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 1.6 p90 -124.24 130.04 51.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.231 0.538 . . . . 0.0 110.091 178.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.631 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -72.32 143.2 33.96 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.948 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 30' ' ' THR . 11.2 m -138.2 66.2 1.45 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.628 0.728 . . . . 0.0 109.088 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -89.01 115.8 26.84 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.33 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.43 35.33 71.57 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.934 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.94 -5.18 77.2 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.787 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 26' ' ' THR . 14.0 m -84.19 123.13 29.77 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 117.066 0.433 . . . . 0.0 110.135 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 39.4 mm -95.33 133.07 37.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.61 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.631 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 23.0 p90 -152.37 135.26 15.55 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 50.1 t0 . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.098 -178.725 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 64.6 m . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 120.814 0.34 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.71 48.27 2.91 Favored Glycine 0 C--O 1.229 -0.175 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 21.5 mm-40 -80.44 -176.05 5.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.743 -0.729 . . . . 0.0 112.801 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 65.9 m -150.6 63.15 0.94 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.481 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.4 p -72.85 57.03 0.43 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.236 0.541 . . . . 0.0 110.368 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -57.52 -40.36 78.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.808 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.1 mt -80.95 -49.33 11.11 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.814 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.09 -39.72 0.46 Allowed Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 p -86.97 142.5 27.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.269 -0.465 . . . . 0.0 110.86 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.4 m -100.04 162.42 12.99 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -89.56 -50.8 5.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.693 0.282 . . . . 0.0 111.151 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.6 m -64.93 118.7 9.46 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.337 0.589 . . . . 0.0 111.61 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -59.95 133.06 55.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.232 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.01 -27.29 20.66 Favored Glycine 0 N--CA 1.44 -1.08 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.506 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.5 m -83.19 112.89 20.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.897 0.38 . . . . 0.0 109.993 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.6 m -102.19 130.06 48.74 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.011 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 24.4 t -62.79 104.88 0.58 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.222 0.534 . . . . 0.0 110.705 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.47 154.82 49.44 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-O 119.196 -0.78 . . . . 0.0 111.194 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.522 ' C ' ' H ' ' A' ' 21' ' ' LYS . 41.5 tt0 -40.31 -42.77 1.6 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.127 0.971 . . . . 0.0 112.873 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.698 ' CD1' ' HB2' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -73.86 25.73 0.07 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.088 0.47 . . . . 0.0 111.304 179.083 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 19' ' ' GLU . 39.9 tttp 52.17 44.8 29.34 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.579 1.151 . . . . 0.0 111.757 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.698 ' HB2' ' CD1' ' A' ' 20' ' ' TRP . 98.0 mt -139.59 119.25 13.16 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.328 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 16' ' ' SER . 31.9 m -70.96 127.6 33.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.195 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -116.64 127.43 54.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.698 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -75.56 130.51 11.23 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.224 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.728 HG23 HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -133.47 64.53 1.61 Allowed 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -95.45 124.35 39.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.518 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.5 34.81 77.14 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.094 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.98 -0.35 72.91 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.665 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 26' ' ' THR . 7.9 m -89.21 121.13 31.22 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.728 HG12 HG23 ' A' ' 26' ' ' THR . 50.7 mt -102.0 131.37 50.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.54 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.525 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 12.6 p90 -156.7 142.31 17.65 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.039 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.7 t0 . . . . . 0 C--N 1.324 -0.533 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.498 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 39.0 m . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.78 61.76 1.26 Allowed Glycine 0 CA--C 1.517 0.206 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.446 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -146.39 173.29 12.4 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.419 0.628 . . . . 0.0 111.576 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.9 p -150.13 135.41 18.03 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.392 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.576 ' SG ' ' HG3' ' A' ' 21' ' ' LYS . 28.8 p -74.61 61.55 0.97 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.089 0.471 . . . . 0.0 111.803 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.624 ' HD1' ' HG ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -65.4 -35.61 81.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.022 179.138 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.624 ' HG ' ' HD1' ' A' ' 6' ' ' PHE . 90.4 mt -99.24 39.03 1.32 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.205 0.526 . . . . 0.0 110.065 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.87 -49.78 3.52 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.292 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 m -123.57 148.47 46.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.867 0.333 . . . . 0.0 111.114 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.4 m -75.35 164.05 26.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.659 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -88.38 -48.11 7.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.45 0.167 . . . . 0.0 111.336 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.7 m -65.1 116.06 6.1 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.285 0.564 . . . . 0.0 111.042 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -59.77 132.01 52.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.108 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.498 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 101.98 -28.16 17.19 Favored Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.501 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 60.3 m -81.3 112.01 18.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.147 0.499 . . . . 0.0 110.118 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m -98.95 137.92 36.81 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.354 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.8 t -72.32 140.07 48.31 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.895 0.379 . . . . 0.0 110.802 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.444 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -144.51 -156.26 6.75 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -43.24 139.52 1.87 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.549 ' HE3' HD11 ' A' ' 22' ' ' LEU . 4.5 t90 60.06 24.36 13.58 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.343 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.576 ' HG3' ' SG ' ' A' ' 5' ' ' CYS . 22.2 ttmm 58.45 37.4 25.68 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.312 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.549 HD11 ' HE3' ' A' ' 20' ' ' TRP . 89.7 mt -94.84 127.84 41.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.417 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.3 m -88.06 130.84 34.88 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.444 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 3.0 p90 -133.83 128.76 35.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.185 0.517 . . . . 0.0 110.403 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.619 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -70.75 140.06 31.04 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.963 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 30' ' ' THR . 6.7 m -138.56 64.71 1.48 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -98.46 126.01 43.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.562 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.31 35.71 79.89 Favored Glycine 0 C--O 1.228 -0.228 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.365 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.3 2.79 74.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.735 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 26' ' ' THR . 10.0 m -94.11 122.98 37.18 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 120.681 0.277 . . . . 0.0 110.411 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.619 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 4.5 mp -102.73 131.42 50.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.201 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.583 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 11.6 p90 -151.05 137.55 18.67 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.046 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.9 t70 . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.245 -178.715 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.55 57.83 2.5 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.233 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -138.2 167.74 21.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.655 0.74 . . . . 0.0 111.91 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t -143.8 132.98 23.03 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.185 -1.37 . . . . 0.0 107.583 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.462 ' SG ' ' HG3' ' A' ' 21' ' ' LYS . 28.8 p -73.4 60.87 0.64 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.332 0.587 . . . . 0.0 111.527 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -66.6 -39.7 88.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.6 mt -93.59 38.47 1.06 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.21 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.62 -50.24 3.2 Favored Glycine 0 CA--C 1.52 0.373 0 CA-C-N 115.835 -0.62 . . . . 0.0 113.087 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 m -125.99 149.16 49.01 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.681 -0.305 . . . . 0.0 110.956 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.6 m -74.05 159.33 32.82 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -88.98 -38.73 14.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.44 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 7.2 m -67.5 122.25 17.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.24 0.543 . . . . 0.0 111.393 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -60.41 127.82 33.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.728 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.09 -26.98 22.14 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.509 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.495 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.9 m -79.69 114.8 18.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.197 0.522 . . . . 0.0 110.205 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.7 m -108.6 138.11 45.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.935 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 5' ' ' CYS . 5.9 t -66.68 134.3 51.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.999 0.428 . . . . 0.0 111.085 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -143.3 -155.45 6.43 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.483 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 26.1 tp10 -42.12 137.7 1.82 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 12.4 t90 65.68 20.33 11.53 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.906 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' HG3' ' SG ' ' A' ' 5' ' ' CYS . 15.0 ttmm 56.0 37.78 29.23 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.969 0.89 . . . . 0.0 109.144 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.4 tp -102.67 136.88 41.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.166 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 61.3 m -87.21 127.66 35.15 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.903 0.383 . . . . 0.0 111.256 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -118.77 128.5 54.54 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.625 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -77.64 131.2 10.86 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.835 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.0 t -134.97 67.91 1.48 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 122.045 0.926 . . . . 0.0 109.104 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -89.13 110.6 21.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.3 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.25 36.65 91.39 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.325 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.25 -7.17 72.94 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.101 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 26' ' ' THR . 9.0 m -84.91 122.36 29.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.132 0.466 . . . . 0.0 109.863 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 5.4 tp -96.55 142.85 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.097 0.475 . . . . 0.0 110.715 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.625 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 23.5 p90 -162.08 132.79 4.97 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.4 t70 . . . . . 0 C--N 1.321 -0.665 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.311 -178.426 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.434 ' C ' ' H ' ' A' ' 3' ' ' GLU . 17.8 m . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.34 42.24 1.91 Allowed Glycine 0 CA--C 1.517 0.215 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.682 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 21.2 mm-40 -90.85 171.46 9.3 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 123.713 0.805 . . . . 0.0 111.647 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.0 m -152.07 119.16 5.86 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.76 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.4 p -78.24 48.94 0.78 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.978 0.418 . . . . 0.0 111.502 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.622 ' HD1' ' HG ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -65.56 -32.1 73.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.723 179.34 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.622 ' HG ' ' HD1' ' A' ' 6' ' ' PHE . 96.2 mt -99.19 39.0 1.32 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.129 0.49 . . . . 0.0 109.953 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.99 -41.47 2.61 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.838 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.3 m -136.2 150.04 48.83 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.55 -0.382 . . . . 0.0 110.63 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.4 m -69.25 160.8 30.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.704 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -87.65 -45.5 10.35 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.249 -0.18 . . . . 0.0 111.418 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.8 m -66.18 113.43 4.53 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.435 0.636 . . . . 0.0 110.595 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -59.38 133.14 55.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.432 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.454 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 101.06 -29.47 12.44 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -178.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.481 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 60.8 m -82.48 113.98 20.59 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 15.8 m -103.24 129.02 50.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.295 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.7 t -63.01 130.54 45.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.875 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -137.2 -153.8 6.49 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.901 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -43.41 139.65 1.94 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.613 ' HE3' HD11 ' A' ' 22' ' ' LEU . 3.4 t90 58.1 27.91 15.63 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.805 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' A' ' 21' ' ' LYS . 11.9 ttpt 60.2 34.99 21.03 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.231 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.613 HD11 ' HE3' ' A' ' 20' ' ' TRP . 92.8 mt -101.58 117.32 34.67 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.289 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.682 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 58.2 m -82.38 127.11 32.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -117.13 129.54 56.04 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.894 0.378 . . . . 0.0 110.521 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -75.8 135.41 17.95 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.514 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 30' ' ' THR . 1.2 t -144.21 65.22 1.3 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 122.193 0.997 . . . . 0.0 109.098 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -92.17 120.15 32.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.223 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.31 34.52 74.7 Favored Glycine 0 C--O 1.228 -0.229 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.252 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.15 -6.8 74.12 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.979 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 26' ' ' THR . 7.0 m -84.59 115.87 22.86 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.25 0.525 . . . . 0.0 109.908 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.663 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 62.7 mt -100.41 133.6 42.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.206 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.594 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 8.6 p90 -154.95 140.77 18.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.018 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 C--N 1.323 -0.563 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.125 -179.088 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.16 58.88 1.48 Allowed Glycine 0 C--O 1.229 -0.165 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.929 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -144.73 161.72 38.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.513 0.673 . . . . 0.0 111.344 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.5 m -135.84 129.7 32.79 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.29 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 25.0 p -69.61 65.98 0.21 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -66.85 -38.55 86.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.3 mt -99.11 45.67 0.99 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.359 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.11 -46.94 3.06 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.264 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -136.91 161.09 36.96 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 96.4 m -85.77 177.68 7.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.484 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -88.55 -43.35 11.46 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.2 m -64.36 110.29 2.21 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.423 0.63 . . . . 0.0 110.634 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.48 ' NZ ' ' HB2' ' A' ' 13' ' ' LYS . 4.4 ttmp? -64.58 123.17 18.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.193 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.429 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 117.58 -29.64 6.55 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 64.2 m -82.23 111.66 18.53 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.219 -0.49 . . . . 0.0 109.863 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 16.1 m -102.12 133.49 46.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.4 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.8 t -67.85 131.42 45.49 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.301 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.22 -140.77 3.22 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-O 119.251 -0.749 . . . . 0.0 111.878 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.453 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 27.7 tp10 -37.08 133.97 0.59 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.642 0.777 . . . . 0.0 112.988 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 42.5 m0 62.94 20.14 12.05 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.553 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.4 tttm 57.72 38.0 27.38 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.748 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.3 mt -113.0 139.82 48.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.298 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 68.7 m -83.99 131.6 34.82 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.391 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -128.24 133.79 48.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.812 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.604 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -70.52 146.09 41.59 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.723 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 30' ' ' THR . 16.9 m -139.92 62.04 1.52 Allowed 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -89.73 116.0 27.51 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.612 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.46 35.39 79.53 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.843 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.99 -4.11 77.08 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.689 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 26' ' ' THR . 16.2 m -84.74 122.4 29.06 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.038 0.419 . . . . 0.0 110.196 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 37.3 mm -98.0 133.59 39.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.311 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.604 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 17.9 p90 -155.34 137.36 14.6 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.7 t70 . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.456 -178.844 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 59.1 m . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.57 48.75 2.28 Favored Glycine 0 N--CA 1.459 0.209 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.591 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 23.5 mm-40 -85.42 174.21 9.7 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.7 0.762 . . . . 0.0 112.854 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.2 m -150.24 74.97 1.22 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.733 -1.122 . . . . 0.0 109.519 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 p -71.25 54.01 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.18 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.671 ' HD1' ' HG ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -65.33 -27.7 68.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.027 0.441 . . . . 0.0 109.996 178.883 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.671 ' HG ' ' HD1' ' A' ' 6' ' ' PHE . 97.0 mt -95.9 27.13 3.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.71 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.12 -43.07 2.19 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.913 -0.585 . . . . 0.0 113.323 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -99.53 148.91 23.78 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.182 0.515 . . . . 0.0 111.431 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 9.5 m -90.74 158.73 16.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.403 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -88.13 -42.91 12.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.968 0.413 . . . . 0.0 110.347 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.0 m -73.96 105.96 5.44 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.278 0.561 . . . . 0.0 109.941 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -60.35 129.84 43.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.374 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.479 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 111.97 -28.6 9.17 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 -178.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.508 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 61.0 m -86.94 116.03 24.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 16.1 m -91.76 127.99 37.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.338 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.584 ' HB2' ' SG ' ' A' ' 10' ' ' CYS . 50.5 t -66.53 115.62 6.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.211 0.529 . . . . 0.0 111.821 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.93 149.45 22.26 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' A' ' 21' ' ' LYS . 85.3 tt0 -40.33 -44.08 1.87 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.882 0.873 . . . . 0.0 113.067 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -75.6 32.69 0.11 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.434 ' HE3' ' HB3' ' A' ' 21' ' ' LYS . 12.6 ttpp 51.82 49.31 21.04 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.013 0.525 . . . . 0.0 110.262 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.2 tp -141.56 111.09 6.46 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.157 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.591 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 42.7 m -79.68 132.57 36.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.69 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -125.89 128.05 46.98 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.145 0.497 . . . . 0.0 110.257 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -68.7 141.3 36.37 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.59 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 30' ' ' THR . 6.2 m -140.73 64.72 1.42 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.708 0.766 . . . . 0.0 109.056 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -95.55 122.78 38.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.318 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.76 34.43 77.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.991 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.58 -2.65 71.81 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.754 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 26' ' ' THR . 10.5 m -87.25 121.59 29.91 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 122.556 -0.379 . . . . 0.0 110.168 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.654 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 62.0 mt -102.1 132.17 48.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.591 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.592 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 10.8 p90 -151.9 140.87 21.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.172 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.9 t70 . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.551 -178.971 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.93 62.19 1.3 Allowed Glycine 0 CA--C 1.518 0.221 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.842 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -146.69 -178.67 6.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.409 0.623 . . . . 0.0 111.425 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.3 m -150.71 119.16 6.43 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.087 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.421 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 1.3 p -73.61 60.83 0.69 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.253 0.549 . . . . 0.0 110.831 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -57.26 -41.37 79.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.745 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.444 HD12 ' H ' ' A' ' 9' ' ' THR . 2.1 pp -97.58 28.17 3.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.623 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.33 -41.18 2.24 Favored Glycine 0 CA--C 1.518 0.239 0 CA-C-N 115.681 -0.69 . . . . 0.0 113.165 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.444 ' H ' HD12 ' A' ' 7' ' ' LEU . 9.0 m -101.7 144.87 29.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.852 0.358 . . . . 0.0 111.097 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 30.3 m -96.61 164.16 12.72 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -88.74 -48.62 7.38 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.122 -0.231 . . . . 0.0 111.285 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.0 m -66.17 116.48 7.29 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.437 0.637 . . . . 0.0 110.921 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.506 ' N ' ' HD2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -62.48 132.8 53.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.354 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.49 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 105.51 -30.4 9.91 Favored Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -178.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.505 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 49.9 m -82.56 115.4 21.52 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m -105.24 139.73 39.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.812 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.9 t -62.6 128.36 35.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.347 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -143.03 -159.57 8.0 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.865 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.555 ' HG2' ' CD1' ' A' ' 20' ' ' TRP . 36.4 tt0 -42.63 140.74 1.2 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.611 0.764 . . . . 0.0 112.639 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.555 ' CD1' ' HG2' ' A' ' 19' ' ' GLU . 41.1 m0 64.57 18.67 11.5 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.226 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.0 tptm 58.56 37.09 25.49 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.67 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.7 mt -103.63 139.75 38.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.387 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 69.2 m -84.8 125.34 32.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.298 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -123.1 123.65 41.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.871 0.367 . . . . 0.0 111.193 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.537 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -73.23 130.6 13.84 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.716 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.759 HG23 HG13 ' A' ' 31' ' ' ILE . 1.1 m -129.74 68.3 1.44 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.501 0.667 . . . . 0.0 109.225 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -98.7 127.56 44.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.877 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.9 36.33 79.82 Favored Glycine 0 C--O 1.228 -0.239 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.233 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.89 4.65 72.36 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.611 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 26' ' ' THR . 12.3 m -95.75 123.71 39.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.759 HG13 HG23 ' A' ' 26' ' ' THR . 4.8 mp -102.37 129.59 53.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.149 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.537 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 13.6 p90 -150.33 138.98 20.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.122 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.4 t0 . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.538 -179.015 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.51 54.21 1.98 Allowed Glycine 0 C--N 1.324 -0.135 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.426 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.681 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 97.0 mt-10 -139.26 152.3 47.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.416 0.627 . . . . 0.0 110.899 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.575 ' HB3' ' HE3' ' A' ' 21' ' ' LYS . 30.4 m -130.03 135.34 48.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.035 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 22.7 p -74.1 55.07 0.56 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.258 0.551 . . . . 0.0 111.635 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -64.1 -36.55 84.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.724 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 25.0 tp -98.8 41.47 1.14 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.857 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.07 -42.1 2.49 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.913 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 m -142.47 152.37 42.66 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.681 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 94.7 m -77.77 -157.27 0.1 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.02 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -117.35 -44.68 2.76 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -68.11 110.54 4.02 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.389 0.614 . . . . 0.0 110.681 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -62.73 122.92 17.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.248 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.86 -27.12 7.64 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 61.2 m -82.46 113.67 20.37 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 16.9 m -98.64 131.51 44.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.329 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 2.8 t -67.83 139.32 56.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.853 0.359 . . . . 0.0 111.025 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.421 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -152.41 -149.07 5.02 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-O 119.496 -0.614 . . . . 0.0 111.7 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.455 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 28.5 tp10 -39.6 135.46 1.15 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.541 0.736 . . . . 0.0 112.756 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 43.1 m0 64.51 19.54 11.84 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.851 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.575 ' HE3' ' HB3' ' A' ' 4' ' ' SER . 34.6 ttpt 59.73 38.21 21.81 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.592 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.9 mt -108.33 134.08 51.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.406 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 32.6 m -87.39 131.74 34.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.213 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.421 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 2.7 p90 -124.14 128.82 49.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.084 0.469 . . . . 0.0 109.883 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.631 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -71.65 142.29 33.43 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.858 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.9 t -143.81 63.77 1.34 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 122.17 0.986 . . . . 0.0 109.115 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -89.35 114.8 26.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.297 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.7 33.14 71.34 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.178 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.05 -8.93 76.64 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.653 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 26' ' ' THR . 3.5 m -80.32 116.24 20.29 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.631 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 63.3 mt -98.47 131.62 45.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.771 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.61 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 12.6 p90 -153.18 136.56 15.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.015 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 50.3 t0 . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.808 -178.903 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 54.5 m . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.16 56.17 1.88 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.462 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -141.76 158.84 43.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.6 0.714 . . . . 0.0 111.515 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.4 m -136.99 134.98 37.22 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.496 -1.229 . . . . 0.0 107.817 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.5 p -72.55 56.41 0.38 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.198 0.523 . . . . 0.0 111.769 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -66.51 -39.28 88.58 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.99 39.91 1.01 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.998 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.11 -51.92 3.27 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.121 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 m -127.05 152.27 47.49 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 122.73 -0.276 . . . . 0.0 110.862 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.7 m -71.2 159.8 34.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.122 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -90.4 -45.27 9.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.622 0.249 . . . . 0.0 111.302 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.3 m -70.71 112.35 6.86 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.304 0.573 . . . . 0.0 110.844 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -58.91 131.98 52.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.598 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.449 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 105.87 -27.59 17.04 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.503 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.1 m -86.73 117.43 25.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m -106.0 135.24 47.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.441 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 t -68.42 139.23 55.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.829 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.47 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -152.41 -154.21 6.58 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-O 119.576 -0.569 . . . . 0.0 111.704 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.458 ' O ' ' HG ' ' A' ' 22' ' ' LEU . 36.9 tt0 -39.06 138.53 0.57 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.567 0.747 . . . . 0.0 112.564 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.471 ' HB3' HD23 ' A' ' 22' ' ' LEU . 9.0 t90 65.62 15.49 10.07 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.071 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.9 tttp 58.84 38.76 24.54 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.527 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.471 HD23 ' HB3' ' A' ' 20' ' ' TRP . 4.3 pp -107.97 144.38 35.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.809 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 61.5 m -92.47 127.98 38.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.921 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.47 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 1.9 p90 -119.54 128.85 54.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.092 0.472 . . . . 0.0 110.36 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 15' ' ' CYS . . . -80.93 141.75 22.77 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.669 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 30' ' ' THR . 48.2 m -148.85 104.97 3.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.132 0.491 . . . . 0.0 110.437 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -150.38 147.03 27.08 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.75 33.03 76.02 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.008 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.41 27.02 72.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.396 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 26' ' ' THR . 17.7 m -125.08 132.32 53.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.685 0.278 . . . . 0.0 110.397 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 58.9 mt -112.24 133.87 56.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.889 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -152.81 140.89 20.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.395 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.9 t70 . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.489 -179.162 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.85 53.96 1.7 Allowed Glycine 0 C--O 1.23 -0.136 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.709 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.61 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 53.8 mt-10 -140.71 155.24 46.51 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.157 0.503 . . . . 0.0 110.818 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 p -127.3 135.47 50.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.746 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.583 ' SG ' ' HG3' ' A' ' 21' ' ' LYS . 26.5 p -71.25 94.6 1.2 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -67.22 -34.37 77.34 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.5 mt -114.85 -129.79 0.3 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.451 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.35 -36.73 92.05 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.821 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.0 t -162.8 -172.52 3.12 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.61 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 96.7 m -86.77 -176.71 5.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.764 0.316 . . . . 0.0 111.491 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -90.96 -36.12 14.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.109 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.667 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -61.31 116.57 4.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.223 0.535 . . . . 0.0 111.087 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -61.41 132.32 53.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.993 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.492 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 95.9 -24.43 29.81 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.578 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.667 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 59.2 m -81.38 113.1 19.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.19 0.519 . . . . 0.0 110.481 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.4 m -102.11 136.56 41.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.729 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.1 t -68.84 142.57 54.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.962 0.411 . . . . 0.0 111.213 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.435 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -146.35 -158.74 7.89 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.486 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -44.47 141.72 1.84 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 62.47 20.73 12.13 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.037 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.583 ' HG3' ' SG ' ' A' ' 5' ' ' CYS . 21.3 ttmm 58.86 37.94 24.68 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.953 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.41 127.83 49.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.141 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 64.4 m -89.14 134.63 33.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.137 0.494 . . . . 0.0 111.572 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.435 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 1.4 p90 -125.58 129.42 49.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.015 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -81.5 143.46 23.65 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.86 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 30' ' ' THR . 8.5 m -141.27 66.23 1.37 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.769 0.795 . . . . 0.0 108.981 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -89.52 120.02 30.47 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.385 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.86 36.25 72.03 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.086 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.5 -4.68 71.92 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.962 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 26' ' ' THR . 7.5 m -86.28 119.21 26.31 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 117.113 0.457 . . . . 0.0 110.263 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 56.8 mt -98.05 132.55 42.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.511 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.531 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 12.2 p90 -153.34 142.53 21.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.222 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.3 t70 . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.994 -179.311 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 82.9 m . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.34 57.23 2.41 Favored Glycine 0 C--N 1.323 -0.144 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.784 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -137.01 -178.13 5.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.515 0.674 . . . . 0.0 111.152 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.6 m -151.44 127.68 10.55 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.157 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 p -75.12 55.96 0.76 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.225 0.536 . . . . 0.0 111.293 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -64.9 -30.37 71.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.201 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.5 tp -103.6 37.76 1.95 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.243 0.544 . . . . 0.0 109.859 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.61 -40.44 2.03 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.087 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -130.19 157.19 43.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.995 0.426 . . . . 0.0 111.087 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.5 m -83.3 165.2 19.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.635 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -89.77 -46.69 8.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.793 0.33 . . . . 0.0 111.065 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.6 m -66.36 118.42 10.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.342 0.591 . . . . 0.0 110.943 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.562 ' HD3' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -58.04 134.03 56.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.664 0.745 . . . . 0.0 111.72 -179.236 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.56 -27.55 19.62 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.531 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.541 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 55.8 m -77.81 111.49 13.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.447 0.641 . . . . 0.0 110.149 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -90.41 138.22 31.72 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.774 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.5 t -60.3 124.62 20.86 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.359 0.599 . . . . 0.0 111.433 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.31 147.36 20.73 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -43.68 -46.29 7.36 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.093 0.557 . . . . 0.0 112.352 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 20.7 m-90 -78.57 37.09 0.27 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.579 0.228 . . . . 0.0 111.473 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 79.8 tttt 55.47 37.61 29.12 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.331 0.652 . . . . 0.0 111.015 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.2 mt -106.95 -161.01 0.76 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.893 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 93.2 m -151.27 126.66 10.02 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -127.89 117.11 21.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.127 0.489 . . . . 0.0 111.202 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.553 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -68.22 127.13 23.79 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.758 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.527 HG23 HG12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -122.89 67.79 0.97 Allowed 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.306 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -88.89 113.47 24.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.702 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.67 38.51 88.22 Favored Glycine 0 C--O 1.228 -0.258 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.485 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.91 -3.98 77.35 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.104 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 26' ' ' THR . 13.6 m -87.71 124.91 34.06 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 117.124 0.462 . . . . 0.0 109.846 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 26' ' ' THR . 66.6 mt -102.16 128.23 54.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.042 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.553 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 17.7 p90 -150.06 135.97 18.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.422 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.8 t0 . . . . . 0 C--N 1.324 -0.535 0 CA-C-O 120.758 0.314 . . . . 0.0 110.573 -178.662 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 80.9 m . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.31 63.18 0.79 Allowed Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.0 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -147.75 -178.45 6.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.514 0.673 . . . . 0.0 111.229 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.564 ' HB2' ' HE2' ' A' ' 21' ' ' LYS . 35.7 p -151.56 124.46 8.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.159 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.66 59.54 0.65 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.095 0.474 . . . . 0.0 111.688 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -62.63 -36.57 83.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.744 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.2 tp -97.78 35.89 1.62 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.844 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.93 -45.25 2.2 Favored Glycine 0 CA--C 1.52 0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.251 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 t -116.64 153.12 32.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.91 0.386 . . . . 0.0 111.237 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.7 m -89.96 166.04 13.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.264 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -89.12 -47.44 8.09 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.489 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.5 m -62.08 115.6 4.23 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.471 0.653 . . . . 0.0 110.624 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -63.49 127.03 29.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.369 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.546 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 110.89 -27.94 10.45 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -178.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.525 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 58.0 m -83.88 115.45 22.28 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.3 m -102.32 141.01 35.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.908 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.65 147.49 47.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.353 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.499 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -168.19 -149.58 6.19 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.944 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -35.23 131.92 0.41 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.283 1.033 . . . . 0.0 113.361 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 58.28 24.27 11.34 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.734 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.564 ' HE2' ' HB2' ' A' ' 4' ' ' SER . 1.2 ttpm? 59.16 44.92 15.13 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.6 mt -107.81 148.72 29.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.109 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.1 m -98.64 127.68 44.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.71 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.499 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 3.0 p90 -129.83 123.7 31.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.331 0.586 . . . . 0.0 110.759 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 14' ' ' GLY . . . -80.16 141.81 23.55 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.487 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 30' ' ' THR . 24.0 m -130.16 112.65 13.6 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.973 0.415 . . . . 0.0 110.024 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -143.98 134.94 25.37 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.83 35.61 87.22 Favored Glycine 0 C--O 1.229 -0.212 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.068 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.1 22.95 71.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.391 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 26' ' ' THR . 19.3 m -120.2 131.9 55.16 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.6 mt -106.54 130.66 57.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.137 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -142.1 139.68 32.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.315 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.5 t70 . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.469 -178.825 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.57 54.97 2.04 Favored Glycine 0 C--O 1.229 -0.177 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.473 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -140.58 159.46 42.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.639 0.733 . . . . 0.0 111.355 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.4 t -140.91 137.62 33.28 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.7 p -70.03 64.29 0.23 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.09 0.471 . . . . 0.0 111.942 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -71.01 -32.27 69.01 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.6 tp -103.4 38.46 1.78 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.354 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.12 -48.11 3.0 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.985 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.2 m -122.6 150.53 42.51 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 122.714 -0.286 . . . . 0.0 110.901 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.8 m -74.01 165.11 25.72 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.828 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -89.07 -43.45 11.07 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 120.669 0.271 . . . . 0.0 110.698 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.8 m -74.16 109.69 7.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.568 0.699 . . . . 0.0 110.321 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.968 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -66.03 119.26 11.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.889 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.442 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 124.13 -29.1 5.18 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -177.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.479 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 61.3 m -87.71 114.96 24.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.056 -0.572 . . . . 0.0 109.798 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 20.4 m -97.28 134.27 40.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.175 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 3.9 t -70.26 110.87 5.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.114 0.483 . . . . 0.0 110.382 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.47 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -82.26 159.77 39.48 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.783 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' A' ' 21' ' ' LYS . 9.2 tp10 -34.99 -47.34 0.36 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.978 1.311 . . . . 0.0 113.732 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 7.6 t90 -75.87 29.08 0.11 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.352 0.596 . . . . 0.0 110.965 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.496 ' H ' ' C ' ' A' ' 19' ' ' GLU . 40.5 tttm 50.49 41.05 24.66 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.184 0.994 . . . . 0.0 111.444 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.8 mt -129.21 121.49 27.76 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.187 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 16' ' ' SER . 49.8 m -74.31 129.93 38.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.614 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.47 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 2.7 p90 -133.13 133.53 43.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.051 0.453 . . . . 0.0 110.058 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -71.25 148.81 44.71 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.725 -0.67 . . . . 0.0 113.359 -178.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 30' ' ' THR . 9.1 m -147.28 60.3 1.17 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.136 0.97 . . . . 0.0 108.485 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -90.08 120.73 31.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.878 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.19 36.5 75.54 Favored Glycine 0 C--O 1.228 -0.278 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.261 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.46 1.34 86.17 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.851 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 26' ' ' THR . 11.4 m -92.86 120.91 33.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.975 0.387 . . . . 0.0 110.127 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 4.5 mp -99.81 132.96 44.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.264 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.598 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 14.0 p90 -151.98 137.32 17.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.984 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.1 t0 . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.982 -178.878 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 37.7 m . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.92 60.7 1.34 Allowed Glycine 0 N--CA 1.454 -0.158 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.53 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -148.04 168.72 21.62 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.652 0.739 . . . . 0.0 111.745 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.5 t -149.68 141.23 23.43 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.694 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.0 p -69.77 64.5 0.21 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.967 0.413 . . . . 0.0 111.618 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -74.98 -31.4 61.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.93 0.395 . . . . 0.0 110.159 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 25.9 tp -103.89 45.59 0.95 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.509 0.671 . . . . 0.0 109.374 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.98 -47.38 3.33 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.516 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -137.48 164.17 29.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.627 0.251 . . . . 0.0 110.581 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.3 m -78.79 158.69 28.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.559 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -88.47 -46.53 9.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.413 0.149 . . . . 0.0 111.279 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.7 m -64.06 113.82 3.75 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.275 0.56 . . . . 0.0 110.765 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -61.1 130.9 48.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.676 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.526 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 105.36 -31.47 8.47 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.492 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 62.4 m -83.3 117.16 22.79 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.8 m -109.56 136.79 48.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.508 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.9 t -68.5 134.17 49.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.957 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.4 ' HA3' ' OH ' ' A' ' 24' ' ' TYR . . . -151.48 -145.6 4.16 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.352 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.463 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 26.6 tp10 -39.01 136.24 0.81 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 8.2 t90 62.53 21.53 12.7 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.137 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.8 tttm 56.76 39.37 29.68 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.886 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.62 137.74 47.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.39 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 17' ' ' CYS . 86.3 m -85.88 129.06 34.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.514 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.4 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 2.3 p90 -135.03 135.34 41.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.036 0.446 . . . . 0.0 110.459 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.643 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -70.59 148.54 45.37 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.754 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 30' ' ' THR . 3.3 t -145.59 62.35 1.27 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.307 1.051 . . . . 0.0 109.368 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -89.22 115.96 27.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.585 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.17 35.57 78.23 Favored Glycine 0 C--O 1.227 -0.302 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.157 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.1 -5.43 76.53 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.858 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 26' ' ' THR . 10.2 m -85.2 118.3 24.67 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 117.045 0.422 . . . . 0.0 109.937 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.643 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 64.3 mt -99.4 132.4 44.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.713 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.636 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 10.8 p90 -149.09 136.57 20.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.865 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.6 t70 . . . . . 0 C--N 1.322 -0.591 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.406 -178.464 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 62.5 m . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.34 52.18 2.61 Favored Glycine 0 C--O 1.228 -0.267 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 177.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.651 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 32.8 mm-40 -114.35 160.9 18.59 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.71 -0.745 . . . . 0.0 111.965 -177.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.2 m -151.72 118.65 5.82 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.927 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.3 p -73.59 67.93 1.15 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.068 0.461 . . . . 0.0 111.904 -178.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -58.52 -40.85 84.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.044 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.4 pp -109.22 38.37 2.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.847 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.18 -44.39 2.63 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.865 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 m -101.11 144.62 29.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.66 0.267 . . . . 0.0 110.922 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.4 m -85.06 163.67 18.69 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -87.84 -43.25 11.96 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.623 0.249 . . . . 0.0 110.617 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.444 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 53.1 m -72.71 100.81 2.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.145 0.497 . . . . 0.0 110.037 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 13' ' ' LYS . 12.2 ttpp -60.83 106.32 0.56 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.255 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.487 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 137.44 -21.94 3.23 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.483 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 59.4 m -97.74 122.02 40.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.509 -0.846 . . . . 0.0 110.002 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.6 m -103.83 131.04 51.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.673 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 2.5 t -61.53 135.02 57.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.176 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.23 -144.72 3.98 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.108 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -38.3 133.96 0.9 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.717 0.807 . . . . 0.0 112.962 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 61.12 23.79 13.95 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.165 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.0 tttp 58.56 35.59 24.66 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.907 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.9 mt -109.87 132.52 54.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.741 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.651 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 30.4 m -84.38 133.23 34.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.778 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -120.53 133.68 55.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.098 0.475 . . . . 0.0 110.314 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.507 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -75.06 139.28 24.82 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.431 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 30' ' ' THR . 5.5 m -124.1 72.08 1.15 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.387 0.613 . . . . 0.0 109.795 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -89.06 116.48 27.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.023 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.08 34.32 72.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.265 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.44 -3.08 86.06 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.685 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 26' ' ' THR . 7.1 m -88.15 124.2 33.57 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.769 0.284 . . . . 0.0 110.256 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 4.2 mp -97.12 127.92 48.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.596 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.507 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 17.3 p90 -143.78 140.98 30.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.674 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.4 t70 . . . . . 0 C--N 1.321 -0.631 0 CA-C-O 121.072 0.463 . . . . 0.0 112.025 -178.386 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 81.2 m . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.05 58.8 1.43 Allowed Glycine 0 CA--C 1.517 0.19 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.743 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -141.27 -176.73 4.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.468 0.652 . . . . 0.0 110.878 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 m -151.15 124.81 9.03 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.491 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.2 p -77.32 54.59 1.13 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.958 0.408 . . . . 0.0 111.593 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.641 ' HD1' ' HG ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -62.39 -33.25 74.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.294 179.214 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.641 ' HG ' ' HD1' ' A' ' 6' ' ' PHE . 99.0 mt -96.13 32.08 2.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.91 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.25 -47.69 3.23 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.802 -0.635 . . . . 0.0 113.336 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.1 p -114.29 149.22 36.27 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 122.545 -0.385 . . . . 0.0 112.014 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.5 m -79.78 163.47 24.42 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -89.94 -48.43 7.23 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.911 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.3 m -64.84 117.38 7.45 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.43 0.633 . . . . 0.0 110.669 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -62.51 128.23 35.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.4 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.572 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 110.8 -27.67 10.84 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -178.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.561 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.6 m -80.55 116.32 20.53 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.7 m -94.64 137.84 33.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.221 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 22' ' ' LEU . 12.1 t -76.92 122.23 24.56 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.193 0.521 . . . . 0.0 111.866 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 20' ' ' TRP . . . -91.76 144.86 17.4 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.441 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 3.5 tp10 -69.95 42.46 0.05 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.505 1.145 . . . . 0.0 113.158 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.48 ' H ' ' C ' ' A' ' 18' ' ' GLY . 96.6 m95 -133.08 12.72 4.27 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 175.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER 62.51 39.55 11.6 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 111.865 -2.425 . . . . 0.0 109.272 -178.838 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 17' ' ' CYS . 90.1 mt -116.11 178.71 4.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.48 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 93.9 m -141.75 127.53 19.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.466 0.174 . . . . 0.0 110.63 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -133.36 122.71 24.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.292 0.567 . . . . 0.0 110.835 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 14' ' ' GLY . . . -77.63 150.04 35.84 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.458 -0.792 . . . . 0.0 113.343 -179.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 30' ' ' THR . 6.6 t -132.21 123.29 26.72 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.349 0.595 . . . . 0.0 109.762 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -150.56 129.18 12.27 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.68 35.27 85.49 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.168 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.89 23.44 74.26 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.476 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 26' ' ' THR . 23.6 m -118.3 132.09 56.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.8 mm -103.38 130.93 52.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.431 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -144.71 129.96 18.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.88 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.9 t70 . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.361 -178.519 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.58 55.16 2.05 Favored Glycine 0 C--N 1.321 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.984 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.53 ' OE2' ' HB2' ' A' ' 11' ' ' TYR . 57.7 mt-10 -135.17 154.42 51.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.192 0.52 . . . . 0.0 111.109 -178.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 t -137.85 132.91 33.26 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.66 ' SG ' ' HE2' ' A' ' 21' ' ' LYS . 8.5 p -69.27 85.56 0.39 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.228 0.537 . . . . 0.0 111.808 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -67.55 -34.62 77.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.483 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.55 39.77 3.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.714 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.86 -40.66 2.3 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.791 -0.64 . . . . 0.0 113.187 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.2 m -102.02 148.89 24.83 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.678 -0.307 . . . . 0.0 111.074 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 35.0 m -85.22 -155.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.53 ' HB2' ' OE2' ' A' ' 3' ' ' GLU . 16.9 m-85 -127.69 -49.71 1.37 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.453 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.437 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 98.6 m -72.32 121.93 20.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.196 0.522 . . . . 0.0 110.538 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -61.21 127.77 33.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.766 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.5 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 106.61 -29.23 11.23 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -178.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.507 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 59.2 m -81.59 120.76 25.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.916 0.389 . . . . 0.0 110.15 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.4 m -112.54 132.33 55.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.214 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 3.8 t -65.7 137.47 57.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.759 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -160.28 -148.88 5.4 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.661 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.504 ' O ' ' HG ' ' A' ' 22' ' ' LEU . 5.8 tp10 -40.81 143.0 0.4 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.889 0.876 . . . . 0.0 113.125 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 12.9 t-105 66.52 17.61 10.67 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.071 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.66 ' HE2' ' SG ' ' A' ' 5' ' ' CYS . 0.2 OUTLIER 56.64 45.18 22.56 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.171 179.406 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 19' ' ' GLU . 4.6 pp -133.42 151.24 51.79 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.649 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 17' ' ' CYS . 78.8 m -89.5 131.11 35.7 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.026 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -128.96 133.51 47.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.038 0.447 . . . . 0.0 110.034 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.744 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -69.85 142.32 36.26 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.45 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.8 t -150.46 62.86 0.95 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.841 0.829 . . . . 0.0 110.084 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.494 ' OD1' ' HB ' ' A' ' 30' ' ' THR . 15.2 p-10 -89.9 112.98 24.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.589 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.99 34.06 65.06 Favored Glycine 0 C--O 1.227 -0.3 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.664 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.88 -14.54 65.15 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.06 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 26' ' ' THR . 2.3 m -75.15 114.42 13.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.292 0.546 . . . . 0.0 109.793 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.626 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 30.9 mm -102.71 135.31 40.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.141 -179.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.744 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 7.2 p90 -158.5 137.47 11.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.895 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.69 -178.855 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.422 ' C ' ' H ' ' A' ' 3' ' ' GLU . 53.3 m . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.11 46.0 2.37 Favored Glycine 0 C--O 1.229 -0.204 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.678 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 40.3 mm-40 -111.62 159.72 17.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.654 -0.773 . . . . 0.0 111.488 -178.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.1 t -151.01 131.93 14.2 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.76 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.464 ' SG ' ' HD2' ' A' ' 21' ' ' LYS . 22.9 p -79.07 51.8 1.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.044 0.449 . . . . 0.0 111.391 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -66.63 -32.94 74.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.923 0.392 . . . . 0.0 110.065 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 26.2 tp -100.02 40.17 1.27 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.423 0.63 . . . . 0.0 109.583 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.52 -43.02 2.68 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.026 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.4 m -138.06 149.06 45.66 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.416 -0.461 . . . . 0.0 110.845 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.6 m -68.88 159.38 32.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.894 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -88.01 -42.7 12.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.63 0.252 . . . . 0.0 111.288 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.466 ' HB ' ' HG3' ' A' ' 3' ' ' GLU . 71.2 m -71.93 106.54 4.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.366 0.603 . . . . 0.0 110.833 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.14 127.38 31.65 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.468 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.51 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 110.9 -28.29 10.05 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.636 -0.985 . . . . 0.0 110.636 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.506 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 62.7 m -85.59 119.03 25.48 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.6 m -102.84 132.01 49.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.597 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 4.0 t -63.09 140.75 58.9 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.074 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.46 -154.0 6.5 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.196 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -43.24 142.84 0.95 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.418 0.687 . . . . 0.0 112.755 -178.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 17.9 t-105 62.56 20.4 11.95 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.121 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.464 ' HD2' ' SG ' ' A' ' 5' ' ' CYS . 3.3 tppp? 57.84 38.85 27.26 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.499 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.1 tp -113.18 131.59 55.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.952 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.678 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 32.0 m -88.79 138.15 31.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.206 0.527 . . . . 0.0 111.451 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -132.38 134.24 44.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.82 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.758 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -67.56 142.67 40.96 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.743 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 30' ' ' THR . 3.2 t -150.82 62.47 0.93 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.813 0.816 . . . . 0.0 110.346 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.418 ' OD1' ' HB ' ' A' ' 30' ' ' THR . 15.1 p-10 -89.83 113.64 25.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.213 0.53 . . . . 0.0 110.728 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.9 34.71 61.88 Favored Glycine 0 C--O 1.227 -0.286 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.804 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.13 -14.54 65.06 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.047 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 26' ' ' THR . 2.3 m -75.22 113.39 12.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.266 0.533 . . . . 0.0 109.733 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.611 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 28.9 mm -103.05 135.58 39.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.201 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.758 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 6.9 p90 -159.63 138.29 10.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.949 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.44 -179.069 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 57.4 m . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 121.2 0.524 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.03 61.22 1.75 Allowed Glycine 0 C--O 1.23 -0.13 0 CA-C-N 115.031 -0.986 . . . . 0.0 113.125 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.459 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 13.2 mt-10 -139.58 -172.07 3.28 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.87 0.367 . . . . 0.0 110.496 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t -150.81 115.21 5.13 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.649 179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 p -79.34 55.94 2.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.343 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.872 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 25.1 t80 -56.5 -40.74 75.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.404 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 54.7 tp -76.86 -49.27 16.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.549 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.24 -38.51 0.16 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.3 m -141.37 143.46 33.99 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.459 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 83.0 m -76.76 -176.79 4.0 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 123.256 0.347 . . . . 0.0 111.013 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -89.12 -40.16 13.11 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.4 m -62.19 111.64 2.05 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.324 0.583 . . . . 0.0 110.854 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -64.86 118.42 9.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.627 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.66 -28.84 5.82 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 61.3 m -80.03 114.1 18.69 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.3 m -101.08 136.55 40.75 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.794 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.6 t -67.61 133.82 50.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.081 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.89 -154.12 6.49 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.478 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -41.69 140.58 0.95 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.549 0.74 . . . . 0.0 112.681 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 11.0 t90 66.71 16.12 10.3 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.135 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.872 ' HE3' ' HA ' ' A' ' 6' ' ' PHE . 56.9 tttp 57.32 41.43 26.6 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.833 0.825 . . . . 0.0 109.04 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.7 tp -116.52 145.0 43.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.647 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 87.4 m -92.49 131.85 37.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.178 0.514 . . . . 0.0 111.615 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -121.47 127.9 51.55 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.679 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -70.3 142.18 35.28 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.152 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.2 t -148.61 60.02 1.08 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 122.584 1.183 . . . . 0.0 108.257 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -89.14 110.85 21.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.294 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.28 34.16 87.15 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.002 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.74 -11.36 68.94 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.764 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 26' ' ' THR . 2.3 m -78.83 114.88 18.13 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.977 0.388 . . . . 0.0 110.002 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.679 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 60.5 mt -100.22 132.99 44.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.64 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.576 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 8.0 p90 -158.78 142.02 14.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.323 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.8 t70 . . . . . 0 C--N 1.323 -0.569 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.442 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 57.2 m . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.07 58.27 2.28 Favored Glycine 0 C--O 1.228 -0.259 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.592 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 2.5 mm-40 -106.21 179.3 4.31 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.6 m -150.02 83.15 1.38 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.836 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.572 ' O ' ' HE2' ' A' ' 21' ' ' LYS . 1.9 p -72.87 56.57 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.883 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -58.53 -34.23 70.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.814 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.5 tp -95.83 24.19 5.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.279 0.561 . . . . 0.0 110.174 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.96 -39.44 2.23 Favored Glycine 0 C--O 1.228 -0.278 0 CA-C-N 116.002 -0.544 . . . . 0.0 113.192 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 t -96.05 147.51 23.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.05 0.452 . . . . 0.0 111.249 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 20.5 m -99.18 156.47 16.95 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -89.51 -39.51 13.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.994 0.426 . . . . 0.0 110.271 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 m -71.55 111.38 6.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.599 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.541 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -61.04 134.45 57.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.544 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.512 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 102.31 -31.02 9.19 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -178.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.512 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.7 m -86.39 119.3 26.51 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m -107.65 136.03 48.09 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.954 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.9 t -66.25 136.12 55.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.027 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.475 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -155.91 -145.57 4.22 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.598 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -40.1 135.0 1.45 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.429 0.691 . . . . 0.0 112.837 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 18.1 t-105 62.54 21.69 12.81 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.142 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.572 ' HE2' ' O ' ' A' ' 5' ' ' CYS . 70.0 tttt 54.91 43.6 29.67 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.245 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.4 tp -113.83 137.5 51.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.997 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.592 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 59.7 m -85.05 126.31 33.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.988 0.423 . . . . 0.0 111.28 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.475 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 1.6 p90 -124.24 130.04 51.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.231 0.538 . . . . 0.0 110.091 178.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.631 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -72.32 143.2 33.96 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.948 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 30' ' ' THR . 11.2 m -138.2 66.2 1.45 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.628 0.728 . . . . 0.0 109.088 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -89.01 115.8 26.84 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.33 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.43 35.33 71.57 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.934 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.94 -5.18 77.2 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.787 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 26' ' ' THR . 14.0 m -84.19 123.13 29.77 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 117.066 0.433 . . . . 0.0 110.135 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 39.4 mm -95.33 133.07 37.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.61 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.631 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 23.0 p90 -152.37 135.26 15.55 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 50.1 t0 . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.098 -178.725 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 64.6 m . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 120.814 0.34 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.71 48.27 2.91 Favored Glycine 0 C--O 1.229 -0.175 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 21.5 mm-40 -80.44 -176.05 5.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.743 -0.729 . . . . 0.0 112.801 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 65.9 m -150.6 63.15 0.94 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.481 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.4 p -72.85 57.03 0.43 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.236 0.541 . . . . 0.0 110.368 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -57.52 -40.36 78.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.808 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.1 mt -80.95 -49.33 11.11 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.814 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.09 -39.72 0.46 Allowed Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 p -86.97 142.5 27.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.269 -0.465 . . . . 0.0 110.86 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.4 m -100.04 162.42 12.99 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -89.56 -50.8 5.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.693 0.282 . . . . 0.0 111.151 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.6 m -64.93 118.7 9.46 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.337 0.589 . . . . 0.0 111.61 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -59.95 133.06 55.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.232 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.01 -27.29 20.66 Favored Glycine 0 N--CA 1.44 -1.08 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.506 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.5 m -83.19 112.89 20.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.897 0.38 . . . . 0.0 109.993 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.6 m -102.19 130.06 48.74 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.011 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 24.4 t -62.79 104.88 0.58 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.222 0.534 . . . . 0.0 110.705 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.47 154.82 49.44 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-O 119.196 -0.78 . . . . 0.0 111.194 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.522 ' C ' ' H ' ' A' ' 21' ' ' LYS . 41.5 tt0 -40.31 -42.77 1.6 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.127 0.971 . . . . 0.0 112.873 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.698 ' CD1' ' HB2' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -73.86 25.73 0.07 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.088 0.47 . . . . 0.0 111.304 179.083 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 19' ' ' GLU . 39.9 tttp 52.17 44.8 29.34 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.579 1.151 . . . . 0.0 111.757 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.698 ' HB2' ' CD1' ' A' ' 20' ' ' TRP . 98.0 mt -139.59 119.25 13.16 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.328 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 16' ' ' SER . 31.9 m -70.96 127.6 33.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.195 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -116.64 127.43 54.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.698 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -75.56 130.51 11.23 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.224 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.728 HG23 HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -133.47 64.53 1.61 Allowed 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -95.45 124.35 39.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.518 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.5 34.81 77.14 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.094 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.98 -0.35 72.91 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.665 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 26' ' ' THR . 7.9 m -89.21 121.13 31.22 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.728 HG12 HG23 ' A' ' 26' ' ' THR . 50.7 mt -102.0 131.37 50.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.54 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.525 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 12.6 p90 -156.7 142.31 17.65 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.039 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.7 t0 . . . . . 0 C--N 1.324 -0.533 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.498 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 39.0 m . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.78 61.76 1.26 Allowed Glycine 0 CA--C 1.517 0.206 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.446 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -146.39 173.29 12.4 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.419 0.628 . . . . 0.0 111.576 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.9 p -150.13 135.41 18.03 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.392 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.576 ' SG ' ' HG3' ' A' ' 21' ' ' LYS . 28.8 p -74.61 61.55 0.97 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.089 0.471 . . . . 0.0 111.803 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.624 ' HD1' ' HG ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -65.4 -35.61 81.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.022 179.138 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.624 ' HG ' ' HD1' ' A' ' 6' ' ' PHE . 90.4 mt -99.24 39.03 1.32 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.205 0.526 . . . . 0.0 110.065 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.87 -49.78 3.52 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.292 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 m -123.57 148.47 46.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.867 0.333 . . . . 0.0 111.114 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.4 m -75.35 164.05 26.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.659 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -88.38 -48.11 7.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.45 0.167 . . . . 0.0 111.336 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.7 m -65.1 116.06 6.1 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.285 0.564 . . . . 0.0 111.042 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -59.77 132.01 52.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.108 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.498 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 101.98 -28.16 17.19 Favored Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.501 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 60.3 m -81.3 112.01 18.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.147 0.499 . . . . 0.0 110.118 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m -98.95 137.92 36.81 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.354 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.8 t -72.32 140.07 48.31 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.895 0.379 . . . . 0.0 110.802 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.444 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -144.51 -156.26 6.75 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -43.24 139.52 1.87 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.549 ' HE3' HD11 ' A' ' 22' ' ' LEU . 4.5 t90 60.06 24.36 13.58 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.343 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.576 ' HG3' ' SG ' ' A' ' 5' ' ' CYS . 22.2 ttmm 58.45 37.4 25.68 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.312 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.549 HD11 ' HE3' ' A' ' 20' ' ' TRP . 89.7 mt -94.84 127.84 41.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.417 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.3 m -88.06 130.84 34.88 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.444 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 3.0 p90 -133.83 128.76 35.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.185 0.517 . . . . 0.0 110.403 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.619 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -70.75 140.06 31.04 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.963 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 30' ' ' THR . 6.7 m -138.56 64.71 1.48 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.538 HD22 ' HZ ' ' A' ' 32' ' ' PHE . 72.9 m-20 -98.46 126.01 43.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.562 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.31 35.71 79.89 Favored Glycine 0 C--O 1.228 -0.228 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.365 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.3 2.79 74.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.735 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 26' ' ' THR . 10.0 m -94.11 122.98 37.18 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 120.681 0.277 . . . . 0.0 110.411 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.619 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 4.5 mp -102.73 131.42 50.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.201 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.583 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 11.6 p90 -151.05 137.55 18.67 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.046 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.9 t70 . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.245 -178.715 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.55 57.83 2.5 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.233 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -138.2 167.74 21.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.655 0.74 . . . . 0.0 111.91 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t -143.8 132.98 23.03 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.185 -1.37 . . . . 0.0 107.583 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.462 ' SG ' ' HG3' ' A' ' 21' ' ' LYS . 28.8 p -73.4 60.87 0.64 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.332 0.587 . . . . 0.0 111.527 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -66.6 -39.7 88.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.6 mt -93.59 38.47 1.06 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.21 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.62 -50.24 3.2 Favored Glycine 0 CA--C 1.52 0.373 0 CA-C-N 115.835 -0.62 . . . . 0.0 113.087 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 m -125.99 149.16 49.01 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.681 -0.305 . . . . 0.0 110.956 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.6 m -74.05 159.33 32.82 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -88.98 -38.73 14.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.44 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 7.2 m -67.5 122.25 17.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.24 0.543 . . . . 0.0 111.393 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -60.41 127.82 33.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.728 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.09 -26.98 22.14 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.509 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.495 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.9 m -79.69 114.8 18.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.197 0.522 . . . . 0.0 110.205 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.7 m -108.6 138.11 45.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.935 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 5' ' ' CYS . 5.9 t -66.68 134.3 51.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.999 0.428 . . . . 0.0 111.085 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -143.3 -155.45 6.43 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.483 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 26.1 tp10 -42.12 137.7 1.82 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 12.4 t90 65.68 20.33 11.53 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.906 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.462 ' HG3' ' SG ' ' A' ' 5' ' ' CYS . 15.0 ttmm 56.0 37.78 29.23 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.969 0.89 . . . . 0.0 109.144 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.4 tp -102.67 136.88 41.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.166 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 61.3 m -87.21 127.66 35.15 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.903 0.383 . . . . 0.0 111.256 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -118.77 128.5 54.54 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.625 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -77.64 131.2 10.86 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.835 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.0 t -134.97 67.91 1.48 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 122.045 0.926 . . . . 0.0 109.104 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -89.13 110.6 21.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.3 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.25 36.65 91.39 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.325 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.25 -7.17 72.94 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.101 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 26' ' ' THR . 9.0 m -84.91 122.36 29.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.132 0.466 . . . . 0.0 109.863 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 5.4 tp -96.55 142.85 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.097 0.475 . . . . 0.0 110.715 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.625 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 23.5 p90 -162.08 132.79 4.97 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.4 t70 . . . . . 0 C--N 1.321 -0.665 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.311 -178.426 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.434 ' C ' ' H ' ' A' ' 3' ' ' GLU . 17.8 m . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.34 42.24 1.91 Allowed Glycine 0 CA--C 1.517 0.215 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.682 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 21.2 mm-40 -90.85 171.46 9.3 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 123.713 0.805 . . . . 0.0 111.647 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.0 m -152.07 119.16 5.86 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.76 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.4 p -78.24 48.94 0.78 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.978 0.418 . . . . 0.0 111.502 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.622 ' HD1' ' HG ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -65.56 -32.1 73.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.723 179.34 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.622 ' HG ' ' HD1' ' A' ' 6' ' ' PHE . 96.2 mt -99.19 39.0 1.32 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.129 0.49 . . . . 0.0 109.953 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.99 -41.47 2.61 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.838 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.3 m -136.2 150.04 48.83 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.55 -0.382 . . . . 0.0 110.63 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.4 m -69.25 160.8 30.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.704 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -87.65 -45.5 10.35 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.249 -0.18 . . . . 0.0 111.418 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.8 m -66.18 113.43 4.53 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.435 0.636 . . . . 0.0 110.595 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -59.38 133.14 55.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.432 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.454 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 101.06 -29.47 12.44 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -178.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.481 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 60.8 m -82.48 113.98 20.59 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 15.8 m -103.24 129.02 50.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.295 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.7 t -63.01 130.54 45.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.875 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -137.2 -153.8 6.49 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.901 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -43.41 139.65 1.94 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.613 ' HE3' HD11 ' A' ' 22' ' ' LEU . 3.4 t90 58.1 27.91 15.63 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.805 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' A' ' 21' ' ' LYS . 11.9 ttpt 60.2 34.99 21.03 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.231 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.613 HD11 ' HE3' ' A' ' 20' ' ' TRP . 92.8 mt -101.58 117.32 34.67 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.289 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.682 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 58.2 m -82.38 127.11 32.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -117.13 129.54 56.04 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.894 0.378 . . . . 0.0 110.521 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -75.8 135.41 17.95 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.514 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 30' ' ' THR . 1.2 t -144.21 65.22 1.3 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 122.193 0.997 . . . . 0.0 109.098 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.422 HD22 ' HZ ' ' A' ' 32' ' ' PHE . 73.5 m-20 -92.17 120.15 32.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.223 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.31 34.52 74.7 Favored Glycine 0 C--O 1.228 -0.229 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.252 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.15 -6.8 74.12 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.979 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 26' ' ' THR . 7.0 m -84.59 115.87 22.86 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.25 0.525 . . . . 0.0 109.908 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.663 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 62.7 mt -100.41 133.6 42.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.206 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.594 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 8.6 p90 -154.95 140.77 18.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.018 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 C--N 1.323 -0.563 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.125 -179.088 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.16 58.88 1.48 Allowed Glycine 0 C--O 1.229 -0.165 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.929 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -144.73 161.72 38.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.513 0.673 . . . . 0.0 111.344 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.5 m -135.84 129.7 32.79 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.29 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 25.0 p -69.61 65.98 0.21 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -66.85 -38.55 86.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.3 mt -99.11 45.67 0.99 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.359 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.11 -46.94 3.06 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.264 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -136.91 161.09 36.96 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 96.4 m -85.77 177.68 7.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.484 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -88.55 -43.35 11.46 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.2 m -64.36 110.29 2.21 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.423 0.63 . . . . 0.0 110.634 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.48 ' NZ ' ' HB2' ' A' ' 13' ' ' LYS . 4.4 ttmp? -64.58 123.17 18.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.193 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.429 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 117.58 -29.64 6.55 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 64.2 m -82.23 111.66 18.53 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.219 -0.49 . . . . 0.0 109.863 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 16.1 m -102.12 133.49 46.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.4 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.8 t -67.85 131.42 45.49 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.301 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.22 -140.77 3.22 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-O 119.251 -0.749 . . . . 0.0 111.878 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.453 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 27.7 tp10 -37.08 133.97 0.59 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.642 0.777 . . . . 0.0 112.988 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 42.5 m0 62.94 20.14 12.05 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.553 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.4 tttm 57.72 38.0 27.38 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.748 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.3 mt -113.0 139.82 48.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.298 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 68.7 m -83.99 131.6 34.82 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.391 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -128.24 133.79 48.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.812 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.604 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -70.52 146.09 41.59 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.723 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 30' ' ' THR . 16.9 m -139.92 62.04 1.52 Allowed 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -89.73 116.0 27.51 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.612 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.46 35.39 79.53 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.843 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.99 -4.11 77.08 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.689 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 26' ' ' THR . 16.2 m -84.74 122.4 29.06 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.038 0.419 . . . . 0.0 110.196 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 37.3 mm -98.0 133.59 39.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.311 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.604 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 17.9 p90 -155.34 137.36 14.6 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.7 t70 . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.456 -178.844 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 59.1 m . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.57 48.75 2.28 Favored Glycine 0 N--CA 1.459 0.209 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.591 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 23.5 mm-40 -85.42 174.21 9.7 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.7 0.762 . . . . 0.0 112.854 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.2 m -150.24 74.97 1.22 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.733 -1.122 . . . . 0.0 109.519 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 p -71.25 54.01 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.18 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.671 ' HD1' ' HG ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -65.33 -27.7 68.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.027 0.441 . . . . 0.0 109.996 178.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.671 ' HG ' ' HD1' ' A' ' 6' ' ' PHE . 97.0 mt -95.9 27.13 3.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.71 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.12 -43.07 2.19 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.913 -0.585 . . . . 0.0 113.323 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -99.53 148.91 23.78 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.182 0.515 . . . . 0.0 111.431 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 9.5 m -90.74 158.73 16.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.403 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -88.13 -42.91 12.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.968 0.413 . . . . 0.0 110.347 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.0 m -73.96 105.96 5.44 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.278 0.561 . . . . 0.0 109.941 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -60.35 129.84 43.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.374 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.479 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 111.97 -28.6 9.17 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 -178.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.508 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 61.0 m -86.94 116.03 24.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 16.1 m -91.76 127.99 37.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.338 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.584 ' HB2' ' SG ' ' A' ' 10' ' ' CYS . 50.5 t -66.53 115.62 6.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.211 0.529 . . . . 0.0 111.821 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.93 149.45 22.26 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' A' ' 21' ' ' LYS . 85.3 tt0 -40.33 -44.08 1.87 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.882 0.873 . . . . 0.0 113.067 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -75.6 32.69 0.11 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.434 ' HE3' ' HB3' ' A' ' 21' ' ' LYS . 12.6 ttpp 51.82 49.31 21.04 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.013 0.525 . . . . 0.0 110.262 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.2 tp -141.56 111.09 6.46 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.157 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.591 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 42.7 m -79.68 132.57 36.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.69 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -125.89 128.05 46.98 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.145 0.497 . . . . 0.0 110.257 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -68.7 141.3 36.37 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.59 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 30' ' ' THR . 6.2 m -140.73 64.72 1.42 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.708 0.766 . . . . 0.0 109.056 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.549 HD22 ' HZ ' ' A' ' 32' ' ' PHE . 72.7 m-20 -95.55 122.78 38.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.318 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.76 34.43 77.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.991 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.58 -2.65 71.81 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.754 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 26' ' ' THR . 10.5 m -87.25 121.59 29.91 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 122.556 -0.379 . . . . 0.0 110.168 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.654 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 62.0 mt -102.1 132.17 48.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.591 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.592 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 10.8 p90 -151.9 140.87 21.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.172 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.9 t70 . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.551 -178.971 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.93 62.19 1.3 Allowed Glycine 0 CA--C 1.518 0.221 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.842 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -146.69 -178.67 6.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.409 0.623 . . . . 0.0 111.425 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.3 m -150.71 119.16 6.43 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.087 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.421 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 1.3 p -73.61 60.83 0.69 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.253 0.549 . . . . 0.0 110.831 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -57.26 -41.37 79.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.745 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.444 HD12 ' H ' ' A' ' 9' ' ' THR . 2.1 pp -97.58 28.17 3.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.623 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.33 -41.18 2.24 Favored Glycine 0 CA--C 1.518 0.239 0 CA-C-N 115.681 -0.69 . . . . 0.0 113.165 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.444 ' H ' HD12 ' A' ' 7' ' ' LEU . 9.0 m -101.7 144.87 29.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.852 0.358 . . . . 0.0 111.097 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 30.3 m -96.61 164.16 12.72 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -88.74 -48.62 7.38 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.122 -0.231 . . . . 0.0 111.285 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.0 m -66.17 116.48 7.29 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.437 0.637 . . . . 0.0 110.921 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.506 ' HD2' ' N ' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -62.48 132.8 53.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.354 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.49 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 105.51 -30.4 9.91 Favored Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -178.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.505 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 49.9 m -82.56 115.4 21.52 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m -105.24 139.73 39.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.812 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.9 t -62.6 128.36 35.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.347 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -143.03 -159.57 8.0 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.865 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.555 ' HG2' ' CD1' ' A' ' 20' ' ' TRP . 36.4 tt0 -42.63 140.74 1.2 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.611 0.764 . . . . 0.0 112.639 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.555 ' CD1' ' HG2' ' A' ' 19' ' ' GLU . 41.1 m0 64.57 18.67 11.5 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.226 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.0 tptm 58.56 37.09 25.49 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.67 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.7 mt -103.63 139.75 38.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.387 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 69.2 m -84.8 125.34 32.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.298 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -123.1 123.65 41.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.871 0.367 . . . . 0.0 111.193 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.537 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -73.23 130.6 13.84 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.716 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.759 HG23 HG13 ' A' ' 31' ' ' ILE . 1.1 m -129.74 68.3 1.44 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.501 0.667 . . . . 0.0 109.225 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.535 HD22 ' HZ ' ' A' ' 32' ' ' PHE . 75.2 m-20 -98.7 127.56 44.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.877 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.9 36.33 79.82 Favored Glycine 0 C--O 1.228 -0.239 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.233 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.89 4.65 72.36 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.611 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 26' ' ' THR . 12.3 m -95.75 123.71 39.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.759 HG13 HG23 ' A' ' 26' ' ' THR . 4.8 mp -102.37 129.59 53.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.149 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.537 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 13.6 p90 -150.33 138.98 20.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.122 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.4 t0 . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.538 -179.015 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.51 54.21 1.98 Allowed Glycine 0 C--N 1.324 -0.135 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.426 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.681 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 97.0 mt-10 -139.26 152.3 47.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.416 0.627 . . . . 0.0 110.899 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.575 ' HB3' ' HE3' ' A' ' 21' ' ' LYS . 30.4 m -130.03 135.34 48.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.035 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 22.7 p -74.1 55.07 0.56 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.258 0.551 . . . . 0.0 111.635 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -64.1 -36.55 84.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.724 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 25.0 tp -98.8 41.47 1.14 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.857 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.07 -42.1 2.49 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.913 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 m -142.47 152.37 42.66 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.681 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 94.7 m -77.77 -157.27 0.1 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.02 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -117.35 -44.68 2.76 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -68.11 110.54 4.02 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.389 0.614 . . . . 0.0 110.681 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -62.73 122.92 17.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.248 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.86 -27.12 7.64 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 61.2 m -82.46 113.67 20.37 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 16.9 m -98.64 131.51 44.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.329 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 2.8 t -67.83 139.32 56.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.853 0.359 . . . . 0.0 111.025 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.421 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -152.41 -149.07 5.02 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-O 119.496 -0.614 . . . . 0.0 111.7 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.455 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 28.5 tp10 -39.6 135.46 1.15 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.541 0.736 . . . . 0.0 112.756 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 43.1 m0 64.51 19.54 11.84 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.851 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.575 ' HE3' ' HB3' ' A' ' 4' ' ' SER . 34.6 ttpt 59.73 38.21 21.81 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.592 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.9 mt -108.33 134.08 51.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.406 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 32.6 m -87.39 131.74 34.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.213 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.421 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 2.7 p90 -124.14 128.82 49.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.084 0.469 . . . . 0.0 109.883 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.631 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -71.65 142.29 33.43 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.858 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.9 t -143.81 63.77 1.34 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 122.17 0.986 . . . . 0.0 109.115 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -89.35 114.8 26.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.297 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.7 33.14 71.34 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.178 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.05 -8.93 76.64 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.653 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 26' ' ' THR . 3.5 m -80.32 116.24 20.29 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.631 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 63.3 mt -98.47 131.62 45.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.771 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.61 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 12.6 p90 -153.18 136.56 15.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.015 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 50.3 t0 . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.808 -178.903 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 54.5 m . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.16 56.17 1.88 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.462 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -141.76 158.84 43.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.6 0.714 . . . . 0.0 111.515 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.4 m -136.99 134.98 37.22 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.496 -1.229 . . . . 0.0 107.817 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.5 p -72.55 56.41 0.38 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.198 0.523 . . . . 0.0 111.769 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -66.51 -39.28 88.58 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.99 39.91 1.01 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.998 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.11 -51.92 3.27 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.121 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 m -127.05 152.27 47.49 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 122.73 -0.276 . . . . 0.0 110.862 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.7 m -71.2 159.8 34.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.122 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -90.4 -45.27 9.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.622 0.249 . . . . 0.0 111.302 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.3 m -70.71 112.35 6.86 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.304 0.573 . . . . 0.0 110.844 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -58.91 131.98 52.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.598 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.449 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 105.87 -27.59 17.04 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.503 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.1 m -86.73 117.43 25.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m -106.0 135.24 47.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.441 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 t -68.42 139.23 55.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.829 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.47 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -152.41 -154.21 6.58 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-O 119.576 -0.569 . . . . 0.0 111.704 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.458 ' O ' ' HG ' ' A' ' 22' ' ' LEU . 36.9 tt0 -39.06 138.53 0.57 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.567 0.747 . . . . 0.0 112.564 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.471 ' HB3' HD23 ' A' ' 22' ' ' LEU . 9.0 t90 65.62 15.49 10.07 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.071 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.9 tttp 58.84 38.76 24.54 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.527 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.471 HD23 ' HB3' ' A' ' 20' ' ' TRP . 4.3 pp -107.97 144.38 35.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.809 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 61.5 m -92.47 127.98 38.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.921 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.47 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 1.9 p90 -119.54 128.85 54.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.092 0.472 . . . . 0.0 110.36 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 15' ' ' CYS . . . -80.93 141.75 22.77 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.669 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 30' ' ' THR . 48.2 m -148.85 104.97 3.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.132 0.491 . . . . 0.0 110.437 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -150.38 147.03 27.08 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.75 33.03 76.02 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.008 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.41 27.02 72.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.396 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 26' ' ' THR . 17.7 m -125.08 132.32 53.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.685 0.278 . . . . 0.0 110.397 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 58.9 mt -112.24 133.87 56.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.889 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -152.81 140.89 20.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.395 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.9 t70 . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.489 -179.162 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.85 53.96 1.7 Allowed Glycine 0 C--O 1.23 -0.136 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.709 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.61 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 53.8 mt-10 -140.71 155.24 46.51 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.157 0.503 . . . . 0.0 110.818 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 p -127.3 135.47 50.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.746 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.583 ' SG ' ' HG3' ' A' ' 21' ' ' LYS . 26.5 p -71.25 94.6 1.2 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -67.22 -34.37 77.34 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.5 mt -114.85 -129.79 0.3 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.451 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.35 -36.73 92.05 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.821 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.0 t -162.8 -172.52 3.12 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.61 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 96.7 m -86.77 -176.71 5.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.764 0.316 . . . . 0.0 111.491 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -90.96 -36.12 14.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.109 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.667 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -61.31 116.57 4.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.223 0.535 . . . . 0.0 111.087 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -61.41 132.32 53.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.993 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.492 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 95.9 -24.43 29.81 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.578 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.667 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 59.2 m -81.38 113.1 19.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.19 0.519 . . . . 0.0 110.481 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.4 m -102.11 136.56 41.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.729 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.1 t -68.84 142.57 54.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.962 0.411 . . . . 0.0 111.213 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.435 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -146.35 -158.74 7.89 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.486 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -44.47 141.72 1.84 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 62.47 20.73 12.13 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.037 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.583 ' HG3' ' SG ' ' A' ' 5' ' ' CYS . 21.3 ttmm 58.86 37.94 24.68 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.953 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.41 127.83 49.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.141 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 64.4 m -89.14 134.63 33.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.137 0.494 . . . . 0.0 111.572 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.435 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 1.4 p90 -125.58 129.42 49.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.015 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -81.5 143.46 23.65 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.86 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 30' ' ' THR . 8.5 m -141.27 66.23 1.37 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.769 0.795 . . . . 0.0 108.981 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -89.52 120.02 30.47 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.385 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.86 36.25 72.03 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.086 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.5 -4.68 71.92 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.962 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 26' ' ' THR . 7.5 m -86.28 119.21 26.31 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 117.113 0.457 . . . . 0.0 110.263 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 56.8 mt -98.05 132.55 42.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.511 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.531 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 12.2 p90 -153.34 142.53 21.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.222 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.3 t70 . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.994 -179.311 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 82.9 m . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.34 57.23 2.41 Favored Glycine 0 C--N 1.323 -0.144 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.784 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -137.01 -178.13 5.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.515 0.674 . . . . 0.0 111.152 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.6 m -151.44 127.68 10.55 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.157 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 p -75.12 55.96 0.76 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.225 0.536 . . . . 0.0 111.293 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -64.9 -30.37 71.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.201 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.5 tp -103.6 37.76 1.95 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.243 0.544 . . . . 0.0 109.859 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.61 -40.44 2.03 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.087 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -130.19 157.19 43.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.995 0.426 . . . . 0.0 111.087 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.5 m -83.3 165.2 19.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.635 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -89.77 -46.69 8.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.793 0.33 . . . . 0.0 111.065 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.6 m -66.36 118.42 10.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.342 0.591 . . . . 0.0 110.943 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.562 ' HD3' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -58.04 134.03 56.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.664 0.745 . . . . 0.0 111.72 -179.236 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.56 -27.55 19.62 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.531 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.541 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 55.8 m -77.81 111.49 13.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.447 0.641 . . . . 0.0 110.149 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -90.41 138.22 31.72 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.774 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.5 t -60.3 124.62 20.86 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.359 0.599 . . . . 0.0 111.433 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.31 147.36 20.73 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -43.68 -46.29 7.36 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.093 0.557 . . . . 0.0 112.352 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 20.7 m-90 -78.57 37.09 0.27 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.579 0.228 . . . . 0.0 111.473 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 79.8 tttt 55.47 37.61 29.12 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.331 0.652 . . . . 0.0 111.015 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.2 mt -106.95 -161.01 0.76 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.893 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 93.2 m -151.27 126.66 10.02 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -127.89 117.11 21.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.127 0.489 . . . . 0.0 111.202 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.553 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -68.22 127.13 23.79 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.758 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.527 HG23 HG12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -122.89 67.79 0.97 Allowed 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.306 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -88.89 113.47 24.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.702 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.67 38.51 88.22 Favored Glycine 0 C--O 1.228 -0.258 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.485 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.91 -3.98 77.35 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.104 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 26' ' ' THR . 13.6 m -87.71 124.91 34.06 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 117.124 0.462 . . . . 0.0 109.846 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 26' ' ' THR . 66.6 mt -102.16 128.23 54.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.042 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.553 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 17.7 p90 -150.06 135.97 18.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.422 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.8 t0 . . . . . 0 C--N 1.324 -0.535 0 CA-C-O 120.758 0.314 . . . . 0.0 110.573 -178.662 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 80.9 m . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.31 63.18 0.79 Allowed Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.0 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -147.75 -178.45 6.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.514 0.673 . . . . 0.0 111.229 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.564 ' HB2' ' HE2' ' A' ' 21' ' ' LYS . 35.7 p -151.56 124.46 8.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.159 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.66 59.54 0.65 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.095 0.474 . . . . 0.0 111.688 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -62.63 -36.57 83.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.744 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.2 tp -97.78 35.89 1.62 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.844 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.93 -45.25 2.2 Favored Glycine 0 CA--C 1.52 0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.251 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 t -116.64 153.12 32.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.91 0.386 . . . . 0.0 111.237 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.7 m -89.96 166.04 13.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.264 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -89.12 -47.44 8.09 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.489 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.5 m -62.08 115.6 4.23 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.471 0.653 . . . . 0.0 110.624 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -63.49 127.03 29.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.369 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.546 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 110.89 -27.94 10.45 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -178.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.525 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 58.0 m -83.88 115.45 22.28 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.3 m -102.32 141.01 35.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.908 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.65 147.49 47.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.353 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.499 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -168.19 -149.58 6.19 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.944 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -35.23 131.92 0.41 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.283 1.033 . . . . 0.0 113.361 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 58.28 24.27 11.34 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.734 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.564 ' HE2' ' HB2' ' A' ' 4' ' ' SER . 1.2 ttpm? 59.16 44.92 15.13 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.6 mt -107.81 148.72 29.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.109 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.1 m -98.64 127.68 44.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.71 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.499 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 3.0 p90 -129.83 123.7 31.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.331 0.586 . . . . 0.0 110.759 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 14' ' ' GLY . . . -80.16 141.81 23.55 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.487 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 30' ' ' THR . 24.0 m -130.16 112.65 13.6 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.973 0.415 . . . . 0.0 110.024 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -143.98 134.94 25.37 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.83 35.61 87.22 Favored Glycine 0 C--O 1.229 -0.212 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.068 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.1 22.95 71.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.391 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 26' ' ' THR . 19.3 m -120.2 131.9 55.16 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.6 mt -106.54 130.66 57.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.137 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -142.1 139.68 32.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.315 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.5 t70 . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.469 -178.825 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.57 54.97 2.04 Favored Glycine 0 C--O 1.229 -0.177 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.473 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -140.58 159.46 42.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.639 0.733 . . . . 0.0 111.355 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.4 t -140.91 137.62 33.28 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.7 p -70.03 64.29 0.23 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.09 0.471 . . . . 0.0 111.942 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -71.01 -32.27 69.01 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.6 tp -103.4 38.46 1.78 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.354 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.12 -48.11 3.0 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.985 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.2 m -122.6 150.53 42.51 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 122.714 -0.286 . . . . 0.0 110.901 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.8 m -74.01 165.11 25.72 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.828 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -89.07 -43.45 11.07 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 120.669 0.271 . . . . 0.0 110.698 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.8 m -74.16 109.69 7.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.568 0.699 . . . . 0.0 110.321 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.968 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -66.03 119.26 11.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.889 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.442 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 124.13 -29.1 5.18 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -177.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.479 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 61.3 m -87.71 114.96 24.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.056 -0.572 . . . . 0.0 109.798 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 20.4 m -97.28 134.27 40.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.175 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 3.9 t -70.26 110.87 5.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.114 0.483 . . . . 0.0 110.382 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.47 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -82.26 159.77 39.48 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.783 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' A' ' 21' ' ' LYS . 9.2 tp10 -34.99 -47.34 0.36 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.978 1.311 . . . . 0.0 113.732 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 7.6 t90 -75.87 29.08 0.11 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.352 0.596 . . . . 0.0 110.965 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.496 ' H ' ' C ' ' A' ' 19' ' ' GLU . 40.5 tttm 50.49 41.05 24.66 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.184 0.994 . . . . 0.0 111.444 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.8 mt -129.21 121.49 27.76 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.187 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 16' ' ' SER . 49.8 m -74.31 129.93 38.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.614 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.47 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 2.7 p90 -133.13 133.53 43.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.051 0.453 . . . . 0.0 110.058 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -71.25 148.81 44.71 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.725 -0.67 . . . . 0.0 113.359 -178.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 30' ' ' THR . 9.1 m -147.28 60.3 1.17 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.136 0.97 . . . . 0.0 108.485 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -90.08 120.73 31.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.878 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.19 36.5 75.54 Favored Glycine 0 C--O 1.228 -0.278 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.261 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.46 1.34 86.17 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.851 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 26' ' ' THR . 11.4 m -92.86 120.91 33.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.975 0.387 . . . . 0.0 110.127 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 4.5 mp -99.81 132.96 44.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.264 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.598 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 14.0 p90 -151.98 137.32 17.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.984 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.1 t0 . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.982 -178.878 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 37.7 m . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.92 60.7 1.34 Allowed Glycine 0 N--CA 1.454 -0.158 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.53 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -148.04 168.72 21.62 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.652 0.739 . . . . 0.0 111.745 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.5 t -149.68 141.23 23.43 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.694 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.0 p -69.77 64.5 0.21 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.967 0.413 . . . . 0.0 111.618 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -74.98 -31.4 61.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.93 0.395 . . . . 0.0 110.159 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 25.9 tp -103.89 45.59 0.95 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.509 0.671 . . . . 0.0 109.374 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.98 -47.38 3.33 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.516 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -137.48 164.17 29.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.627 0.251 . . . . 0.0 110.581 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.3 m -78.79 158.69 28.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.559 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -88.47 -46.53 9.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.413 0.149 . . . . 0.0 111.279 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.7 m -64.06 113.82 3.75 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.275 0.56 . . . . 0.0 110.765 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -61.1 130.9 48.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.676 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.526 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 105.36 -31.47 8.47 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.492 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 62.4 m -83.3 117.16 22.79 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.8 m -109.56 136.79 48.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.508 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.9 t -68.5 134.17 49.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.957 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.4 ' HA3' ' OH ' ' A' ' 24' ' ' TYR . . . -151.48 -145.6 4.16 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.352 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.463 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 26.6 tp10 -39.01 136.24 0.81 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 8.2 t90 62.53 21.53 12.7 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.137 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.8 tttm 56.76 39.37 29.68 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.886 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.62 137.74 47.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.39 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 17' ' ' CYS . 86.3 m -85.88 129.06 34.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.514 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.4 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 2.3 p90 -135.03 135.34 41.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.036 0.446 . . . . 0.0 110.459 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.643 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -70.59 148.54 45.37 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.754 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 30' ' ' THR . 3.3 t -145.59 62.35 1.27 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.307 1.051 . . . . 0.0 109.368 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -89.22 115.96 27.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.585 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.17 35.57 78.23 Favored Glycine 0 C--O 1.227 -0.302 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.157 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.1 -5.43 76.53 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.858 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 26' ' ' THR . 10.2 m -85.2 118.3 24.67 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 117.045 0.422 . . . . 0.0 109.937 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.643 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 64.3 mt -99.4 132.4 44.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.713 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.636 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 10.8 p90 -149.09 136.57 20.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.865 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.6 t70 . . . . . 0 C--N 1.322 -0.591 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.406 -178.464 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 62.5 m . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.34 52.18 2.61 Favored Glycine 0 C--O 1.228 -0.267 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 177.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.651 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 32.8 mm-40 -114.35 160.9 18.59 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.71 -0.745 . . . . 0.0 111.965 -177.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.2 m -151.72 118.65 5.82 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.927 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.3 p -73.59 67.93 1.15 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.068 0.461 . . . . 0.0 111.904 -178.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -58.52 -40.85 84.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.044 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.4 pp -109.22 38.37 2.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.847 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.18 -44.39 2.63 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.865 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 m -101.11 144.62 29.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.66 0.267 . . . . 0.0 110.922 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.4 m -85.06 163.67 18.69 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -87.84 -43.25 11.96 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.623 0.249 . . . . 0.0 110.617 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.444 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 53.1 m -72.71 100.81 2.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.145 0.497 . . . . 0.0 110.037 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 13' ' ' LYS . 12.2 ttpp -60.83 106.32 0.56 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.255 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.487 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 137.44 -21.94 3.23 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.483 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 59.4 m -97.74 122.02 40.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.509 -0.846 . . . . 0.0 110.002 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.6 m -103.83 131.04 51.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.673 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 2.5 t -61.53 135.02 57.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.176 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.23 -144.72 3.98 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.108 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -38.3 133.96 0.9 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.717 0.807 . . . . 0.0 112.962 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 61.12 23.79 13.95 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.165 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.0 tttp 58.56 35.59 24.66 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.907 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.9 mt -109.87 132.52 54.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.741 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.651 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 30.4 m -84.38 133.23 34.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.778 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -120.53 133.68 55.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.098 0.475 . . . . 0.0 110.314 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.507 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -75.06 139.28 24.82 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.431 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 30' ' ' THR . 5.5 m -124.1 72.08 1.15 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.387 0.613 . . . . 0.0 109.795 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -89.06 116.48 27.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.023 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.08 34.32 72.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.265 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.44 -3.08 86.06 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.685 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 26' ' ' THR . 7.1 m -88.15 124.2 33.57 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.769 0.284 . . . . 0.0 110.256 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 4.2 mp -97.12 127.92 48.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.596 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.507 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 17.3 p90 -143.78 140.98 30.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.674 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.4 t70 . . . . . 0 C--N 1.321 -0.631 0 CA-C-O 121.072 0.463 . . . . 0.0 112.025 -178.386 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 81.2 m . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.05 58.8 1.43 Allowed Glycine 0 CA--C 1.517 0.19 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.743 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -141.27 -176.73 4.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.468 0.652 . . . . 0.0 110.878 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 m -151.15 124.81 9.03 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.491 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.2 p -77.32 54.59 1.13 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.958 0.408 . . . . 0.0 111.593 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.641 ' HD1' ' HG ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -62.39 -33.25 74.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.294 179.214 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.641 ' HG ' ' HD1' ' A' ' 6' ' ' PHE . 99.0 mt -96.13 32.08 2.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.91 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.25 -47.69 3.23 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.802 -0.635 . . . . 0.0 113.336 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.1 p -114.29 149.22 36.27 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 122.545 -0.385 . . . . 0.0 112.014 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.5 m -79.78 163.47 24.42 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -89.94 -48.43 7.23 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.911 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.3 m -64.84 117.38 7.45 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.43 0.633 . . . . 0.0 110.669 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -62.51 128.23 35.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.4 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.572 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 110.8 -27.67 10.84 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -178.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.561 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.6 m -80.55 116.32 20.53 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.7 m -94.64 137.84 33.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.221 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 22' ' ' LEU . 12.1 t -76.92 122.23 24.56 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.193 0.521 . . . . 0.0 111.866 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 20' ' ' TRP . . . -91.76 144.86 17.4 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.441 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 3.5 tp10 -69.95 42.46 0.05 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.505 1.145 . . . . 0.0 113.158 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.48 ' H ' ' C ' ' A' ' 18' ' ' GLY . 96.6 m95 -133.08 12.72 4.27 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 175.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER 62.51 39.55 11.6 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 111.865 -2.425 . . . . 0.0 109.272 -178.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 17' ' ' CYS . 90.1 mt -116.11 178.71 4.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.48 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 93.9 m -141.75 127.53 19.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.466 0.174 . . . . 0.0 110.63 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -133.36 122.71 24.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.292 0.567 . . . . 0.0 110.835 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 14' ' ' GLY . . . -77.63 150.04 35.84 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.458 -0.792 . . . . 0.0 113.343 -179.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 30' ' ' THR . 6.6 t -132.21 123.29 26.72 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.349 0.595 . . . . 0.0 109.762 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -150.56 129.18 12.27 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.68 35.27 85.49 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.168 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.89 23.44 74.26 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.476 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 26' ' ' THR . 23.6 m -118.3 132.09 56.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.8 mm -103.38 130.93 52.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.431 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -144.71 129.96 18.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.88 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.9 t70 . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.361 -178.519 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.58 55.16 2.05 Favored Glycine 0 C--N 1.321 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.984 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.53 ' OE2' ' HB2' ' A' ' 11' ' ' TYR . 57.7 mt-10 -135.17 154.42 51.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.192 0.52 . . . . 0.0 111.109 -178.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 t -137.85 132.91 33.26 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.66 ' SG ' ' HE2' ' A' ' 21' ' ' LYS . 8.5 p -69.27 85.56 0.39 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.228 0.537 . . . . 0.0 111.808 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -67.55 -34.62 77.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.483 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.55 39.77 3.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.714 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.86 -40.66 2.3 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.791 -0.64 . . . . 0.0 113.187 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.2 m -102.02 148.89 24.83 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.678 -0.307 . . . . 0.0 111.074 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 35.0 m -85.22 -155.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.53 ' HB2' ' OE2' ' A' ' 3' ' ' GLU . 16.9 m-85 -127.69 -49.71 1.37 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.453 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.437 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 98.6 m -72.32 121.93 20.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.196 0.522 . . . . 0.0 110.538 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -61.21 127.77 33.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.766 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.5 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 106.61 -29.23 11.23 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -178.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.507 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 59.2 m -81.59 120.76 25.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.916 0.389 . . . . 0.0 110.15 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.4 m -112.54 132.33 55.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.214 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 3.8 t -65.7 137.47 57.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.759 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -160.28 -148.88 5.4 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.661 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.504 ' O ' ' HG ' ' A' ' 22' ' ' LEU . 5.8 tp10 -40.81 143.0 0.4 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.889 0.876 . . . . 0.0 113.125 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 12.9 t-105 66.52 17.61 10.67 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.071 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.66 ' HE2' ' SG ' ' A' ' 5' ' ' CYS . 0.2 OUTLIER 56.64 45.18 22.56 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.171 179.406 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 19' ' ' GLU . 4.6 pp -133.42 151.24 51.79 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.649 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 17' ' ' CYS . 78.8 m -89.5 131.11 35.7 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.026 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -128.96 133.51 47.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.038 0.447 . . . . 0.0 110.034 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.744 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -69.85 142.32 36.26 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.45 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.8 t -150.46 62.86 0.95 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.841 0.829 . . . . 0.0 110.084 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.494 ' OD1' ' HB ' ' A' ' 30' ' ' THR . 15.2 p-10 -89.9 112.98 24.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.589 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.99 34.06 65.06 Favored Glycine 0 C--O 1.227 -0.3 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.664 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.88 -14.54 65.15 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.06 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 26' ' ' THR . 2.3 m -75.15 114.42 13.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.292 0.546 . . . . 0.0 109.793 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.626 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 30.9 mm -102.71 135.31 40.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.141 -179.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.744 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 7.2 p90 -158.5 137.47 11.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.895 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.69 -178.855 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.422 ' C ' ' H ' ' A' ' 3' ' ' GLU . 53.3 m . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.11 46.0 2.37 Favored Glycine 0 C--O 1.229 -0.204 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.678 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 40.3 mm-40 -111.62 159.72 17.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.654 -0.773 . . . . 0.0 111.488 -178.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.1 t -151.01 131.93 14.2 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.76 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.464 ' SG ' ' HD2' ' A' ' 21' ' ' LYS . 22.9 p -79.07 51.8 1.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.044 0.449 . . . . 0.0 111.391 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -66.63 -32.94 74.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.923 0.392 . . . . 0.0 110.065 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 26.2 tp -100.02 40.17 1.27 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.423 0.63 . . . . 0.0 109.583 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.52 -43.02 2.68 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.026 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.4 m -138.06 149.06 45.66 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.416 -0.461 . . . . 0.0 110.845 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.6 m -68.88 159.38 32.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.894 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -88.01 -42.7 12.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.63 0.252 . . . . 0.0 111.288 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.466 ' HB ' ' HG3' ' A' ' 3' ' ' GLU . 71.2 m -71.93 106.54 4.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.366 0.603 . . . . 0.0 110.833 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.14 127.38 31.65 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.468 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.51 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 110.9 -28.29 10.05 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.636 -0.985 . . . . 0.0 110.636 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.506 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 62.7 m -85.59 119.03 25.48 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.6 m -102.84 132.01 49.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.597 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 4.0 t -63.09 140.75 58.9 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.074 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.46 -154.0 6.5 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.196 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -43.24 142.84 0.95 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.418 0.687 . . . . 0.0 112.755 -178.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 17.9 t-105 62.56 20.4 11.95 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.121 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.464 ' HD2' ' SG ' ' A' ' 5' ' ' CYS . 3.3 tppp? 57.84 38.85 27.26 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.499 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.1 tp -113.18 131.59 55.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.952 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.678 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 32.0 m -88.79 138.15 31.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.206 0.527 . . . . 0.0 111.451 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -132.38 134.24 44.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.82 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.758 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -67.56 142.67 40.96 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.743 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 30' ' ' THR . 3.2 t -150.82 62.47 0.93 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.813 0.816 . . . . 0.0 110.346 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.418 ' OD1' ' HB ' ' A' ' 30' ' ' THR . 15.1 p-10 -89.83 113.64 25.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.213 0.53 . . . . 0.0 110.728 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.9 34.71 61.88 Favored Glycine 0 C--O 1.227 -0.286 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.804 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.13 -14.54 65.06 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.047 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 26' ' ' THR . 2.3 m -75.22 113.39 12.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.266 0.533 . . . . 0.0 109.733 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.611 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 28.9 mm -103.05 135.58 39.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.201 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.758 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 6.9 p90 -159.63 138.29 10.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.949 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.44 -179.069 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 57.4 m . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 121.2 0.524 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.03 61.22 1.75 Allowed Glycine 0 C--O 1.23 -0.13 0 CA-C-N 115.031 -0.986 . . . . 0.0 113.125 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.459 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 13.2 mt-10 -139.58 -172.07 3.28 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.87 0.367 . . . . 0.0 110.496 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t -150.81 115.21 5.13 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.649 179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 p -79.34 55.94 2.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.343 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.872 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 25.1 t80 -56.5 -40.74 75.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.404 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 54.7 tp -76.86 -49.27 16.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.549 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.24 -38.51 0.16 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.3 m -141.37 143.46 33.99 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.459 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 83.0 m -76.76 -176.79 4.0 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 123.256 0.347 . . . . 0.0 111.013 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -89.12 -40.16 13.11 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.4 m -62.19 111.64 2.05 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.324 0.583 . . . . 0.0 110.854 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -64.86 118.42 9.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.627 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.66 -28.84 5.82 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 61.3 m -80.03 114.1 18.69 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.3 m -101.08 136.55 40.75 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.794 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.6 t -67.61 133.82 50.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.081 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.89 -154.12 6.49 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.478 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -41.69 140.58 0.95 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.549 0.74 . . . . 0.0 112.681 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 11.0 t90 66.71 16.12 10.3 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.135 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.872 ' HE3' ' HA ' ' A' ' 6' ' ' PHE . 56.9 tttp 57.32 41.43 26.6 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.833 0.825 . . . . 0.0 109.04 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.7 tp -116.52 145.0 43.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.647 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 87.4 m -92.49 131.85 37.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.178 0.514 . . . . 0.0 111.615 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -121.47 127.9 51.55 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.679 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -70.3 142.18 35.28 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.152 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.2 t -148.61 60.02 1.08 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 122.584 1.183 . . . . 0.0 108.257 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -89.14 110.85 21.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.294 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.28 34.16 87.15 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.002 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.74 -11.36 68.94 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.764 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 26' ' ' THR . 2.3 m -78.83 114.88 18.13 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.977 0.388 . . . . 0.0 110.002 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.679 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 60.5 mt -100.22 132.99 44.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.64 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.576 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 8.0 p90 -158.78 142.02 14.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.323 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.8 t70 . . . . . 0 C--N 1.323 -0.569 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.442 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 57.2 m . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.07 58.27 2.28 Favored Glycine 0 C--O 1.228 -0.259 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.592 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 2.5 mm-40 -106.21 179.3 4.31 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.6 m -150.02 83.15 1.38 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.836 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.572 ' O ' ' HE2' ' A' ' 21' ' ' LYS . 1.9 p -72.87 56.57 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.883 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -58.53 -34.23 70.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.814 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.5 tp -95.83 24.19 5.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.279 0.561 . . . . 0.0 110.174 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.96 -39.44 2.23 Favored Glycine 0 C--O 1.228 -0.278 0 CA-C-N 116.002 -0.544 . . . . 0.0 113.192 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 t -96.05 147.51 23.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.05 0.452 . . . . 0.0 111.249 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 20.5 m -99.18 156.47 16.95 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -89.51 -39.51 13.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.994 0.426 . . . . 0.0 110.271 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 m -71.55 111.38 6.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.599 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.541 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -61.04 134.45 57.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.544 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.512 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 102.31 -31.02 9.19 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -178.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.512 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.7 m -86.39 119.3 26.51 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m -107.65 136.03 48.09 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.954 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.9 t -66.25 136.12 55.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.027 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.475 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -155.91 -145.57 4.22 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.598 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -40.1 135.0 1.45 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.429 0.691 . . . . 0.0 112.837 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 18.1 t-105 62.54 21.69 12.81 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.142 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.572 ' HE2' ' O ' ' A' ' 5' ' ' CYS . 70.0 tttt 54.91 43.6 29.67 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.245 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.4 tp -113.83 137.5 51.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.997 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.592 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 59.7 m -85.05 126.31 33.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.988 0.423 . . . . 0.0 111.28 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.475 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 1.6 p90 -124.24 130.04 51.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.231 0.538 . . . . 0.0 110.091 178.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.631 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -72.32 143.2 33.96 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.948 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 30' ' ' THR . 11.2 m -138.2 66.2 1.45 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.628 0.728 . . . . 0.0 109.088 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -89.01 115.8 26.84 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.33 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.43 35.33 71.57 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.934 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.94 -5.18 77.2 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.787 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 26' ' ' THR . 14.0 m -84.19 123.13 29.77 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 117.066 0.433 . . . . 0.0 110.135 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 39.4 mm -95.33 133.07 37.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.61 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.631 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 23.0 p90 -152.37 135.26 15.55 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 50.1 t0 . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.098 -178.725 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 64.6 m . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 120.814 0.34 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.71 48.27 2.91 Favored Glycine 0 C--O 1.229 -0.175 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 21.5 mm-40 -80.44 -176.05 5.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.743 -0.729 . . . . 0.0 112.801 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 65.9 m -150.6 63.15 0.94 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.481 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.4 p -72.85 57.03 0.43 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.236 0.541 . . . . 0.0 110.368 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -57.52 -40.36 78.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.808 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.1 mt -80.95 -49.33 11.11 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.814 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.09 -39.72 0.46 Allowed Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 p -86.97 142.5 27.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.269 -0.465 . . . . 0.0 110.86 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.4 m -100.04 162.42 12.99 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -89.56 -50.8 5.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.693 0.282 . . . . 0.0 111.151 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.6 m -64.93 118.7 9.46 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.337 0.589 . . . . 0.0 111.61 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -59.95 133.06 55.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.232 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.01 -27.29 20.66 Favored Glycine 0 N--CA 1.44 -1.08 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.506 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.5 m -83.19 112.89 20.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.897 0.38 . . . . 0.0 109.993 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.6 m -102.19 130.06 48.74 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.011 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 24.4 t -62.79 104.88 0.58 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.222 0.534 . . . . 0.0 110.705 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.47 154.82 49.44 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-O 119.196 -0.78 . . . . 0.0 111.194 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.522 ' C ' ' H ' ' A' ' 21' ' ' LYS . 41.5 tt0 -40.31 -42.77 1.6 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.127 0.971 . . . . 0.0 112.873 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.698 ' CD1' ' HB2' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -73.86 25.73 0.07 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.088 0.47 . . . . 0.0 111.304 179.083 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 19' ' ' GLU . 39.9 tttp 52.17 44.8 29.34 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.579 1.151 . . . . 0.0 111.757 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.698 ' HB2' ' CD1' ' A' ' 20' ' ' TRP . 98.0 mt -139.59 119.25 13.16 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.328 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 16' ' ' SER . 31.9 m -70.96 127.6 33.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.195 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -116.64 127.43 54.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.698 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -75.56 130.51 11.23 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.224 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.728 HG23 HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -133.47 64.53 1.61 Allowed 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -95.45 124.35 39.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.518 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.5 34.81 77.14 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.094 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.98 -0.35 72.91 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.665 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 26' ' ' THR . 7.9 m -89.21 121.13 31.22 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.728 HG12 HG23 ' A' ' 26' ' ' THR . 50.7 mt -102.0 131.37 50.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.54 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.525 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 12.6 p90 -156.7 142.31 17.65 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.039 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.7 t0 . . . . . 0 C--N 1.324 -0.533 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.498 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 39.0 m . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.78 61.76 1.26 Allowed Glycine 0 CA--C 1.517 0.206 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.446 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -146.39 173.29 12.4 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.419 0.628 . . . . 0.0 111.576 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.9 p -150.13 135.41 18.03 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.392 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.576 ' SG ' ' HG3' ' A' ' 21' ' ' LYS . 28.8 p -74.61 61.55 0.97 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.089 0.471 . . . . 0.0 111.803 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.624 ' HD1' ' HG ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -65.4 -35.61 81.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.022 179.138 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.624 ' HG ' ' HD1' ' A' ' 6' ' ' PHE . 90.4 mt -99.24 39.03 1.32 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.205 0.526 . . . . 0.0 110.065 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.87 -49.78 3.52 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.292 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 m -123.57 148.47 46.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.867 0.333 . . . . 0.0 111.114 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.4 m -75.35 164.05 26.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.659 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -88.38 -48.11 7.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.45 0.167 . . . . 0.0 111.336 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.7 m -65.1 116.06 6.1 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.285 0.564 . . . . 0.0 111.042 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -59.77 132.01 52.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.108 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.498 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 101.98 -28.16 17.19 Favored Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.501 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 60.3 m -81.3 112.01 18.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.147 0.499 . . . . 0.0 110.118 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m -98.95 137.92 36.81 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.354 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.8 t -72.32 140.07 48.31 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.895 0.379 . . . . 0.0 110.802 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.444 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -144.51 -156.26 6.75 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -43.24 139.52 1.87 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.549 ' HE3' HD11 ' A' ' 22' ' ' LEU . 4.5 t90 60.06 24.36 13.58 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.343 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.576 ' HG3' ' SG ' ' A' ' 5' ' ' CYS . 22.2 ttmm 58.45 37.4 25.68 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.312 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.549 HD11 ' HE3' ' A' ' 20' ' ' TRP . 89.7 mt -94.84 127.84 41.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.417 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.3 m -88.06 130.84 34.88 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.444 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 3.0 p90 -133.83 128.76 35.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.185 0.517 . . . . 0.0 110.403 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.619 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -70.75 140.06 31.04 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.963 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 30' ' ' THR . 6.7 m -138.56 64.71 1.48 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.538 HD22 ' HZ ' ' A' ' 32' ' ' PHE . 72.9 m-20 -98.46 126.01 43.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.562 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.31 35.71 79.89 Favored Glycine 0 C--O 1.228 -0.228 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.365 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.3 2.79 74.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.735 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 26' ' ' THR . 10.0 m -94.11 122.98 37.18 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 120.681 0.277 . . . . 0.0 110.411 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.619 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 4.5 mp -102.73 131.42 50.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.201 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.583 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 11.6 p90 -151.05 137.55 18.67 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.046 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.9 t70 . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.245 -178.715 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.55 57.83 2.5 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.233 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -138.2 167.74 21.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.655 0.74 . . . . 0.0 111.91 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t -143.8 132.98 23.03 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.185 -1.37 . . . . 0.0 107.583 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.462 ' SG ' ' HG3' ' A' ' 21' ' ' LYS . 28.8 p -73.4 60.87 0.64 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.332 0.587 . . . . 0.0 111.527 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -66.6 -39.7 88.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.6 mt -93.59 38.47 1.06 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.21 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.62 -50.24 3.2 Favored Glycine 0 CA--C 1.52 0.373 0 CA-C-N 115.835 -0.62 . . . . 0.0 113.087 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 m -125.99 149.16 49.01 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.681 -0.305 . . . . 0.0 110.956 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.6 m -74.05 159.33 32.82 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -88.98 -38.73 14.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.44 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 7.2 m -67.5 122.25 17.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.24 0.543 . . . . 0.0 111.393 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -60.41 127.82 33.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.728 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.09 -26.98 22.14 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.509 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.495 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.9 m -79.69 114.8 18.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.197 0.522 . . . . 0.0 110.205 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.7 m -108.6 138.11 45.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.935 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 5' ' ' CYS . 5.9 t -66.68 134.3 51.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.999 0.428 . . . . 0.0 111.085 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -143.3 -155.45 6.43 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.483 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 26.1 tp10 -42.12 137.7 1.82 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 12.4 t90 65.68 20.33 11.53 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.906 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' HG3' ' SG ' ' A' ' 5' ' ' CYS . 15.0 ttmm 56.0 37.78 29.23 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.969 0.89 . . . . 0.0 109.144 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.4 tp -102.67 136.88 41.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.166 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 61.3 m -87.21 127.66 35.15 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.903 0.383 . . . . 0.0 111.256 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -118.77 128.5 54.54 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.625 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -77.64 131.2 10.86 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.835 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.0 t -134.97 67.91 1.48 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 122.045 0.926 . . . . 0.0 109.104 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -89.13 110.6 21.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.3 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.25 36.65 91.39 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.325 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.25 -7.17 72.94 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.101 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 26' ' ' THR . 9.0 m -84.91 122.36 29.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.132 0.466 . . . . 0.0 109.863 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 5.4 tp -96.55 142.85 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.097 0.475 . . . . 0.0 110.715 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.625 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 23.5 p90 -162.08 132.79 4.97 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.4 t70 . . . . . 0 C--N 1.321 -0.665 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.311 -178.426 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.434 ' C ' ' H ' ' A' ' 3' ' ' GLU . 17.8 m . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.34 42.24 1.91 Allowed Glycine 0 CA--C 1.517 0.215 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.682 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 21.2 mm-40 -90.85 171.46 9.3 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 123.713 0.805 . . . . 0.0 111.647 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.0 m -152.07 119.16 5.86 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.76 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.4 p -78.24 48.94 0.78 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.978 0.418 . . . . 0.0 111.502 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.622 ' HD1' ' HG ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -65.56 -32.1 73.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.723 179.34 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.622 ' HG ' ' HD1' ' A' ' 6' ' ' PHE . 96.2 mt -99.19 39.0 1.32 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.129 0.49 . . . . 0.0 109.953 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.99 -41.47 2.61 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.838 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.3 m -136.2 150.04 48.83 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.55 -0.382 . . . . 0.0 110.63 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.4 m -69.25 160.8 30.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.704 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -87.65 -45.5 10.35 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.249 -0.18 . . . . 0.0 111.418 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.8 m -66.18 113.43 4.53 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.435 0.636 . . . . 0.0 110.595 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -59.38 133.14 55.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.432 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.454 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 101.06 -29.47 12.44 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -178.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.481 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 60.8 m -82.48 113.98 20.59 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 15.8 m -103.24 129.02 50.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.295 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.7 t -63.01 130.54 45.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.875 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -137.2 -153.8 6.49 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.901 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -43.41 139.65 1.94 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.613 ' HE3' HD11 ' A' ' 22' ' ' LEU . 3.4 t90 58.1 27.91 15.63 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.805 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' A' ' 21' ' ' LYS . 11.9 ttpt 60.2 34.99 21.03 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.231 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.613 HD11 ' HE3' ' A' ' 20' ' ' TRP . 92.8 mt -101.58 117.32 34.67 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.289 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.682 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 58.2 m -82.38 127.11 32.94 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -117.13 129.54 56.04 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.894 0.378 . . . . 0.0 110.521 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -75.8 135.41 17.95 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.514 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 30' ' ' THR . 1.2 t -144.21 65.22 1.3 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 122.193 0.997 . . . . 0.0 109.098 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.422 HD22 ' HZ ' ' A' ' 32' ' ' PHE . 73.5 m-20 -92.17 120.15 32.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.223 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.31 34.52 74.7 Favored Glycine 0 C--O 1.228 -0.229 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.252 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.15 -6.8 74.12 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.979 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 26' ' ' THR . 7.0 m -84.59 115.87 22.86 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.25 0.525 . . . . 0.0 109.908 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.663 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 62.7 mt -100.41 133.6 42.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.206 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.594 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 8.6 p90 -154.95 140.77 18.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.018 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 C--N 1.323 -0.563 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.125 -179.088 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.16 58.88 1.48 Allowed Glycine 0 C--O 1.229 -0.165 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.929 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -144.73 161.72 38.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.513 0.673 . . . . 0.0 111.344 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.5 m -135.84 129.7 32.79 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.29 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 25.0 p -69.61 65.98 0.21 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -66.85 -38.55 86.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.3 mt -99.11 45.67 0.99 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.359 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.11 -46.94 3.06 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.264 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -136.91 161.09 36.96 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 96.4 m -85.77 177.68 7.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.484 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -88.55 -43.35 11.46 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.2 m -64.36 110.29 2.21 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.423 0.63 . . . . 0.0 110.634 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.48 ' NZ ' ' HB2' ' A' ' 13' ' ' LYS . 4.4 ttmp? -64.58 123.17 18.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.193 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.429 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 117.58 -29.64 6.55 Favored Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 64.2 m -82.23 111.66 18.53 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.219 -0.49 . . . . 0.0 109.863 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 16.1 m -102.12 133.49 46.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.4 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.8 t -67.85 131.42 45.49 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.301 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.22 -140.77 3.22 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-O 119.251 -0.749 . . . . 0.0 111.878 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.453 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 27.7 tp10 -37.08 133.97 0.59 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.642 0.777 . . . . 0.0 112.988 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 42.5 m0 62.94 20.14 12.05 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.553 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.4 tttm 57.72 38.0 27.38 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.748 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.3 mt -113.0 139.82 48.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.298 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 68.7 m -83.99 131.6 34.82 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.391 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -128.24 133.79 48.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.812 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.604 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -70.52 146.09 41.59 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.723 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 30' ' ' THR . 16.9 m -139.92 62.04 1.52 Allowed 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -89.73 116.0 27.51 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.612 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.46 35.39 79.53 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.843 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.99 -4.11 77.08 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.689 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 26' ' ' THR . 16.2 m -84.74 122.4 29.06 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.038 0.419 . . . . 0.0 110.196 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 37.3 mm -98.0 133.59 39.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.311 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.604 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 17.9 p90 -155.34 137.36 14.6 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.7 t70 . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.456 -178.844 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 59.1 m . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.57 48.75 2.28 Favored Glycine 0 N--CA 1.459 0.209 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.591 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 23.5 mm-40 -85.42 174.21 9.7 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.7 0.762 . . . . 0.0 112.854 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.2 m -150.24 74.97 1.22 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.733 -1.122 . . . . 0.0 109.519 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 p -71.25 54.01 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.18 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.671 ' HD1' ' HG ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -65.33 -27.7 68.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.027 0.441 . . . . 0.0 109.996 178.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.671 ' HG ' ' HD1' ' A' ' 6' ' ' PHE . 97.0 mt -95.9 27.13 3.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.71 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.12 -43.07 2.19 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.913 -0.585 . . . . 0.0 113.323 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -99.53 148.91 23.78 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.182 0.515 . . . . 0.0 111.431 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 9.5 m -90.74 158.73 16.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.403 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -88.13 -42.91 12.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.968 0.413 . . . . 0.0 110.347 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.0 m -73.96 105.96 5.44 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.278 0.561 . . . . 0.0 109.941 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -60.35 129.84 43.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.374 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.479 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 111.97 -28.6 9.17 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 -178.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.508 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 61.0 m -86.94 116.03 24.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 16.1 m -91.76 127.99 37.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.338 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.584 ' HB2' ' SG ' ' A' ' 10' ' ' CYS . 50.5 t -66.53 115.62 6.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.211 0.529 . . . . 0.0 111.821 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.93 149.45 22.26 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' A' ' 21' ' ' LYS . 85.3 tt0 -40.33 -44.08 1.87 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.882 0.873 . . . . 0.0 113.067 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -75.6 32.69 0.11 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.434 ' HE3' ' HB3' ' A' ' 21' ' ' LYS . 12.6 ttpp 51.82 49.31 21.04 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.013 0.525 . . . . 0.0 110.262 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.2 tp -141.56 111.09 6.46 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.157 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.591 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 42.7 m -79.68 132.57 36.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.69 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -125.89 128.05 46.98 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.145 0.497 . . . . 0.0 110.257 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -68.7 141.3 36.37 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.59 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 30' ' ' THR . 6.2 m -140.73 64.72 1.42 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.708 0.766 . . . . 0.0 109.056 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.549 HD22 ' HZ ' ' A' ' 32' ' ' PHE . 72.7 m-20 -95.55 122.78 38.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.318 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.76 34.43 77.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.991 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.58 -2.65 71.81 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.754 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 26' ' ' THR . 10.5 m -87.25 121.59 29.91 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 122.556 -0.379 . . . . 0.0 110.168 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.654 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 62.0 mt -102.1 132.17 48.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.591 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.592 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 10.8 p90 -151.9 140.87 21.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.172 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.9 t70 . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.551 -178.971 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.93 62.19 1.3 Allowed Glycine 0 CA--C 1.518 0.221 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.842 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -146.69 -178.67 6.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.409 0.623 . . . . 0.0 111.425 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.3 m -150.71 119.16 6.43 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.087 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.421 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 1.3 p -73.61 60.83 0.69 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.253 0.549 . . . . 0.0 110.831 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -57.26 -41.37 79.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.745 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.444 HD12 ' H ' ' A' ' 9' ' ' THR . 2.1 pp -97.58 28.17 3.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.623 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.33 -41.18 2.24 Favored Glycine 0 CA--C 1.518 0.239 0 CA-C-N 115.681 -0.69 . . . . 0.0 113.165 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.444 ' H ' HD12 ' A' ' 7' ' ' LEU . 9.0 m -101.7 144.87 29.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.852 0.358 . . . . 0.0 111.097 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 30.3 m -96.61 164.16 12.72 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -88.74 -48.62 7.38 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.122 -0.231 . . . . 0.0 111.285 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.0 m -66.17 116.48 7.29 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.437 0.637 . . . . 0.0 110.921 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.506 ' HD2' ' N ' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -62.48 132.8 53.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.354 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.49 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 105.51 -30.4 9.91 Favored Glycine 0 N--CA 1.441 -1.007 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -178.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.505 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 49.9 m -82.56 115.4 21.52 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m -105.24 139.73 39.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.812 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.9 t -62.6 128.36 35.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.347 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -143.03 -159.57 8.0 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.865 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.555 ' HG2' ' CD1' ' A' ' 20' ' ' TRP . 36.4 tt0 -42.63 140.74 1.2 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.611 0.764 . . . . 0.0 112.639 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.555 ' CD1' ' HG2' ' A' ' 19' ' ' GLU . 41.1 m0 64.57 18.67 11.5 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.226 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.0 tptm 58.56 37.09 25.49 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.67 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.7 mt -103.63 139.75 38.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.387 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 69.2 m -84.8 125.34 32.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.298 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -123.1 123.65 41.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.871 0.367 . . . . 0.0 111.193 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.537 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -73.23 130.6 13.84 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.716 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.759 HG23 HG13 ' A' ' 31' ' ' ILE . 1.1 m -129.74 68.3 1.44 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.501 0.667 . . . . 0.0 109.225 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.535 HD22 ' HZ ' ' A' ' 32' ' ' PHE . 75.2 m-20 -98.7 127.56 44.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.877 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.9 36.33 79.82 Favored Glycine 0 C--O 1.228 -0.239 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.233 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.89 4.65 72.36 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.611 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 26' ' ' THR . 12.3 m -95.75 123.71 39.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.759 HG13 HG23 ' A' ' 26' ' ' THR . 4.8 mp -102.37 129.59 53.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.149 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.537 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 13.6 p90 -150.33 138.98 20.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.122 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.4 t0 . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.538 -179.015 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.51 54.21 1.98 Allowed Glycine 0 C--N 1.324 -0.135 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.426 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.681 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 97.0 mt-10 -139.26 152.3 47.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.416 0.627 . . . . 0.0 110.899 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.575 ' HB3' ' HE3' ' A' ' 21' ' ' LYS . 30.4 m -130.03 135.34 48.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.035 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 22.7 p -74.1 55.07 0.56 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.258 0.551 . . . . 0.0 111.635 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -64.1 -36.55 84.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.724 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 25.0 tp -98.8 41.47 1.14 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.857 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.07 -42.1 2.49 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.913 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 m -142.47 152.37 42.66 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.681 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 94.7 m -77.77 -157.27 0.1 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.02 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -117.35 -44.68 2.76 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -68.11 110.54 4.02 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.389 0.614 . . . . 0.0 110.681 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -62.73 122.92 17.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.248 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.86 -27.12 7.64 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 61.2 m -82.46 113.67 20.37 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 16.9 m -98.64 131.51 44.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.329 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 2.8 t -67.83 139.32 56.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.853 0.359 . . . . 0.0 111.025 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.421 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -152.41 -149.07 5.02 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-O 119.496 -0.614 . . . . 0.0 111.7 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.455 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 28.5 tp10 -39.6 135.46 1.15 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.541 0.736 . . . . 0.0 112.756 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 43.1 m0 64.51 19.54 11.84 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.851 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.575 ' HE3' ' HB3' ' A' ' 4' ' ' SER . 34.6 ttpt 59.73 38.21 21.81 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.592 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.9 mt -108.33 134.08 51.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.406 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 32.6 m -87.39 131.74 34.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.213 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.421 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 2.7 p90 -124.14 128.82 49.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.084 0.469 . . . . 0.0 109.883 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.631 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -71.65 142.29 33.43 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.858 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.9 t -143.81 63.77 1.34 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 122.17 0.986 . . . . 0.0 109.115 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -89.35 114.8 26.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.297 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.7 33.14 71.34 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.178 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.05 -8.93 76.64 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.653 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 26' ' ' THR . 3.5 m -80.32 116.24 20.29 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.631 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 63.3 mt -98.47 131.62 45.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.771 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.61 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 12.6 p90 -153.18 136.56 15.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.015 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 50.3 t0 . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.808 -178.903 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 54.5 m . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.16 56.17 1.88 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.462 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -141.76 158.84 43.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.6 0.714 . . . . 0.0 111.515 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.4 m -136.99 134.98 37.22 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.496 -1.229 . . . . 0.0 107.817 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.5 p -72.55 56.41 0.38 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.198 0.523 . . . . 0.0 111.769 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -66.51 -39.28 88.58 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.99 39.91 1.01 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.998 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.11 -51.92 3.27 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.121 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 m -127.05 152.27 47.49 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 122.73 -0.276 . . . . 0.0 110.862 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.7 m -71.2 159.8 34.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.122 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -90.4 -45.27 9.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.622 0.249 . . . . 0.0 111.302 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.3 m -70.71 112.35 6.86 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.304 0.573 . . . . 0.0 110.844 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -58.91 131.98 52.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.598 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.449 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 105.87 -27.59 17.04 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.503 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.1 m -86.73 117.43 25.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m -106.0 135.24 47.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.441 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 t -68.42 139.23 55.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.829 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.47 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -152.41 -154.21 6.58 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-O 119.576 -0.569 . . . . 0.0 111.704 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.458 ' O ' ' HG ' ' A' ' 22' ' ' LEU . 36.9 tt0 -39.06 138.53 0.57 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.567 0.747 . . . . 0.0 112.564 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.471 ' HB3' HD23 ' A' ' 22' ' ' LEU . 9.0 t90 65.62 15.49 10.07 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.071 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.9 tttp 58.84 38.76 24.54 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.527 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.471 HD23 ' HB3' ' A' ' 20' ' ' TRP . 4.3 pp -107.97 144.38 35.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.809 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 61.5 m -92.47 127.98 38.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.921 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.47 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 1.9 p90 -119.54 128.85 54.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.092 0.472 . . . . 0.0 110.36 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 15' ' ' CYS . . . -80.93 141.75 22.77 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.669 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 30' ' ' THR . 48.2 m -148.85 104.97 3.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.132 0.491 . . . . 0.0 110.437 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -150.38 147.03 27.08 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.75 33.03 76.02 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.008 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.41 27.02 72.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.396 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 26' ' ' THR . 17.7 m -125.08 132.32 53.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.685 0.278 . . . . 0.0 110.397 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 58.9 mt -112.24 133.87 56.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.889 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -152.81 140.89 20.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.395 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.9 t70 . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.489 -179.162 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.85 53.96 1.7 Allowed Glycine 0 C--O 1.23 -0.136 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.709 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.61 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 53.8 mt-10 -140.71 155.24 46.51 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.157 0.503 . . . . 0.0 110.818 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 p -127.3 135.47 50.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.746 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.583 ' SG ' ' HG3' ' A' ' 21' ' ' LYS . 26.5 p -71.25 94.6 1.2 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -67.22 -34.37 77.34 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.5 mt -114.85 -129.79 0.3 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.451 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.35 -36.73 92.05 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.821 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.0 t -162.8 -172.52 3.12 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.61 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 96.7 m -86.77 -176.71 5.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.764 0.316 . . . . 0.0 111.491 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -90.96 -36.12 14.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.109 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.667 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -61.31 116.57 4.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.223 0.535 . . . . 0.0 111.087 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -61.41 132.32 53.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.993 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.492 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 95.9 -24.43 29.81 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.578 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.667 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 59.2 m -81.38 113.1 19.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.19 0.519 . . . . 0.0 110.481 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.4 m -102.11 136.56 41.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.729 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.1 t -68.84 142.57 54.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.962 0.411 . . . . 0.0 111.213 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.435 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -146.35 -158.74 7.89 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.486 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -44.47 141.72 1.84 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 62.47 20.73 12.13 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.037 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.583 ' HG3' ' SG ' ' A' ' 5' ' ' CYS . 21.3 ttmm 58.86 37.94 24.68 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.953 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.41 127.83 49.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.141 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 64.4 m -89.14 134.63 33.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.137 0.494 . . . . 0.0 111.572 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.435 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 1.4 p90 -125.58 129.42 49.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.015 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -81.5 143.46 23.65 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.86 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 30' ' ' THR . 8.5 m -141.27 66.23 1.37 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.769 0.795 . . . . 0.0 108.981 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -89.52 120.02 30.47 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.385 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.86 36.25 72.03 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.086 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.5 -4.68 71.92 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.962 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 26' ' ' THR . 7.5 m -86.28 119.21 26.31 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 117.113 0.457 . . . . 0.0 110.263 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 56.8 mt -98.05 132.55 42.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.511 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.531 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 12.2 p90 -153.34 142.53 21.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.222 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.3 t70 . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.994 -179.311 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 82.9 m . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.34 57.23 2.41 Favored Glycine 0 C--N 1.323 -0.144 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.784 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -137.01 -178.13 5.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.515 0.674 . . . . 0.0 111.152 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.6 m -151.44 127.68 10.55 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.157 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 p -75.12 55.96 0.76 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.225 0.536 . . . . 0.0 111.293 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -64.9 -30.37 71.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.201 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.5 tp -103.6 37.76 1.95 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.243 0.544 . . . . 0.0 109.859 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.61 -40.44 2.03 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.087 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -130.19 157.19 43.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.995 0.426 . . . . 0.0 111.087 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.5 m -83.3 165.2 19.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.635 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -89.77 -46.69 8.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.793 0.33 . . . . 0.0 111.065 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.6 m -66.36 118.42 10.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.342 0.591 . . . . 0.0 110.943 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.562 ' HD3' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -58.04 134.03 56.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.664 0.745 . . . . 0.0 111.72 -179.236 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.56 -27.55 19.62 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.531 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.541 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 55.8 m -77.81 111.49 13.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.447 0.641 . . . . 0.0 110.149 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -90.41 138.22 31.72 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.774 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.5 t -60.3 124.62 20.86 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.359 0.599 . . . . 0.0 111.433 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.31 147.36 20.73 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -43.68 -46.29 7.36 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.093 0.557 . . . . 0.0 112.352 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 20.7 m-90 -78.57 37.09 0.27 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.579 0.228 . . . . 0.0 111.473 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 79.8 tttt 55.47 37.61 29.12 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.331 0.652 . . . . 0.0 111.015 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.2 mt -106.95 -161.01 0.76 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.893 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 93.2 m -151.27 126.66 10.02 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -127.89 117.11 21.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.127 0.489 . . . . 0.0 111.202 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.553 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -68.22 127.13 23.79 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.758 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.527 HG23 HG12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -122.89 67.79 0.97 Allowed 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.306 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -88.89 113.47 24.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.702 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.67 38.51 88.22 Favored Glycine 0 C--O 1.228 -0.258 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.485 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.91 -3.98 77.35 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.104 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 26' ' ' THR . 13.6 m -87.71 124.91 34.06 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 117.124 0.462 . . . . 0.0 109.846 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.527 HG12 HG23 ' A' ' 26' ' ' THR . 66.6 mt -102.16 128.23 54.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.042 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.553 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 17.7 p90 -150.06 135.97 18.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.422 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.8 t0 . . . . . 0 C--N 1.324 -0.535 0 CA-C-O 120.758 0.314 . . . . 0.0 110.573 -178.662 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 80.9 m . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.31 63.18 0.79 Allowed Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.0 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -147.75 -178.45 6.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.514 0.673 . . . . 0.0 111.229 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.564 ' HB2' ' HE2' ' A' ' 21' ' ' LYS . 35.7 p -151.56 124.46 8.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.159 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.66 59.54 0.65 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.095 0.474 . . . . 0.0 111.688 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -62.63 -36.57 83.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.744 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.2 tp -97.78 35.89 1.62 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.844 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.93 -45.25 2.2 Favored Glycine 0 CA--C 1.52 0.388 0 CA-C-N 115.911 -0.586 . . . . 0.0 113.251 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 t -116.64 153.12 32.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.91 0.386 . . . . 0.0 111.237 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.7 m -89.96 166.04 13.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.264 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -89.12 -47.44 8.09 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.489 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.5 m -62.08 115.6 4.23 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.471 0.653 . . . . 0.0 110.624 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -63.49 127.03 29.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.369 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.546 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 110.89 -27.94 10.45 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -178.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.525 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 58.0 m -83.88 115.45 22.28 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.3 m -102.32 141.01 35.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.908 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.65 147.49 47.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.353 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.499 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -168.19 -149.58 6.19 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.944 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -35.23 131.92 0.41 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.283 1.033 . . . . 0.0 113.361 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 58.28 24.27 11.34 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.734 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.564 ' HE2' ' HB2' ' A' ' 4' ' ' SER . 1.2 ttpm? 59.16 44.92 15.13 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.6 mt -107.81 148.72 29.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.109 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.1 m -98.64 127.68 44.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.71 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.499 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 3.0 p90 -129.83 123.7 31.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.331 0.586 . . . . 0.0 110.759 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 14' ' ' GLY . . . -80.16 141.81 23.55 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.487 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 30' ' ' THR . 24.0 m -130.16 112.65 13.6 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.973 0.415 . . . . 0.0 110.024 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -143.98 134.94 25.37 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.83 35.61 87.22 Favored Glycine 0 C--O 1.229 -0.212 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.068 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.1 22.95 71.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.391 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 26' ' ' THR . 19.3 m -120.2 131.9 55.16 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.6 mt -106.54 130.66 57.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.137 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -142.1 139.68 32.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.315 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.5 t70 . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.469 -178.825 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.57 54.97 2.04 Favored Glycine 0 C--O 1.229 -0.177 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.473 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -140.58 159.46 42.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.639 0.733 . . . . 0.0 111.355 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.4 t -140.91 137.62 33.28 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.7 p -70.03 64.29 0.23 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.09 0.471 . . . . 0.0 111.942 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -71.01 -32.27 69.01 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.6 tp -103.4 38.46 1.78 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.354 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.12 -48.11 3.0 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.985 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.2 m -122.6 150.53 42.51 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 122.714 -0.286 . . . . 0.0 110.901 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.8 m -74.01 165.11 25.72 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.828 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -89.07 -43.45 11.07 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 120.669 0.271 . . . . 0.0 110.698 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.8 m -74.16 109.69 7.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.568 0.699 . . . . 0.0 110.321 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.968 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -66.03 119.26 11.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.889 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.442 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 124.13 -29.1 5.18 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -177.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.479 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 61.3 m -87.71 114.96 24.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.056 -0.572 . . . . 0.0 109.798 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 20.4 m -97.28 134.27 40.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.175 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 3.9 t -70.26 110.87 5.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.114 0.483 . . . . 0.0 110.382 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.47 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -82.26 159.77 39.48 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.783 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' A' ' 21' ' ' LYS . 9.2 tp10 -34.99 -47.34 0.36 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.978 1.311 . . . . 0.0 113.732 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 7.6 t90 -75.87 29.08 0.11 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.352 0.596 . . . . 0.0 110.965 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.496 ' H ' ' C ' ' A' ' 19' ' ' GLU . 40.5 tttm 50.49 41.05 24.66 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.184 0.994 . . . . 0.0 111.444 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.8 mt -129.21 121.49 27.76 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.187 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 16' ' ' SER . 49.8 m -74.31 129.93 38.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.614 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.47 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 2.7 p90 -133.13 133.53 43.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.051 0.453 . . . . 0.0 110.058 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -71.25 148.81 44.71 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.725 -0.67 . . . . 0.0 113.359 -178.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 30' ' ' THR . 9.1 m -147.28 60.3 1.17 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.136 0.97 . . . . 0.0 108.485 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -90.08 120.73 31.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.878 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.19 36.5 75.54 Favored Glycine 0 C--O 1.228 -0.278 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.261 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.46 1.34 86.17 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.851 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 26' ' ' THR . 11.4 m -92.86 120.91 33.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.975 0.387 . . . . 0.0 110.127 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 4.5 mp -99.81 132.96 44.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.264 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.598 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 14.0 p90 -151.98 137.32 17.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.984 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.1 t0 . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.982 -178.878 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 37.7 m . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.92 60.7 1.34 Allowed Glycine 0 N--CA 1.454 -0.158 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.53 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -148.04 168.72 21.62 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.652 0.739 . . . . 0.0 111.745 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.5 t -149.68 141.23 23.43 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.694 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.0 p -69.77 64.5 0.21 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.967 0.413 . . . . 0.0 111.618 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -74.98 -31.4 61.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.93 0.395 . . . . 0.0 110.159 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 25.9 tp -103.89 45.59 0.95 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.509 0.671 . . . . 0.0 109.374 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.98 -47.38 3.33 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.516 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -137.48 164.17 29.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.627 0.251 . . . . 0.0 110.581 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.3 m -78.79 158.69 28.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.559 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -88.47 -46.53 9.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.413 0.149 . . . . 0.0 111.279 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.7 m -64.06 113.82 3.75 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.275 0.56 . . . . 0.0 110.765 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -61.1 130.9 48.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.676 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.526 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 105.36 -31.47 8.47 Favored Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.492 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 62.4 m -83.3 117.16 22.79 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.8 m -109.56 136.79 48.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.508 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.9 t -68.5 134.17 49.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.957 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.4 ' HA3' ' OH ' ' A' ' 24' ' ' TYR . . . -151.48 -145.6 4.16 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.352 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.463 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 26.6 tp10 -39.01 136.24 0.81 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 8.2 t90 62.53 21.53 12.7 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.137 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.8 tttm 56.76 39.37 29.68 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.886 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.62 137.74 47.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.39 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 17' ' ' CYS . 86.3 m -85.88 129.06 34.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.514 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.4 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 2.3 p90 -135.03 135.34 41.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.036 0.446 . . . . 0.0 110.459 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.643 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -70.59 148.54 45.37 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.754 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 30' ' ' THR . 3.3 t -145.59 62.35 1.27 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.307 1.051 . . . . 0.0 109.368 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -89.22 115.96 27.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.585 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.17 35.57 78.23 Favored Glycine 0 C--O 1.227 -0.302 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.157 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.1 -5.43 76.53 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.858 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 26' ' ' THR . 10.2 m -85.2 118.3 24.67 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 117.045 0.422 . . . . 0.0 109.937 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.643 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 64.3 mt -99.4 132.4 44.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.713 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.636 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 10.8 p90 -149.09 136.57 20.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.865 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.6 t70 . . . . . 0 C--N 1.322 -0.591 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.406 -178.464 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 62.5 m . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.34 52.18 2.61 Favored Glycine 0 C--O 1.228 -0.267 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 177.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.651 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 32.8 mm-40 -114.35 160.9 18.59 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.71 -0.745 . . . . 0.0 111.965 -177.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.2 m -151.72 118.65 5.82 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.927 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.3 p -73.59 67.93 1.15 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.068 0.461 . . . . 0.0 111.904 -178.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -58.52 -40.85 84.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.044 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.4 pp -109.22 38.37 2.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.847 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.18 -44.39 2.63 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.865 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 m -101.11 144.62 29.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.66 0.267 . . . . 0.0 110.922 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.4 m -85.06 163.67 18.69 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -87.84 -43.25 11.96 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.623 0.249 . . . . 0.0 110.617 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.444 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 53.1 m -72.71 100.81 2.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.145 0.497 . . . . 0.0 110.037 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 13' ' ' LYS . 12.2 ttpp -60.83 106.32 0.56 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.255 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.487 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 137.44 -21.94 3.23 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.483 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 59.4 m -97.74 122.02 40.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.509 -0.846 . . . . 0.0 110.002 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.6 m -103.83 131.04 51.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.673 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 2.5 t -61.53 135.02 57.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.176 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.23 -144.72 3.98 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.108 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -38.3 133.96 0.9 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.717 0.807 . . . . 0.0 112.962 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 61.12 23.79 13.95 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.165 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.0 tttp 58.56 35.59 24.66 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.907 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.9 mt -109.87 132.52 54.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.741 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.651 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 30.4 m -84.38 133.23 34.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.778 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -120.53 133.68 55.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.098 0.475 . . . . 0.0 110.314 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.507 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -75.06 139.28 24.82 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.431 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 30' ' ' THR . 5.5 m -124.1 72.08 1.15 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.387 0.613 . . . . 0.0 109.795 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -89.06 116.48 27.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.023 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.08 34.32 72.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.265 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.44 -3.08 86.06 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.685 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 26' ' ' THR . 7.1 m -88.15 124.2 33.57 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.769 0.284 . . . . 0.0 110.256 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 4.2 mp -97.12 127.92 48.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.596 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.507 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 17.3 p90 -143.78 140.98 30.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.674 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.4 t70 . . . . . 0 C--N 1.321 -0.631 0 CA-C-O 121.072 0.463 . . . . 0.0 112.025 -178.386 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 81.2 m . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.05 58.8 1.43 Allowed Glycine 0 CA--C 1.517 0.19 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.743 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -141.27 -176.73 4.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.468 0.652 . . . . 0.0 110.878 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 m -151.15 124.81 9.03 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.491 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.2 p -77.32 54.59 1.13 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.958 0.408 . . . . 0.0 111.593 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.641 ' HD1' ' HG ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -62.39 -33.25 74.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.294 179.214 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.641 ' HG ' ' HD1' ' A' ' 6' ' ' PHE . 99.0 mt -96.13 32.08 2.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.91 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.25 -47.69 3.23 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.802 -0.635 . . . . 0.0 113.336 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.1 p -114.29 149.22 36.27 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 122.545 -0.385 . . . . 0.0 112.014 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.5 m -79.78 163.47 24.42 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -89.94 -48.43 7.23 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.911 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.3 m -64.84 117.38 7.45 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.43 0.633 . . . . 0.0 110.669 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -62.51 128.23 35.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.4 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.572 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 110.8 -27.67 10.84 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -178.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.561 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.6 m -80.55 116.32 20.53 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.7 m -94.64 137.84 33.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.221 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 22' ' ' LEU . 12.1 t -76.92 122.23 24.56 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.193 0.521 . . . . 0.0 111.866 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 20' ' ' TRP . . . -91.76 144.86 17.4 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.441 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 3.5 tp10 -69.95 42.46 0.05 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.505 1.145 . . . . 0.0 113.158 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.48 ' H ' ' C ' ' A' ' 18' ' ' GLY . 96.6 m95 -133.08 12.72 4.27 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 175.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER 62.51 39.55 11.6 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 111.865 -2.425 . . . . 0.0 109.272 -178.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 17' ' ' CYS . 90.1 mt -116.11 178.71 4.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.48 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 93.9 m -141.75 127.53 19.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.466 0.174 . . . . 0.0 110.63 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -133.36 122.71 24.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.292 0.567 . . . . 0.0 110.835 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 14' ' ' GLY . . . -77.63 150.04 35.84 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.458 -0.792 . . . . 0.0 113.343 -179.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 30' ' ' THR . 6.6 t -132.21 123.29 26.72 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.349 0.595 . . . . 0.0 109.762 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -150.56 129.18 12.27 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.68 35.27 85.49 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.168 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.89 23.44 74.26 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.476 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 26' ' ' THR . 23.6 m -118.3 132.09 56.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.8 mm -103.38 130.93 52.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.431 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -144.71 129.96 18.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.88 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.9 t70 . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.361 -178.519 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.58 55.16 2.05 Favored Glycine 0 C--N 1.321 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.984 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.53 ' OE2' ' HB2' ' A' ' 11' ' ' TYR . 57.7 mt-10 -135.17 154.42 51.63 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.192 0.52 . . . . 0.0 111.109 -178.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 t -137.85 132.91 33.26 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.66 ' SG ' ' HE2' ' A' ' 21' ' ' LYS . 8.5 p -69.27 85.56 0.39 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.228 0.537 . . . . 0.0 111.808 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -67.55 -34.62 77.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.483 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.55 39.77 3.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.714 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.86 -40.66 2.3 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.791 -0.64 . . . . 0.0 113.187 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.2 m -102.02 148.89 24.83 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.678 -0.307 . . . . 0.0 111.074 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 35.0 m -85.22 -155.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.53 ' HB2' ' OE2' ' A' ' 3' ' ' GLU . 16.9 m-85 -127.69 -49.71 1.37 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.453 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.437 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 98.6 m -72.32 121.93 20.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.196 0.522 . . . . 0.0 110.538 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -61.21 127.77 33.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.766 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.5 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 106.61 -29.23 11.23 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -178.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.507 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 59.2 m -81.59 120.76 25.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.916 0.389 . . . . 0.0 110.15 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.4 m -112.54 132.33 55.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.214 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 3.8 t -65.7 137.47 57.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.759 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -160.28 -148.88 5.4 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.661 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.504 ' O ' ' HG ' ' A' ' 22' ' ' LEU . 5.8 tp10 -40.81 143.0 0.4 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.889 0.876 . . . . 0.0 113.125 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 12.9 t-105 66.52 17.61 10.67 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.071 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.66 ' HE2' ' SG ' ' A' ' 5' ' ' CYS . 0.2 OUTLIER 56.64 45.18 22.56 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.171 179.406 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 19' ' ' GLU . 4.6 pp -133.42 151.24 51.79 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.649 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 17' ' ' CYS . 78.8 m -89.5 131.11 35.7 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.026 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -128.96 133.51 47.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.038 0.447 . . . . 0.0 110.034 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.744 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -69.85 142.32 36.26 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.45 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.8 t -150.46 62.86 0.95 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.841 0.829 . . . . 0.0 110.084 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.494 ' OD1' ' HB ' ' A' ' 30' ' ' THR . 15.2 p-10 -89.9 112.98 24.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.589 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.99 34.06 65.06 Favored Glycine 0 C--O 1.227 -0.3 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.664 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.88 -14.54 65.15 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.06 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 26' ' ' THR . 2.3 m -75.15 114.42 13.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.292 0.546 . . . . 0.0 109.793 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.626 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 30.9 mm -102.71 135.31 40.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.141 -179.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.744 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 7.2 p90 -158.5 137.47 11.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.895 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.69 -178.855 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.422 ' C ' ' H ' ' A' ' 3' ' ' GLU . 53.3 m . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.11 46.0 2.37 Favored Glycine 0 C--O 1.229 -0.204 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.678 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 40.3 mm-40 -111.62 159.72 17.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.654 -0.773 . . . . 0.0 111.488 -178.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.1 t -151.01 131.93 14.2 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.76 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.464 ' SG ' ' HD2' ' A' ' 21' ' ' LYS . 22.9 p -79.07 51.8 1.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.044 0.449 . . . . 0.0 111.391 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -66.63 -32.94 74.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.923 0.392 . . . . 0.0 110.065 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 26.2 tp -100.02 40.17 1.27 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.423 0.63 . . . . 0.0 109.583 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.52 -43.02 2.68 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.026 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.4 m -138.06 149.06 45.66 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.416 -0.461 . . . . 0.0 110.845 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.6 m -68.88 159.38 32.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.894 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -88.01 -42.7 12.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.63 0.252 . . . . 0.0 111.288 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.466 ' HB ' ' HG3' ' A' ' 3' ' ' GLU . 71.2 m -71.93 106.54 4.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.366 0.603 . . . . 0.0 110.833 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.14 127.38 31.65 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.468 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.51 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 110.9 -28.29 10.05 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.636 -0.985 . . . . 0.0 110.636 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.506 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 62.7 m -85.59 119.03 25.48 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.6 m -102.84 132.01 49.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.597 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 4.0 t -63.09 140.75 58.9 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.074 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.46 -154.0 6.5 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.196 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -43.24 142.84 0.95 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.418 0.687 . . . . 0.0 112.755 -178.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 17.9 t-105 62.56 20.4 11.95 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.121 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.464 ' HD2' ' SG ' ' A' ' 5' ' ' CYS . 3.3 tppp? 57.84 38.85 27.26 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.499 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.1 tp -113.18 131.59 55.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.952 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.678 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 32.0 m -88.79 138.15 31.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.206 0.527 . . . . 0.0 111.451 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -132.38 134.24 44.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.82 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.758 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -67.56 142.67 40.96 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.743 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 30' ' ' THR . 3.2 t -150.82 62.47 0.93 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.813 0.816 . . . . 0.0 110.346 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.418 ' OD1' ' HB ' ' A' ' 30' ' ' THR . 15.1 p-10 -89.83 113.64 25.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.213 0.53 . . . . 0.0 110.728 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.9 34.71 61.88 Favored Glycine 0 C--O 1.227 -0.286 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.804 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.13 -14.54 65.06 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.047 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 26' ' ' THR . 2.3 m -75.22 113.39 12.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.266 0.533 . . . . 0.0 109.733 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.611 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 28.9 mm -103.05 135.58 39.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.201 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.758 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 6.9 p90 -159.63 138.29 10.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.949 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.44 -179.069 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 57.4 m . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 121.2 0.524 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.03 61.22 1.75 Allowed Glycine 0 C--O 1.23 -0.13 0 CA-C-N 115.031 -0.986 . . . . 0.0 113.125 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.459 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 13.2 mt-10 -139.58 -172.07 3.28 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.87 0.367 . . . . 0.0 110.496 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t -150.81 115.21 5.13 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.649 179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 p -79.34 55.94 2.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.343 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.872 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 25.1 t80 -56.5 -40.74 75.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.404 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 54.7 tp -76.86 -49.27 16.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.549 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.24 -38.51 0.16 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.3 m -141.37 143.46 33.99 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.459 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 83.0 m -76.76 -176.79 4.0 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 123.256 0.347 . . . . 0.0 111.013 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -89.12 -40.16 13.11 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.4 m -62.19 111.64 2.05 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.324 0.583 . . . . 0.0 110.854 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -64.86 118.42 9.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.627 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.66 -28.84 5.82 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 61.3 m -80.03 114.1 18.69 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.3 m -101.08 136.55 40.75 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.794 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.6 t -67.61 133.82 50.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.081 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.89 -154.12 6.49 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.478 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -41.69 140.58 0.95 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.549 0.74 . . . . 0.0 112.681 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 11.0 t90 66.71 16.12 10.3 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.135 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.872 ' HE3' ' HA ' ' A' ' 6' ' ' PHE . 56.9 tttp 57.32 41.43 26.6 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.833 0.825 . . . . 0.0 109.04 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.7 tp -116.52 145.0 43.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.647 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 87.4 m -92.49 131.85 37.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.178 0.514 . . . . 0.0 111.615 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -121.47 127.9 51.55 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.679 ' O ' ' HA ' ' A' ' 31' ' ' ILE . . . -70.3 142.18 35.28 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.152 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.2 t -148.61 60.02 1.08 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 122.584 1.183 . . . . 0.0 108.257 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -89.14 110.85 21.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.294 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.28 34.16 87.15 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.002 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.74 -11.36 68.94 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.764 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 26' ' ' THR . 2.3 m -78.83 114.88 18.13 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.977 0.388 . . . . 0.0 110.002 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.679 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 60.5 mt -100.22 132.99 44.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.64 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.576 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 8.0 p90 -158.78 142.02 14.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.323 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.8 t70 . . . . . 0 C--N 1.323 -0.569 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.442 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 57.2 m . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.07 58.27 2.28 Favored Glycine 0 C--O 1.228 -0.259 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.592 ' HB2' ' HB2' ' A' ' 23' ' ' CYS . 2.5 mm-40 -106.21 179.3 4.31 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.6 m -150.02 83.15 1.38 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.836 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.572 ' O ' ' HE2' ' A' ' 21' ' ' LYS . 1.9 p -72.87 56.57 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.883 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -58.53 -34.23 70.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.814 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.5 tp -95.83 24.19 5.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.279 0.561 . . . . 0.0 110.174 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.96 -39.44 2.23 Favored Glycine 0 C--O 1.228 -0.278 0 CA-C-N 116.002 -0.544 . . . . 0.0 113.192 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 t -96.05 147.51 23.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.05 0.452 . . . . 0.0 111.249 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 20.5 m -99.18 156.47 16.95 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -89.51 -39.51 13.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.994 0.426 . . . . 0.0 110.271 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 m -71.55 111.38 6.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.599 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.541 ' H ' ' HD2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -61.04 134.45 57.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.544 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.512 ' O ' ' HA2' ' A' ' 25' ' ' GLY . . . 102.31 -31.02 9.19 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -178.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.512 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.7 m -86.39 119.3 26.51 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m -107.65 136.03 48.09 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.954 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.9 t -66.25 136.12 55.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.027 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.475 ' HA3' ' CE2' ' A' ' 24' ' ' TYR . . . -155.91 -145.57 4.22 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.598 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -40.1 135.0 1.45 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.429 0.691 . . . . 0.0 112.837 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 18.1 t-105 62.54 21.69 12.81 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.142 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.572 ' HE2' ' O ' ' A' ' 5' ' ' CYS . 70.0 tttt 54.91 43.6 29.67 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.245 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.4 tp -113.83 137.5 51.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.997 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.592 ' HB2' ' HB2' ' A' ' 3' ' ' GLU . 59.7 m -85.05 126.31 33.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.988 0.423 . . . . 0.0 111.28 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.475 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 1.6 p90 -124.24 130.04 51.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.231 0.538 . . . . 0.0 110.091 178.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.631 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -72.32 143.2 33.96 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.948 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 30' ' ' THR . 11.2 m -138.2 66.2 1.45 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.628 0.728 . . . . 0.0 109.088 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -89.01 115.8 26.84 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.33 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.43 35.33 71.57 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.934 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.94 -5.18 77.2 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.787 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 26' ' ' THR . 14.0 m -84.19 123.13 29.77 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 117.066 0.433 . . . . 0.0 110.135 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 39.4 mm -95.33 133.07 37.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.61 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.631 ' CE1' ' HA3' ' A' ' 25' ' ' GLY . 23.0 p90 -152.37 135.26 15.55 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 50.1 t0 . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.098 -178.725 . . . . . . . . 0 0 . 1 stop_ save_